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Abstract 
ABSTRACT 
This thesis describes tfid UV-visible, fluorescence quenching, 
fluorescence enhancement, resonance Rayleigh scattering (RRS), second-order 
scattering (SOS) and frequency doubling scattering (FDS) n^ethods of analysis 
of drugs and their interaction with metal ions. In some cases the drug has also 
been analysed in pharmaceutical formulations by its ion-association reaction 
with metal ions. The sensitivity of these methods has also been compared with 
trivial analytical techniques. The stability constant and molar ratio of drug to 
metal has been determined by UV and fluorescence spectrophotometery. 
First part of the thesis reports spectrophotometric investigation of the 
interaction of Cefpodoxime proxetil (CFP) with Ca(II), Mg(II), Mn(II), Fe(III), 
Co(II), Ni(II), Cu(II) and Zn(II) in acidic medium which showed the formation 
of 1:1 complex. The linearity of CFP was followed in the range 2xl0'^-6xl0 ' 
mg/ml and the correlation factor (R )^ was found to be 0.9236. The absorption 
spectrum of pure drug exhibits two prominent peaks at 270 and 345 nm, but its 
spectra scanned at several pH exhibited two isosbestic points (305 and 330 nm) 
indicating the presence of zwitterionic condition of drug in solution phase. The 
fluorescence emission spectra of CFP in presence of different concentrations of 
metal ions showed enhancement in fluorescence intensity which is ascribed to 
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chelating enhancement fluorescence effect (CHEF). The stoichiometry of the 
complexes was determined by Job's and Benesi-Hildebrand method. The 
stability of the complexes between CFP and metal ions follows the 
order Ca(II)<Mg(II)<Co(II)<Ni(II)<Zn(II)<Mn(II)<Cu(II)<Fe(III). Considering 
the dependence of the binding constant on the temperature a thermodynamic 
process was considered to be responsible for this interaction. The AG, AH and 
AS were, therefore, analyzed to understand the forces acting between drug and 
metal ions. 
The second chapter describes the fluorescence quenching of 
ciprofloxacin by Fe(III) and Zn(II). Absorbance and fluorescence spectral 
pattern of ciprofloxacin in the absence and presence of metal ions has been 
studied at room temperature under physiological condition. The fluorescence 
spectra of drug in presence of different concentrations of the Fe(III) and Zn(Il) 
showed the quenching of intensity of ciprofloxacin. It was observed that with 
increasing concentration of the quencher (metal ions) the emission intensity 
decreases with negligible variation in the peak position. The absorption spectra 
of the drug at different pH exhibits two isosbestic points at 320 and 350 nm 
indicating the presence of different chemical species or zwitterionic condition 
in solution. The ratio of the two reacting components, the drug and the metal 
ions was determined by Job's and fluorometrir methods. The -ve value of AG 
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suggests that the interaction is spontaneous. The +ve AS value is characteristic 
of chelation and the +ve value of AH indicates that the process is endothermic. 
The binding of metal ions with ciprofloxacin is mainly entropy driven, with 
little contribution from the enthalpy factor. 
The binding interaction of ofloxacin (OFL) and levofloxacin (LFL) with 
Cd(II), Hg(n) and Pb(II) was investigated in aqueous acidic medium. The 
experimental results showed that the metal ions quench the fluorescence 
intensity of drugs by forming complex in 2:1 (drug-metal) molar ratio. The 
main reason for fluorescence quenching is static. Quenching of the drugs by 
toxic metal ions follows the order Hg(II)>Cd(II)>Pb(II). The stoichiometry and 
logK of complex was determined by absorption and fluorescence emission 
spectrophotometry. The quenching constant Ksv, binding sites "n" and 
thermodynamic parameters were determined at 25 and 35 °C. The positive 
entropy change indicated the gain in configurational entropy as a result of 
chelation. The process of interaction was spontaneous and mainly AS-driven. 
Chapter four deals with the development of novel uv and fluorescence 
spectrophotometric methods for quantitative determination of alprazolam in 
dosage forms using As(III)-SDS system. These methods are based on the 
formation of ALP-As(III) complex in presence of SDS. The UV-spectrum of 
ALP (SxlO'^ M) in 30:70 (methanol:water) solution of pH 6.5 in Mclivaine 
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buffer was run between 200-380 nm. It exhibited two peaks with a X„a^ at 255 
nm and a weak band at 325 nm. When the spectra of the drug were run at 
varying pH in the above region, an isosbestic point at 290 nm was observed 
which indicated the presence of two ionic species in solution. The 
spectrophotometric method was found to be linear in 8.0-17.0 ligml' range 
with detection limit of 13.520 ngml', while spectrofluorimetric method 
showed linearity in 0.05-9.5 lagmf' region with detection limit of 1.048^10'^  
l^gml'. The mean percentage recovery of the added quantity was found to be 
99.54 and 100.22. The % RSD determined spectrophotometrically and 
spectrofluorimetrically, respectively are lower than 0.478 and 0.296. The 
proposed methods have been successfully applied to the assay of ALP in tablets 
and the results were statistically evaluated. The molar ratio and stability 
constant of the complex were determined by both Job's and fluorimetric 
method at 25 and 35 °C. The thermodynamic parameters were also evaluated. 
The chapter five deals with the resonance Raleigh scattering, second-
order scattering and frequency doubling scattering spectra of Cu(II)-flutamide 
system in presence of anionic surfactants and its analytical applications. The 
simple, sensitive and rapid methods for the determination of FLD have been 
developed on the basis of ion-association reaction. Flutamide (FLD) forms 1:1 
cationic chelate with Cu(II) in Mclivaine buffer of pH 2.2-7.0, which further 
IV 
Abstract 
reacts with anionic surfactants (AS) like sodium dodecyl sulfate (SDS), sodium 
lauryl sulfonate (SLS) and sodium dodecylbenzene sulfonate (SDBS) to form 
1:1 ion-association complex. The ratio of the ternary complex for FLD-Cu(II)-
AS was found to be 1:1:1 as established by Job's method of continuous 
variation. As a result, the resonance Rayleigh scattering (RRS), second-order 
scattering (SOS) and frequency doubling scattering (FDS) were enhanced to 
the highest degree. The maximum RRS, SOS and FDS wavelengths of three 
ion-association complexes were located at 345/345 nm, 610/305 nm and 
430/860 nm, respectively. The increments of scattering intensity (AI) were 
directly proportional to the concentration of FLD in certain ranges. The 
linearity of these methods was 0.042-6.8, 0.41-5.9 and 0.28-3.5 for RRS, SOS 
and FDS respectively. The detection limits (3o) of FLD for SDS, SLS and 
SDBS systems were 1.9 ngmf', 2.1 ngmf' and 2.2 ngmr'(RRS method), 2.4 
ngmf', 2.7 ngmf' and 2.6 ngmf' (SOS method) and 2.3 ngmf", 2.4 ngmf' 
and 2.5 ngmf' (FDS method) separately. The sensitivity of RRS method was 
higher than those of FDS and SOS methods. The optimum conditions of RRS 
method, influence factors, the composition of ion-association complexes and 
the reaction mechanism have been discussed. The effects of concomitant 
substances were tested and it showed that the method is highly selective 
The interaction of Leflunomide (LFD) with Co(II) and eosinY (EY) has 
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been investigated by resonance Rayleigh scattering (RRS), frequency doubling 
scattering (FDS), second-order scattering (SOS) and absorption 
spectrophotometry. Leflunomide reacts with Co(II) to form 1:1 cationic chelate 
in a weakly acidic Britton-Robinson (BR) buffer of pH 5.5, which further 
reacts with EY to form 2:1 ion-association complex. As a result, the intensity 
of RRS, SOS and FDS markedly enhanced. The peak maxima of RRS, SOS 
and FDS were located at 350 nm, 520 nm and 390 nm, respectively. The 
increment of scattering intensities were directly proportional to the 
concentration of LFD in the range 0.009-3.0 ngmf' for RRS, 0.07-2.8 ^gmf' 
for SOS and 0.09-2.7 ngmf' for FDS. The methods are highly sensitive and 
selective as reflected by the detection limits, 0.641 ngmf' (RRS). 2.87 ngml' 
(SOS) and 4.55 ngmf' (FDS) respectively. These three methods were 
therefore, employed to determinate the trace amounts of LFD. The recovery for 
the determination of pharmaceutical samples lies between 99.80% and 100.5%. 
The reasons for the enhancement of scattering spectra and the energy transfer 
between absorption, fluorescence and RRS have been discussed. 
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CHAPTER-I 
Interaction ofCFPwith Metal Ions: Determination by Absorption 
Interaction of CFP with Metal Ions: Its 
Determination by Absorption and Fluorescence 
Spectrophotometry 
INTRODUCTION 
Cefpodoxime proxetil (CFP) is a semisynthetic P-lactum antibiotic 
known as (RS)-l(isopropoxycarbonyloxy) ethyl (+)-(6R,7R)-7-[2-(2-amino-4-
thiazolyl) - 2-{(Z)methoxyimino} acetamido] -3- methoxymethyl - 8-oxo-5-
thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylate. It is an ester prodrug of 
cefpodoxime acid where a proxetil radical is attached to cefpodoxime acid 
(Fig.l). It is the third generation cephalosporin ester, used in the treatment of 
upper respiratory tract and urinary tract infection. In biological system 
cefpodoxime undergoes ester hydrolysis and converted into cefpodoxime acid 
to exhibit its antibiotic activity [1,2]. It has an asymmetric carbon at position 4 
and is supplied as racemic mixture of R and S-enantiomers. 
Only a few methods are reported to quantify CFP [3,4], and they employ 
RP-HPLC. They are based on separation of the R- and S-isomers [5]. However, 
both the isomers are reported to exhibit similar biological activity [1]. When it 
was demonstrated that penicillin kills infectious bacteria the use of antibiotics 
became prevalent. With the increased need for treating wound infections 
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during the World War II, huge resources were devoted to elucidate the 
chemical structure and eventually developed penicillin G as the first antibiotic. 
The total synthesis of penicillin was reported for the first time in 1962 [6]. 
The discovery of cephalosporin from C.acremonium culture [7], 
demonstration of its remarkable stability towards aqueous solution at pH as low 
as 2 and, its excellent in vitro activity against penicillin-resistant organisms 
[8,9] were major breakthroughs in the history of P-lactam antibiotics. 
Investigation of microbial culture led to the discovery of several non-classical 
P-lactams like carbapenem [10] and oxacephems [11]. The reactivity of P-
lactam anfibiotics is fundamentally linked to antimicrobial activity [12]. The 
first total cephalosporin synthesis by ring expansion of penicillin was reported 
in 1966. Both penicillin and cephalosporin were produced by fermentation of 
C.acremonium on a large scale, and further processed to give, 6-amino-
penicillanic acid (APA) and 7-amino-cephalosporanic acid (ACA) respectively. 
These two key intermediates served as basis for chemical programs leading to a 
large variety of new semisynthetic antibiotics. Thienamycin, a naturally 
occurring carbapenem was isolated in late 1970s from a culture broth of 
Streptomyces cattleya [13]. The carbapenem nucleus had to be synthesized de 
novo, requiring a vast chemical effort to identify new compounds with 
improved propeities. Following the discovery of nocardicin A, the first 
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naturally occurring monobactam, sulfazecin were isolated from Gram-negative 
bacteria (e.g., Pseudomonas acidophila and Acetobacter) [14-16]. Research 
efforts in this class led to the commercialization of aztreonam and carumonam 
[17-19]. 
The use of highly sophisticated and time-consuming methods are not 
always required for routine analysis of CFP in dosage forms. Although several 
methods have been developed to determine the drug in biological fluids and 
pharmaceutical preparations [20] no effort seems to have been made to 
investigate the interaction of the drug with metal ions because consumption of 
trace metal in the diet is inevitable. 
In the present work an earnest effort has been made to study the 
interaction of the CFP with metal ions by fluorescence emission and absorption 
spectrophotometric measurements. Since quenching or enhancement in 
fluorescence intensity of the drug in presence of metal ions occurs, the spectra 
of the drug in presence of different concentrations of metal ions such as Mg(II), 
Ca(II), Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) were scanned. The ratio 
of the drug to metal ions was determined by Job's and Benesi-Hildebrand 
methods [21,22]. The absorption spectra of the drug in the pH range 
2.32-11.50 were run to see the zwitterionic condition, apparent ionization 
constant and the isosbestic point which indicate the presence of different 
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species in solution. The stability constant of the complexes formed between the 
drug and metal ion was also evaluated. 
EXPERIMENTAL 
Instruments 
The absorption spectra were obtained with Elico-SL-169 double beam 
UV-visible spectrophotometer. Fluorescence emission spectra were scanned 
with Hitachi-F-2500FL-spectrophotometer. All potentiometric measurements 
were done with Elico-LI-120 pH meter. These apparatus were used throughout. 
Material and methods 
Double distilled water was used throughout Cefpodoxime proxetil 
(Lupin Pharmaceutical Ltd, India), sodium hydroxide, metal chloride (Merck 
Ltd, Mumbai, India) and HCl (Ranbaxy Fine Chem. Ltd, India) were used as 
received. 
Preparation of solution 
Stock solution of Cefpodoxime proxetil and metal salts (IxlO'^'M) were 
prepared in 1 x 10"^  M HCl and stored at 4 °C. 
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Spectrophotometric method 
Solutions of equimolar concentration (1X10"''M) of C F P and metal ions 
were prepared. The pH of the drug was adjusted between 2.32-11.50 by adding 
sodium hydroxide and hydrochloric acid (1X10"'M and IxlO'^M) respectively. 
The absorption spectra were recorded in the range 250-380 nm. The ratio of 
metal to CFP was determined by Job's method. The Beer's-Lambert law was 
obeyed in the concentration range 2xl0"''-6xl0"'' mgrnl"'. The correlation factor 
(R )^ was found to be 0.9236. 
Spectrojluorimetric method 
The Beer-Lambert law was followed in the concentration range 
1X10"*-3 X10"^  mgrnl"'. The correlation factor (R^) was found to be 0.9652. 
Solution of the drug (7xl0''^M) and those of the metal ions 
( Ix lO-^xio-^M) were prepared from the stock solution. Their spectra were 
recorded immediately after sample preparation in 370-430 nm range at 
optimum excitation wavelength of 335 nm. 
RESULTS AND DISCUSSION 
Spectrophotometric study 
The absorption spectnim of CFP (1 xJO^M) was run in the region 250-380 nm. 
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It exhibited two peaics at 270 and 345 nm (Fig.2). Since the first peaic was very 
strong it was selected for further absorption studies. 
When the spectra of the drug were run at varying pH in the region 
250-380 nm two isosbestic points, one at 305 nm and another at 330 nm were 
observed which indicated the presence of zwitterionic condition (Fig.3) in 
solution [23]. The apparent ionization constant (pKa') of the drug was 
calculated (8.92) by the following equation: 
pKa' = pH+ log {(A, -AM)/(A -A,M)} (1) 
where Aj = absorbance of drug in basic medium, AM = absorbance of drug in 
acidic medium, A = absorbance of drug in aqueous medium. 
The concentration of metal ions and drug (CFP) were identical (lxl0"^M). 
The absorption spectra of the drug and metal complexes were obtained in 
acidic medium. The stoichiometry of the complexes was obtained by Job's 
method [21,24] the plot of which is shown in fig.4. The stability constant 
(Table 1) of metal chelate was calculated by the following equation: 
A/A„ Cx 
K = (2) 
(CM - A/Aex Cx) (CL - nA/Ae, Cx)" 
where K = stability constant of the metal chelate, n = X/(l-X) and X = mole 
fraction of the ligand at maximum absorption. A/Agx = ratio of the absorbance 
«tfRSl>S 
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to that indicated by the tangent for the same wavelength. Cx. CM and Ci are the 
limiting concentrations of the complex, metal ion and the drug, respectively. 
The metal ions probably chelate through the carbonyl group of the P-lactum 
and, amide nitrogen of CFP. The mechanism of chelate formation and its 
hydrolysis is shown in fig.5. The stability constant is related to the standard 
enthalpy changes, AH and other thermodynamic function by the equation: 
AG = - 2.303RTlogK = AH-TAS (3) 
where R = gas constant T = experimental temperature. K = binding constant. 
From the value of stability constant at different temperatures the enthalpy 
changes can be calculated from the equation 4: 
LogKz/K, = [l/T,-l/T2lAH/2.303R (4) 
The negative value of AG suggests spontaneous nature of the 
complexation process [25,26]. The positive value of AH suggests that these 
processes are endothermic and are favourable at higher temperature. Also, it is 
entropically favourable. The positive value of H and S indicate that 
hydrophobic force may play a major role in this interaction [27]. It is 
reasonable to think, on the basis of these results, that the metal ions form a five 
membered chelate ring with CFP. 
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Fluorescence Enhancement study 
The fluorescence emission spectrum of the pure drug is markedly 
different from its absorption spectrum in UV region. The emission spectrum 
run between 350-450 nm at excitation wavelength of 335 nm showed a peak, at 
400 nm. It is known that the addition of metal ions to the drug causes 
enhancement or quenching in the fluorescence spectrum. An enhancement in 
fluorescence intensity at 400 nm (Fig.6) was noted when Mg(II), (Ca(Il). 
Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) were added, although the shape 
and position of emission spectrum remains unchanged. 
The stoichiometry and stability constant of the complexes was 
determined by Benesi-Hildebrand method [22]. In case of a 1:1 complex, the 
following equation is applicable: 
1/F-Fo = 1/(F^-F„)K [Melo + 1/(F.-F„) (6) 
In this approach, a plot of l/(F-Fo) versus l/[Me]o, was made where F is the 
observed fluorescence at each concentration tested, Fo is the fluorescence 
intensity of analyte in the absence of metal ion, F, is the maximum 
fluorescence intensity in presence of metal ions and [Me]o is the concentration 
of metal ion. A linear plot is required for this double reciprocal plot in order to 
conclude 1:1 stoichiometry. In such cases, a linear relationship has to be 
Interaction ofCFP with Metal Ions: Determination by Absorption 
obtained when l/(F-Fo) versus l/[Me]o is plotted. The stability constant (Table 
2) was determined by dividing the intercept by the slope of the straight line 
obtained in the double-reciprocal plot (Fig.7). 
Influence of metal ion concentration 
The influence of metal ion concentration (lxlO"^-10xlO"^M) was 
studied by fluorescence spectrophotometry. A 1:1, CFP:Metal complex is 
formed in acidic aqueous medium. In general, the enhancement in fluorescence 
intensity is observed as the complexation by cations causes increase in the 
redox potential of the donor so that the relevant HOMO energy decreases to a 
level lower than that of tluorophore. Consequently, the excited state energy of 
fluorophore is dumped as a visible emission [28]. The reason of this 
enhancement lies in strong perturbation of the excited state upon coordination 
of the metal ion. A low lying internal charge transfer state due to the presence 
of electron donor and acceptor group in the CFP is the lowest excited state. 
This is, however, a less emitting state and, in equilibrium with the n-n excited 
state of the molecule. The PCT interaction becomes weaker upon coordination 
with metal since the electron withdrawing group is now electron rich moiety 
due to the deprotonation of -NH group necessary for coordination of metal. 
Since the enhancement in fluorescence intensity of the CFP occurs in presence 
of the metal ions, the spectra of the drug in presence of different concentrations 
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of several metal ions were scanned. 
CONCLUSION 
The nature and magnitude of the interaction of CFP with biologically 
important metal ion was investigated by UV and fluorescence spectra. The 
results indicated the formation of 1:1 complex of CFP with metal ions in acidic 
medium. The absorption spectra at different pH showed the presence of two 
isosbestic points indicating the existence of zwitterionic condition. The 
thermodynamic parameters showed that the interaction between CFP and metal 
ion was spontaneous and that the hydrophobic force was a major factor in the 
interaction. 
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Fig.4(A) Continuous variation curves ofCFP-Mg(II) complex at 25 and 35 °C 
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Fig.4(B) Continuous variation curves of CFP -Ca(II) complex at 25 and 35 °C 
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Fig, 7(A) Benesi'Hildebrand's plot for 1:1 fCFP: Mg(II) complex] at 25 °C 
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Table 1. Stability constant and other thermodynamic parameters ofCFP 
complexes 
Metal 
Ions 
logK 
25 "C 35 'C 
-AG/kJ.mol' 
25 "C 35 "C 
AH/J.mor' AS/J.mor'lC' 
25 "C 35 "C 
Mg(II) 5.915 6.044 33.75 35.43 164.93 113.82 115.56 
Ca(II) 5.600 5.846 31.95 34.47 
Mn(II) 6.200 6.289 35.38 37.08 
Fe(III) 6.287 6.356 35.87 37.83 
Co(II) 5.983 6.122 34.13 36.10 
Ni(II) 6.130 6.276 34.97 37.01 
Cu(II) 6.211 6.315 35.44 37.24 
Zn(II) 6.184 6.297 35.28 37.13 190.29 119.04 121.16 
270.22 
49.97 
260.34 
244.95 
178.43 
240.25 
108.13 
118.91 
121.22 
115.38 
117.97 
119.93 
112.79 
120.55 
123.66 
118.00 
120.74 
121.68 
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Table 2. Stability constant, Gibbs energy change (AG) ofCFP complexes 
(Benesi-Hildebrand method) at 25 T 
Metal ions 
Mg(Il) 
Ca(II) 
Mn(II) 
Fe(III) 
Co(II) 
Ni(II) 
Cu(II) 
Zn(II) 
logK 
6.869 
6.854 
6.886 
6.919 
6.883 
6.884 
6.896 
6.889 
-AG (kJ.mor') 
39.19 
39.11 
39.29 
39.48 
39.27 
39.28 
39.34 
39.30 
R' 
0.9784 
0.9843 
0.9769 
0.9914 
0.9807 
0.9845 
0.9668 
0.9706 
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Binding Constant: Fluorescence Quenching of Ciprofloxacin 
Binding Constant: Fluorescence Quenching of 
Ciprofloxacin with Fe(III) and Zn(II) 
INTRODUCTION 
Ciprofloxacin is chemically known as [l-cyclopropyl-6-fluoro-l,4-
dihydro-4-oxo-7-(piperazinyl)-quinolone-3-carboxylic acid]. It is one of the 
fluoroquinolones used as broad spectrum drug against both gram positive and 
gram negative bacteria. It has been found that the activity of quinolone drugs is 
completely lost if consumed with antacids containing aluminum or magnesium 
because the drug is neutralized. At higher pH precipitation occurs and the drug 
is made unavailable for absorption [1-4]. The mechanism of interaction of 
quinolone with metal ions is based on the chelation of the metal with the 
carbonyl and carboxyl groups of the drug (Fig. 1). The antibacterial activity of 
the drug has also been found to be reduced manifold after chelation [5] of the 
metal ions via these groups. 
The development of quinolone drugs began with the introduction of 
nalidixic acid in 1962 used for the treatment of kidney infections in humans. 
The drug was discovered by George Lesher [6] and coworkers in a distillate 
during chloroquine synthesis. Nalidixic acid, a predecessor of all members of 
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the family of topoisomerase inhibitors, is thus a by-product of antimalarial 
drug. Due to modest serum and tissue kinetics, a consequence of high protein 
binding, and imfavourable antibacterial activity, the benefits of therapy with 
nalidixic acid were limited to gram-negative infections of the urinary tract in 
humans. New 4-quinolones such as pipemidic acid, oxolinic acid and 
cinoxacin, introduced in the 1970s, were only marginal improvements over 
nalidixic acid. Rapid progress came with the introduction of a fluorine atom at 
the C6 and, piperazine substituents at C7 into the basic structure. After the 
discoveries of norfloxacin (1980) around 10,000 new analogues have been 
described [6]. The third generation quinolones have a broad spectrum against 
gram-negative and gram-positive bacteria. They have since become the most 
important agents in systemic therapy of infections of the urinary and 
respiratory tract, skin, bones and numerous additional indications. 
Enrofloxacin, which was first synthesized by Bayer researchers Grohe and 
Peterson in 1980, has been developed exclusively for use in veterinary. 
Introduced to the market in 1988, it has become the most important quinolone 
for the treatment of bacterial infections in dogs and cats worldwide [7]. 
The interaction of fluoroquinolones with metal ions has attracted 
considerable interest not only for the development of analytical techniques but 
also to provide information about the mechanism of action of the 
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pharmaceutical preparation [8]. Since the metal ions cause fluorescence 
quenching of the drug, spectrofluorimetric method for quantitative 
determination of the quinolone type drugs has been developed [9,10] besides 
titrimetric [II] spectrophotometeric [12] electrochemical [13] electrophoretic 
[14] and chromatographic[15] techniques. The maximum solubility of the 
ciprofloxacin has been reported at 37 °C, which also happens to be the normal 
temperature of human body although the interaction of drug with metal ions 
has been studied in a wide range of temperature between 25-60 °C [ 16.17]. 
We have studied, under this project, the interaction of Fe(III) and Zn(II) 
with ciprofloxacin at room temperature using absorption and fluorescence 
emission spectrophotometry at pH 3.98. The stability of the Fe(III) and Zn(Il) 
complexes has been calculated by both spectrophotometric and fluorescence 
emission techniques. The fluorescence spectroscopy has been widely used to 
monitor the molecular interaction because of its high sensitivity, reproducibility 
and relatively easy use. 
Since no detailed fluorescence study on the binding interaction of 
ciprofloxacin with Fe(III) and Zn(II) has been done so far, a thorough 
investigation was, therefore, made using this technique. The binding 
mechanism, binding constant and binding sites can, therefore, be obtained in 
addition to the thermodynamic parameters of the process. 
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EXPERIMENTAL 
Material and methods 
Reagents 
Ciprofloxacin was purchased from Windlas Biotech. Ltd. (India). All 
solvents and chemicals were of analytical grade. NaOH, Fe(N03)3.9H20 
(Merck Ltd., Mumbai, India) ZnCb (anhydrous) (SDH Pvt. Ltd. India), and 
HCl (Ranbaxy Fine Chem. Ltd., India) were used as received. Double distilled 
water was used throughout. 
Preparation of solutions 
The stock solution of ciprofloxacin.HCl (SxlO'^M) prepared in IxlO'^ M 
HCl was stored at 4°C and those of the metal salts (IxlO'^M) were prepared in 
double distilled water. All working solutions were prepared by dilution with 
water. 
Spectrophotometeric methods 
Solutions of equimolar concentration (lxlO"'*M) of ciprofloxacin.HCl 
and metal ions were prepared. The pH of the drug was adjusted between 
2.12-10.50 by adding sodium hydroxide and hydrochloric acid (lxlO"'-lxlO'^M). 
The absorption spectra were recorded in the range 230-360 nm. The ratio of 
33 
Binding Constant: Fluorescence Quenching of Ciprofloxacin 
metal to ciprofloxacin.HCl was determined by Job's method. The linearity of 
the drug was found in the range S-SxlO'^ -^T-SxlO"^  mgml' with the correlation 
factor (R )^ 0.9629. 
Fluorescence spectrophotomeiric methods 
Solution of the dmg (5x10"^ and those of metal ions (Ixl0"^-10.50xl0^ 
were prepared. Further dilutions were made from this solution. Spectra were 
recorded immediately after sample preparation in the range 300-600 nm at 
optimum excitation wavelength of 315 nm. For calibration curve an aliquot of 
stock solution (5xlO'^-lxlO'" mgml'') was prepared which showed linearity 
with correlation factor (R )^ 0.9739. 
RESULTS AND DISCUSSION 
Absorption studies 
The absorption spectrum of ciprofloxacin recorded at room temperature 
and constant pH (3.98) displayed a strong peak at 272 nm and a weak 
absorption at 315 nm (Fig.2). When the UV spectra of the drug were run at 
varying pH, the strong peak was shifted to lower wavelength while the broad 
peak was shifted to higher wavelength. The decrease in the position and 
intensity of the first peak is attributed to the extent of ionization of the 
carboxylic group while the increase in the intensity and height of the peak at 
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315 nm occurs as a consequence of protonation of the piperazinyl nitrogen at 
carbon-7. Two isosbestic points appearing at 320 and 350 nm indicated tlie 
presence of different chemical species in solution (Fig.3) under different pH 
similar to those observed by Bark [16]. 
The apparent ionization constant (pKa') of the drug was calculated 
(6.871) by the following equation: 
pKa- = pH+ log {(A, - AM)/(A - A^)} (1) 
where A| = Absorbance of drug in basic medium, AM = Absorbance of drug in 
acidic medium, A = Absorbance of drug in aqueous medium. The pure drug 
has maximum solubility at pH 5 although it increases in the presence of Fe(ll) 
and Fe(III) ions [18]. The stability constant of the complexes were calculated 
by continuous variation method (Fig.4) using the following equation: 
A/AexCx 
K = (2) 
(CM - A/Ae, Cx) (CL - nA/Ae, Cx)" 
where K = stability constant of the metal chelate formed in solution, n = 
X/(l-X) and X = fraction of the ligand at maximum absorption. A/Aex is the 
ratio of the observed absorbance to that indicated by the tangent for the same 
wavelength. Cx, CM and CL are the limiting concentrations of the complex, 
metal ion and ligand respectively. 
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The drug to metal ratio is 2:1, which is quite obvious. The fairly large 
value of logK of the complexes (Table. 1) suggests that they are pretty stable in 
acidic medium only. The drug under this condition must be acting as ionophore 
since the solubility of the drug is maximum in presence of Fe(IIl). However, 
precipitation occurs when the solution becomes alkaline [19,20]. 
Fluorescence study 
The absorption spectrum of the drug is markedly different from its 
emission spectrum, which is attributed to different molecular geometries 
(Fig.5) in ground and excited states. The piperazinyl group of ciprofloxacin 
acts as electron donor while the keto group acts as electron acceptor. Since all 
investigations were done in acidic medium, ciprofloxacin exists in zwitterionic 
form. The peaks in the absorption spectra are due to intramolecular charge 
transfer, the greater the number of resonating structures the stronger the 
fluorescence emission. 
The emission spectra of the drug in presence of the Fe(III) and Zn(Il) 
quencher (Fig.6) showed a consistent decrease in the intensity of fluorescence 
emission with increasing concentration of the metal ion, until it was nearly 
completely quenched, as a consequence of the complex formation between the 
metal ions and ciprofloxacin. 
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Many workers [21,22] have studied the interaction of drug with metal 
ions at temperature exceeding 37 °C in order to show the Stem-Volmer plot 
although such experiments above body temperature do not mimic the biological 
system. We, therefore, did all the experiments at room temperature. The 
fluorescence intensity increases rapidly with decrease in temperature. The 
lower stability at higher temperature also supports lowering in 
quenching. The fluorophore is quenched by both collision and complex 
formation with the metal ions. The complex formation is mainly due to ion 
dipole interaction. 
Fluorescence quenching refers to any process in which the fluorescence 
intensity of a given fluorophore decreases upon adding a quencher. Assuming 
that the fluorescence intensity of a fluorophore-quencher complex is negligible 
as compared to an unquenched fluorophore, the intensity in the absence (Fo) 
and presence (F) of the quencher is expressed by Stem-Volmer equation: 
F„/F=l+Ksv[Q] (3) 
where [Q] = the concentration of quencher, Ksv = the Stem-Volmer constant 
which is also the equilibrium constant of the complex formed in the static 
quenching process. If a system obeys the Stem-Volmer equation, a plot of Fo/F -1 
against [Q] will give straight line with a slope of Ksv and y-axis intercept. The 
37 
Binding Constant: Fluorescence Quenching of Ciprofloxacin 
linearity of Stem-Volmer plot (Fig.7) increases with increasing concentration of 
quencher. The values of Ksv and correlation coefficient are shown in Table 2. 
The metal ions with large nuclear charge and small size will experience greater 
ion-dipole interaction and hence the emission intensity in the case of Zn(II) 
should be less than that for Fe(III) although it has greater nuclear charge and 
smaller ionic radius. The large value of stability constant reflects strong 
interaction between the drug and the metal ions. 
Binding Constant and Binding sites 
For static quenching, the relationship between intensity and the 
concentration of quencher can be described by the binding constant formula; 
[23,24] 
log(Fo- F)/F= log K+ nIoglQl (4) 
where K = binding constant, and n = number of binding sites per ciprofloxacin. 
After the fluorescence quenching intensities of ciprofloxacin were measured at 
315nm, the double- logarithm algorithm was assessed by equation (4). Fig.8 
shows double-logarithm curve which gives logK and n (Table 2). The linear 
correlation coefficients for all the curves are higher than 0.9504 which agrees 
well with the site binding model underlying equation (4). The results indicated 
a strong binding force between drug and metal ions. Approximately two 
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binding sites would be formed in each case which is consistent with the 
previous results that in acidic medium ciprofloxacin and metal ions form 2:1 
complex. 
Thermodynamic parameters and nature of binding forces 
Considering the dependence of the binding constant on the temperature 
a thermodynamic process was considered to be responsible for this interaction. 
It was analyzed in order to further characterize the forces acting between drug 
and metal ions. The changes in enthalpy (AH), entropy (AS), and free energy 
(AG) are the main evidences to determine the binding mode. If the temperature 
does not vary significantly, the enthalpy changes (AH) can be regarded as 
constant. The AG can be estimated from the following equation, based on the 
binding constant at different temperatures. 
AG = - 2.303RTlogK (3) 
where R = gas constant T = experimental temperature, K = binding constant. 
From the stability constant at different temperatures the enthalpy changes can 
be calculated from the following equation: 
logKz/K, = [1/T,-1/T2]AH/2.303R (4) 
The entropy changes can be calculated from: 
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AG = AH-TAS (5) 
The negative value of AG means that the interaction is spontaneous 
(Table 3). The +ve AS value is characteristic of chelation. It occurs because the 
water molecules that are normally arranged in an orderly fashion around the 
ciprofloxacin and metal ions have acquired a random configuration as a result 
of chelation. This is referred to as gain in configurational entropy [25]. The 
formation of drug-metal chelate (Fig.9) can be explained on the basis of 
chelation theory [26]. The polarity of the metal ion will be reduced to a 
greater extent after chelation due to the overlap of the ligand orbital and 
partial sharing of the positive charge of the metal ion with donor groups. Such 
chelation may enhance the lipophilic character of the central metal atom, which 
subsequently favors its permeation through the lipid layer of the cell membrane 
[27,28]. The +ve value of AH indicates that the process is endothermic and 
binding between metal ions and ciprofloxacin is mainly AS-driven, with little 
contribution from the enthalpy factor. 
CONCLUSION 
It is concluded that the drug stays as zwitterions. Ionization of 
carboxylic group and protonation of piperazinyl group occurs. The two 
isosbestic points indicate the presence of different chemical species in solution. 
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The result shows that the complex of ciprofloxacin with Fe(IIl) and Zn(II) are 
fairly stable. The thermodynamic parameters showed that the drug to metal 
interaction between ciprofloxacin and metal ion is spontaneous and, that the 
hydrophobic force is a major factor in the interaction. 
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Fig.l Structure of ciprofloxacin,HCl 
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Fig.4(A) Continuous variation curve of equimolar solution of ciprofloxacin 
and Fe(III) at 25'C 
-r 
0.4 0.6 0.8 
Mole fraction of drug 
Fig.4(A) Continuous variation curve of equimolar solution of ciprofloxacin 
and Zn(II) at 25 "C 
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solution phase at varying pH 
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Fig.9 Possible structure of complex of ciprofloxacin with metal ions 
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Table 1. Stability constant and AG of the complexes at 25 "C by absorption 
study 
Metal ions logR AG/kJ.mor' 
Fe(III) 9.378 -53.509 
Zn(II) 9.381 -53.526 
Table 2. Stern-Volmer constant (Ksv), logK, binding site and regression 
coefficient at 25 and 35 "C 
Metal Ksy/mor' logK n F 
ions 25 "C 35 "C 25 "C 35 "C 25 "C 35 "C 25 "C 35 "C 
Fe(III) 3.36x10" 2.77x10'' 9^ 42 9^ 58 \M r97 0.9821 0.9504 
Zn(II) 2.97x10" 2.48x10" 9.46 9.60 1.89 2.01 0.9813 0.9655 
Table 3. Thermodynamics parameters at 25 C and 35 "C 
Metal ions 
Fe(III) 
Zn(II) 
AG/kJ.moV 
25 "C 
-53.77 
-54.01 
35 "C 
-56.54 
-56.62 
AH/J.mor' 
118.59 
98.94 
AS/J.mor'lC' 
25 "C 
180.85 
181.57 
35 "C 
183.96 
184.16 
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CHAPTER'III 
Interaction and Fluorescence Quenching of Ofloxacin 
Fluorescence Quenching of Ofloxacin and 
Levofloxacin with Divalent Toxic Metal Ions 
INTRODUCTION 
Levofloxacin (LFL) is the active (-) S isomer of ofloxacin (OFL), 
isolated from the racemic mixture. The ofloxacin is a chiral compound, 
chemically known as (±)9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-l-
piperazinyl)-7-oxo-7-H-pyrido(l ,2,3-de)-l ,4-benzoxazine-6-carboxylic acid, is 
one of the third generation members of quinolone synthetic antibiotics. It is a 
broad spectrum drug used in the treatment of respiratory tract and urinary tract 
infections. It acts against gram-positive and gram-negative bacteria [1,2] 
through inhibition of their DNA gyrase [3,4]. The chelation of certain metal 
ions with the carbonyl and carboxyl groups of these drugs [5] makes them 
more accessible to the biological system. The ability of the quinolone 
antibiotics to interact with cellular components is mediated by their 
complexation with divalent metal ions [6]. Although, the antibacterial action of 
the quinolones is not linearly proportional to their concentration the bacterial 
population increases with decreasing concentration of the drug in human 
body. However, such an optimum concentration must be maintained before the 
surviving bacteria start regrowing [7]. In the case of fluoroquinolones (FQs), 
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the number of the surviving bacteria is lower, but the unusual dependence is 
retained. The limiting concentration of FQs has, therefore, been determined. 
The pharmacopeia method is based on a microbiological test involving the 
diffusion of the antibiotic into agar (nutrient medium) and the growth inhibiting 
effect of the known concentrations of the drug on the microorganism with 
reference to samples [8]. The intrinsic fluorescence of FQs is used for their 
determination in biological samples after their preliminary extraction with 
organic solvents [9]. A method was proposed to determine these antibiotics in 
biological fluids using a mixed-ligand complex formed by terbium and 
triphenylphosphine oxide, the detection limit was 1.2 pico mole [10]. 
The interaction of fluoroquinolones with metal ions has attracted 
considerable interest not only for the development of analytical techniques but 
also to provide information about the mechanism of action of the 
pharmaceutical preparation [11]. Since the metal ions cause fluorescence 
quenching of the drug spectrofluorimetric method for quantitative 
determination of the quinolone type drugs has been developed [12] besides 
titrimetric [13] spectrophotometeric [14] electrochemical [15] electrophoretic 
[16] and chromatographic [17] techniques. 
Since a thorough study of the stability of complexes of toxic metal 
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ions with the above drugs has not been undertaken thus far, we have 
determined the binding constant (logK) and binding site (n) of the complexes 
by absorption and fluorescence emission spectrophotometry. In addition, the 
thermodynamic parameters of the process were also determined in-this-work. 
4f-' 
EXPERIMENTAL 
• ) A C C . N O )± • 
Reagents ^ ' V > - ^ ^ ^ - ' < ^ Z/ 
Ofloxacin and Levofloxacin were purchased from Morepen Laboratory 
Ltd. (India). All solvents and chemicals were of analytical grade. Double 
distilled water was used throughout. NaOH, CdCl2.H20, HgClj, Pb(N03)2 
(Merck Ltd., Mumbai, India) and HCl (Ranbaxy fine chem. Ltd., India) were 
used as received. 
Preparation of solutions 
The stock solution of LFL and OFL (3xlO'^M) prepared in IxlO'^M 
HCl were stored at 4 °C and those of the metal salts (IxlO'^M) were prepared 
in water respectively. All working solutions were prepared by dilution with 
water. 
Spectrophotometeric methods 
Solutions of equimolar concentration (S^IO'^ M) of drug and metal ions 
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were prepared. The ratio of metal to drug was determined by Job's method. The 
linearity of LFL, OFL was obeyed in the range 2.0xlO'^-3.0xlO'V and 
2.4X10'^-3.5X10"''M respectively. The correlation factor (R )^ of LFL and OFL 
are 0.9889 and 0.9935 
Fluorescence spectrophotometric methods 
Solution of the drug (6xlO'^M) and those of metal ions (2x10'*'to 12x10-
^M) were diluted from this stock. Spectra were recorded immediately after 
sample preparation in 360-600 nm range at optimum excitation wavelength of 
330 run and 340 nm for LFL and OFL respectively. For calibration curve, stock 
solution of LFL (4.5xlO"*-0.5xlO"^M) and OFL (5.0x10"M.6xlO-^M) was 
prepared which showed linearity with correlation factor (R ) of 0.9929 and 
0.9948 respectively. 
RSULTS AND DISCUSSION 
Spectrophotometric studies 
The absorption spectra of LFL and OFL at constant pH (6.25) displayed 
a strong peak at 278, 285 nm and, a weak absorption at 325 and 330 nm, 
respectively (Fig.l). 
The binding constant of the complexes were calculated by the 
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continuous variation method at 25 and 35 °C using the following equation [18] 
A/Afx Cx 
K = ( 0 
(CM - A/Ae, Cx) (CL - nA/A„ Cx)" 
where K = binding constant of the metal chelate formed in solution, n = 
X/(l-X) and X = mole fraction of the ligand at maximum absorption. A/Aex = 
ratio of the observed absorbance to that indicated by the tangent for the same 
wavelength. Cx, CM and CL are the limiting concentrations of complex, metal 
ion and ligand respectively. 
The continuous variation curves (Fig.2) shows 2:1 molar ratio of drug to 
metal, which is quite obvious. The fairly large value of logK of the two 
complexes suggests that they are pretty stable in acidic medium only (Table 1). 
The drug under this condition must be acting as ionophore. 
Spectrofluorimetric study 
The emission spectra of drugs in absence and presence of different 
concentrations of metal ions showed (Fig.3) that their fluorescence intensity 
decreased steadily with increasing concentration of metal ions without any 
change in emission maxima and shape of the peak. As there was no significant 
)tem shift with the addition of metal ion, it is indicated that metal ion can quench 
inner fluorescence of the drug and the interaction indeed existed without 
inducing any conformational change. Quenching can occur by a variety of 
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molecular interactions, viz., excited-state reactions, molecular rearrangement 
and energy transfer of ground state complex formation (static quenching). If the 
Stem-Volmer constant (K,sv) decreases with increasing temperature it may be 
concluded that the quenching process is static rather than dynamic [19,20]. 
Static quenching implies either the existence of a sphere of effective quenching 
or the formation of a ground state non-fluorescent complex, whereas collisional 
or dynamic quenching involves the collision and subsequent formation of a 
transient complex between an excited state fluorophore and a ground state 
quencher. The excited state complex dissociates upon radiative and non-
radiative deactivation. In order to confirm the quenching mechanism the 
procedure of fluorescence quenching was first assumed to be dynamic. For 
dynamic quenching the mechanism can be described by the Stem-Volmer 
equation [21]. 
Fo/F=l + Ksv[QI (2) 
Here FQ and F are the fluorescence intensities in absence and presence of the 
quencher respectively. Ksv ^ dynamic quenching constant, [Q] = concentration 
of quencher. Fig.4 displays the Stem-Volmer plots of quenching of LFL and 
OFL by metal ions at different temperatures. 
It has been observed in all cases that Ksv decrease with increasing 
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temperature (Table 2). It can, therefore, be concluded that quenching is not 
initiated by dynamic, but probably by static process. Cu"^ ^ is well known as a 
strong quencher because of its electronic structure (d^).Quenching by this type 
of substance, most likely, involves the donation of electron from the 
fluorophore to the quencher. The ion-dipole interaction between Cu*^  and the 
drug molecule will also be strong due to the large nuclear charge and the 
relatively small size of Cu*^  as compared with other metals. Cu"^ ^ usually 
introduces easily accessible low energy levels, which is capable of quenching 
the fluorescent excited state of the molecule [22]. 
Binding Constant and Binding sites 
For static quenching, the relationship between intensity and the 
concentration of quencher can be described [23,24] by the binding constant 
formula: 
log(Fo-F)/F = log K+ nlog[Q J (3) 
where K = the binding constant (Table.2.), n = the number of binding sites per 
drug molecule and [Q] ^ concentration of quencher. After measuring the 
fluorescence quenching intensities of LFL and OFL at X^x 330 and 340 nm 
respectively, the double-logarithm algorithm was assessed by equation (3). 
Double-logarithm curve gives the corresponding calculated results (Fig.5). The 
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linear correlation coefficient for all the curves is greater than 0.9533, indicating 
that the interaction between metal ions and drugs agrees well with the site-
binding model underlying equation (3). The results illustrate that there is a 
strong binding force between drug and the metal ions and, approximately two 
binding sites are involved. 
Thermodynamic parameters and nature of binding forces 
Considering the dependence of the binding constant on the temperature 
a thermodynamic process was considered to be responsible for this interaction. 
The temperature dependent parameters were analyzed in order to further 
characterize the forces acting between drug and metal ions. The free energy 
change (AG) can be estimated from the following equation, based on the 
binding constant at different temperatures. 
AG = - 2.303RTlogK (4) 
From the logK the enthalpy and entropy changes can be calculated by using 
equation 5 and 6 respectively, 
logKz/K, = [1/T,-1/T2]AH/2.303R (5) 
AG = AH-TAS (6) 
The negative value of AG means that the interaction process is spontaneous 
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(Tablel&3). The +ve AS value is characteristic of chelation. The formation of 
drug-metal chelate can be explained on the basis of chelation theory [25]. The 
polarity of the metal ion will be reduced to a greater extent after chelate 
formation due to the overlap of the ligand orbital and partial sharing of the 
positive charge of the metal ion with donor groups. Such chelation may 
enhance the lipophilic character of the central metal atom [26,27]. This is 
referred to as gain in configurational entropy [28]. The +ve value of AH 
indicate that the processes is endothermic and is mainly AS-driven. 
CONCLUSION 
In this paper the nature and magnitude of the interaction of LFL and 
OFL with toxic metal ions Cd(II), Hg(II) and Pb(II) have been investigated by 
fluorescence emission and UV spectral pattern. The results indicated the 
formation of 2:1 (drug:metal) complexes in acidic medium. The 
thermodynamic parameters showed that the interaction between drug and toxic 
metal ion was spontaneous and, the hydrophobic force was a major factor in the 
interaction. 
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Table 1. Stability constant and thermodynamic parameters of LFL and OFL 
complexes (Job's method) 
l.LFL 
Metal logK -AG/kJ.mor' AH/J.mor' AS/J.mor'lC' 
ions 25 °C 35 °C 25 °C 35 °C 25 °C 35 °C 
Cd(II) 9.399 9.579 53.629 56.490 301.58 180.97 184.38 
Hg(II) 9.499 9.684 54.199 57.109 226.18 182.63 186.15 
Pb(II) 9.459 9.522 53.971 56.154 206.00 181.80 182.98 
2. OFL 
Cd(II) 9.285 9.435 52.978 55.641 251.31 178.62 181.46 
Hg(II) 9.379 9.539 53.151 56.254 268.07 179.25 183.51 
Pb(II) 9.347 9.487 53.332 55.947 234.56 179.75 182.41 
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Table 2. Stern-Volmer constant (Kgy), binding constant (logK), binding site 
and regression coefficient at 25 and 35 °C 
l.LFL 
Metal Ksi/mor' logK « F 
ions 25 °C 35 °C 25 °C 35 °C 25 °C 35 °C 25 °C 35 °C 
Cd(II) 4.22x10' 3.57x10' 9.466 9.602 1.895 2.009 0.9817 0.9652 
Hg(II) 4.88x10' 3.72x10' 9.598 9.717 1.921 1.991 0.9809 0.9904 
Pb(II) 4.71x10' 3.65x10' 9.585 9.680 1.918 1.994 0.9810 0.9573 
2.0FL 
Cd(II) 7.07x10' 6.42x10' 9.424 9.545 1.885 r99l 0.9729 0.9533 
Hg(II) 7.25x10' 6.81x10' 9.513 9.652 1.903 2.012 0.9719 0.9562 
Pb(II) 7.16x10' 6.61x10' 9.464 9.557 1.893 1.993 0.9724 0.9536 
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Table 3. Thermodynamic parameters at 25 and 35 "C 
l.LFL 
Metal 
ions 
-AG/kJ.mor AH/J.mor 
25 °C 35 °C 
AS/J.mor'K' 
25 °C 35 °C 
Cd(II) 
Pb(II) 
Hg(II) 
54.011 
54.764 
54.690 
56.625 
57.262 
57.085 
227.86 
187.64 
159.16 
182.01 
184.40 
184.58 
186.52 
184.05 185.87 
2.0FL 
Cd(II) 
Hg(II) 
Pb(II) 
53.772 
54.279 
54.400 
56.289 
56.921 
56.360 
202.72 
199.37 
155.81 
181.12 
182.81 
183.07 
183.4! 
185.45 
177.13 
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CHAPTER-IV 
Development of UV and Fluorescence Spectrophotometric Methods 
Development of UV and Fluorescence 
Spectrophotometric Methods for the Quantitative 
Determination of Alprazolam in Dosage Forms 
Using As(III)-SDS System 
INTRODUCTUION 
Alprazolam (ALP) {8-chloro-l-methyl-6-phenyl-4H-s-triazolo (4, 3-
a)(l,4) benzodiazepine} (Fig.l) belongs to the class of benzodiazepine with 
anxiolytic, muscle relaxant and anticonvulsant properties which is generally 
used as hypnotic and tranquilizer [1-3]. It is most frequently prescribed in the 
therapy of anxiety as being relatively safe with mild side effects. It has no 
appreciable solubility in water at physiological pH. It is rapidly and completely 
absorbed after oral administration, with peak levels in plasma occurring within 
1 to 2 h after oral administration [4]. The predominant metabolites in human 
plasma are d-hydroxy alprazolam, 4-hydroxyalprazolam and d-
benzophenone.The pharmacological activity of d-hydroxyalprazolam and 4-
hydroxyalprazolam is about 60% but 20% less than that of ALP. The 
benzophenone is essentially inactive [5,6]. Since ALP is highly photolabile 
special care should be taken to avoid light exposure during its storage and 
handling. The photodegradation process can result in the loss of potency of the 
drug and also in adverse effects due to the formation of minor toxic 
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degradation products [7,8]. 
A large number of analytical and pharmacological techniques for the 
determination of some benzodiazepines have been reported f9-13|. Since there 
is no report on the use of metal ion as analytical reagent for the determination 
of ALP, we have developed a highly sensitive spectrophotometric and 
fluorescence quenching methods for its determination by complex formation 
with As(III) in presence of SDS. The complexation of Co(II), Ni(II), and Zn(Il) 
with ALP has also been investigated by UV and fluorescence 
spectrophotometry although the interaction of ALP with these metal ions can 
cause fluorescence quenching. The binding mechanism, binding constant and 
binding sites can be obtained using fluorescence quenching of ALP in presence 
of these metal ions. The stoichiometry of the drug to metal ions was determined 
by continuous variation method and fluorescence quenching. The absorption 
spectra of the drug were run in the pH range 2.25-10.50 to defect isosbestic 
point which indicates the presence of different ionic species formed in solution. 
The stability constant and thermodynamic parameters of the process were also 
evaluated. 
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EXPERIMENTAL 
Material and methods 
Pure ALP (Sigma Laboratories Ltd. India) and tablets (Morepen Labs. 
Ltd. India), sodium hydroxide, arsenic oxide, metal chloride (Merck Ltd, 
Mumbai, India) and HCl (Ranbaxy Fine Chem. Ltd, India) were used as 
received. Double distilled water was used throughout. 
Preparation of standard solutions 
The stock solution (IxlO'^M) of ALP was prepared by dissolving 
0.3088g of ALP in 30% aqueous methanol, metal salt solution (IxlO'^M) and 
sodium dodeycyl sulfate (SDS) (1x10' M) were prepared in water. 
Procedure for commercial tablets 
Thirty tablets (1.5 mg of ALP each) were accurately weighed, finely 
powdered and quantity equivalent to 25 mg was extracted by shaking with 25 
ml of 30% aqueous methanol followed by three extractions each with 15 ml of 
30% aqueous methanol. It was filtered by Whatman filter paper No. 42 and 
made up to 100 ml over the same solvent. 
Spectrophotomeiric measurements 
The solution containing 8.0-17.0 p-gml'' of drug was transferred into a 
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series of 10 ml volumetric flask. 1 ml (5xlO"^M) of As(III) solution, 1.5 ml 
SDS and 1 ml Mclivaine buffer of pH 6.5 were added. The mixture was then 
made up to the mark. The absorbance of the resulting solution was measured at 
specific wavelength (nm) cited in table 1 against reagent blank. 
Spectrofluorimetric measurements 
Fluorescence emission spectra were measured at 25°C and optimized 
excitation wavelength. To an aliquot of the solution containing 0.05-9.5 \igm\' 
of ALP, were added 1 ml (2xlO"V) of As(III) solution, 1.5 ml SDS and 1 ml 
Mclivaine buffer (pH 6.5). The fluorescence intensity of solution were 
measured at 520 nm with the excitation at 325 nm against a reagent blank 
prepared with the reagent concentration but not ALP. 
Determination ofstoichiometry, binding constant and binding sites 
The stoichiometry, binding constant and binding sites were determined 
by spectrophotometric and spectrofluorimetric methods. 
Spectrophotometric method 
Solutions of equimolar concentration of ALP (5xlO"^M) and metal ions 
were prepared. In order to calculate the apparent ionization constant of the 
drug, its pH was adjusted between 2.25-10.50 by adding sodium hydroxide and 
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hydrochloric acid (1X10"'M andlxlO"^M) respectively. The absorption spectra 
were recorded 30 min after sample preparation in the range 200-380 nm. The 
binding constant and ratio of metal to ALP was determined by Job's method in 
presence of 1.5 ml SDS (IxlO'V) and 1 ml Mclivaine buffer of pH 6.5. 
Spectrofluorimetric method 
Solution of the ALP (2.4xlO"^M) and those of metal ions 
(0.2xlO-^-1.2xlO"*M) were prepared. To prepare dilute solutions, an aliquot 
of stock was transferred to a 10 ml volumetric flask and made up to the mark 
with distilled water. Spectra were recorded 30 min after the sample preparation 
in 480-560 nm region at optimum excitation wavelength of 325 nm. 
RESULTS AND DISCUSSION 
Spectrophotometric measurements 
The UV-spectrum of 30% methanolic solution of ALP (12.0 lagml"') at 
pH 6.5 (Mclivaine buffer) was run between 200-380 nm. It exhibits a strong 
and a weak abruption at 255 and 325 nm (Fig.2). The first peak was selected 
for further studies. 
The Beer's law was validated from 8.0-17.0 i^gml"' for ALP. The 
spectrophotometric method is based on complexation of ALP with As(III)-SDS 
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system under mild acidic condition. Under the experimental condition the 
linear regression equation: A = 0.362X-2.694 (r = 0.9875), where A is the 
absorbance and X = concentration in ng/ml. The apparent molar absorptivity 
was 3.956x10" L/mol.cm. The detection limit and the limit of quantification 
determined with the acceptable accuracy and precision was 13.520 [igml' and 
1.048x10''^  ^igml'', respectively. 
The low detection and quantification limits showed negligible scatter 
of the points with respect to the line of regression. Concerning the effect of pH 
and buffer, it was found that maximum absorbance was achieved at pH 6.5 in 
Mclivaine buffer (Fig.3). It was observed that 5xl0"^M of As(III) and lxlO"'*M 
SDS concentration has maximum absorbance. 
Spectrofluorimetric method 
The fluorescence emission spectra were run between 480-560 nm at 
optimum excitation wavelength of 325 nm. The spectra of blank, ALP and 
ALP-As(III)-SDS system are shown in fig.4. Maximum emission occurs at 520 
nm with no significant change in peak position. The fluorescence intensity of 
ALP was enhanced in presence of SDS but quenched when AS(III) was added 
to it. Considering the non-interference effect, stability and lower value of blank 
signal the excited wavelength of 325 nm was selected for recording emission 
spectra (A-em =520 nm) in the subsequent experiment. A linear correlation was 
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obtained between the fluorescence intensity and concentration of ALP in the 
range 0.05-9.5 ngml'' and the correlation coefficient was not less than 0.9944. 
The concentrations of different sample of ALP in pharmaceutical formulation 
were calculated from the regression equation: F = 178.17X+ 280.16 (X = 
concentration of ALP in iigml"' and F = fluorescence intensity of ALP-As(III)-
SDS system). The maximum fluorescence intensity were obtained at pH 6.5 
with 0.6x10"^M of As(III) and lxlO"V of SDS. 
Optimum conditions for the reaction 
Effect of the acidity 
The effect of Mclivaine, BR and HCl-NaAc buffer on the reaction 
system were tested and found that Mclivaine buffer of pH 6.5 yields better 
results. Optimum pH range for the reaction was kept between 5.0-7.0. Thus, 
1,0 ml of Mclivaine's buffer of pH 6.5 was taken in each case. 
Effect of the SDS concentration 
When the concentration of SDS was kept at IxlO'^M, the absorbance 
and fluorescence intensity reached the maximum. The reaction was incomplete 
without enough SDS, but when SDS is large excess, the absorbance and 
fluorescence intensity decreases because of the formation of SDS dimers by 
self-aggregation 
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Effect of ionic strength 
The effect of ionic strength on the intensities of AI was studied. The 
results showed that it had little effect on spectrum if NaCl concentration 
was less than SxlO'^M. Therefore, the ion-association reaction would occur at 
low ionic strength condition. 
Analytical performance 
Validation of the proposed methods 
The validity of the method for linearity, specificity, accuracy, 
repeatability and precision was tested according to recommendations [14]. The 
results are shown in table 1. The limits of detection (LOD) were determined by 
establishing the minimum level at which the analyte can be reliably detected. 
The LOQ and LOD were calculated according to the following equation: 
LOQ=10o/S (1) 
LOD= 3.3 o /S (2) 
where a = standard deviation of the intercept of regression line and S = slope of 
calibration curve. The proposed methods were evaluated for the accuracy as 
percent relative error (%Er) and the precision as percent relative standard 
deviation (%RSD) (Table 2). 
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Accuracy and precision 
The reproducibility or precision of tiie method was evaluated by 
statistical analysis of the regression data regarding standard deviation of the 
residuals (Sy/x), the intercept (Sa) and the slope (Sb). The small values of the 
figures point out the low scattering of the calibration graph and high precision. 
Accuracy 
To test the accuracy of the proposed method a certain amount of ALP 
was assayed by the proposed method. The mean percentage recovery of the 
added quantity was found to be 99.54 (spectrophotometric method) and 100.22 
(spectrofluorimetric method). 
Precision 
The precision assay was done by both these method. An amount 9.0, 12, 
15 ngmf' for spectrophotometric and 1.0, 3.0, 7.0 figml'' of ALP for 
spectrofluorimetric measurements were taken respectively. The results 
indicated (Table 2) that the % RSD value for precision determined 
spectrophotomerically and spectrofluorimetrically is lower than 0.478 and 
0.296 respectively. 
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Specificity 
The specificity of the method was verified by checking any interference 
encountered by the excipients in the drug. Lactose which is frequently co-
formulated with ALP did not interfere. 
Robustness of the method 
The robustness of the method is demonstrated by the consistency of the 
absorbance with the deliberate minor changes in volume of As(III) (1.0±0.1 ml) 
and that of SDS (1.5±0.1 ml). These minor changes did not affect the 
absorbance of the reaction product. 
Determination of stoichiometry, binding constant and binding sites 
Spectrophotometric method 
Ratio of the two reacting component was determined by Job's method 
[16,17] at 265 nm, at pH = 6.5 and t = 25 and 35 °C. The Job's curves at 
different temperature showed the formation of 2:1 (drug:metal) complexes 
(Fig.5). The stability constant of the complexes was calculated by the following 
equation [15]: 
A/A„ Cx 
K = (3) 
(CM - A/Aex Cx) (CL - nA/Aex Cx)" 
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where K = binding constant of the metal chelate formed in solution, n = X/( 1-
X) where X = mole fraction of the ligand at maximum absorption. A/Ae^ = ratio 
of the observed absorbance to that indicated by the tangent for the same 
wavelength. Cx, CM and CL are the limiting concentration of complex, metal 
ion and the ligand respectively. The logK increases with increase in 
temperature (Table 4). It has been observed that the logK increases with the 
temperature linearity in presence of metal ions. 
Calculation of apparent ionization constant 
When the spectra of the drug were run at varying pH in the region 200-
380 nm one isosbestic point (Fig.6) at 290 nm was observed which indicated 
the presence of two ionic species in solution [16,17]. The apparent ionization 
constant (pKa') of the drug was calculated (9.29) by the following equation. 
pKa' = pH+ log {(A, - AM)/(A - A^)} (4) 
where Ai = absorbance of drug in basic medium. AM = absorbance of drug in 
acidic medium, A = absorbance of drug in aqueous medium. 
Spectrofluorimetric method 
The fluorescence emission spectrum of the pure drug scanned in 480-
560 nm range {X^^ = 320 nm) is markedly different from its UV spectrum 
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(Fig.7) in presence of metal ions. Although, the fluorescence intensity of ALP-
SDS system decreases steadily with increasing concentration of metal ions, the 
emission maximum remains unchanged. As there was no significant Xem shift 
with the addition of metal ions, it indicated that metal ion can quench intrinsic 
fluorescence of ALP and that the interaction between ALP and metal ion 
indeed existed without inducing any conformational change in it under the 
experimental condition. Quenching can occur by a variety of molecular 
interactions, viz., excited state reactions, molecular rearrangement, energy 
transfer, ground state complex formation (static quenching) and collisional or 
dynamic quenching. Static and dynamic quenching can be distinguished from 
their dependence on temperature and excited state life time. Dynamic 
quenching is diffusion controlled because the quencher must diffuse to the 
fluorophore during the life time of excited state. If the Ksv decreased with 
increase in temperature it may be concluded that the quenching process is static 
rather than dynamic [18,19]. Static quenching refers to the existence of a 
sphere of effective quenching or the formation of a ground state non-
fluorescent complex, whereas collisional or dynamic quenching involves the 
collision and subsequent formation of a transient complex between an excited 
state fluorophore and a ground state quencher. The excited state complex 
dissociates upon radiative and non-radiative deactivation. In order to confirm 
the quenching mechanism the procedure of fluorescence quenching was first 
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assumed to be dynamic for which the mechanism can be described by the 
Stem-Volmer equation [20]. 
Fo/F=l + KsvlQl (5) 
where FQ and F are the fluorescence intensities in the absence and presence of 
the quencher, respectively. Ksv ^ dynamic quenching constant (Table 5). Fig.8 
displays the Stem-Volmer plots of quenching of the ALP by metal ions at 
different temperatures. For static quenching, the relationship between intensity 
and the concentration of quencher can be described by the binding constant 
formula; [21,22] 
log(Fo-F)/F = logK+ nlog[Q] (6) 
where K = binding constant and n = number of binding sites per ALP [Q] = 
concemtration of metal ion. Fig.9 shows double-logarithm curve and table 5 
shows the corresponding calculated results. The linear correlation coefficients 
of all the curves are larger than 0.9852, suggesting interaction of metal ions 
with ALP which agrees well with the site-binding model underlying equation 
(6). 
Thermodynamic parameters and nature of binding forces 
Considering the dependence of the binding constant on the temperature 
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a thermodynamic process was considered and analyzed in order to further 
characterize the forces acting between ALP and metal ions. If the temperature 
does not vary significantly, the enthalpy changes (AH) can be regarded as 
constant. The AG, AH and AS can be estimated from the following standard 
equations: 
AG = -2.303RT logK = AH-TAS (7) 
log K2/K, = [l/T.-l/TzlAH/ 2.303R (8) 
Since AG negative the process was spontaneous. The positive AS value 
is indicative chelation (Table4,6). It occurs only because the water molecules 
that are normally arranged in an orderly fashion around the drug and metal ions 
acquire a random configuration as a result of chelation. It indicates a gain 
in conflgurational entropy [23]. The +ve value of AH suggest that the 
process is endothermic and binding between metal ions and ALP is mainly AS-
driven, with little contribution from the enthalpy factor. 
CONCLUSION 
The proposed methods are simple and sensitive. These do not require 
any pretreatment of the drug and tedious extraction procedure. The methods 
have wider linear range with good accuracy and precision. The results 
presented in this work demonstrate that the proposed methods are accurate and 
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precise. It can be extended for routine analysis of ALP in pharmaceutical 
formulation, hospital and research laboratory. Since the stability increases in 
presence of the metal ions the drug may absorbed with traces of useflil 
elements. 
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Fig.l Structure of Alprazolam (ALP) 
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Fig.2 Absorption spectrum of ALP (S^lOr^ M) at pH 6.50 at 25 "C 
Fig.3 Effect ofpH on complex formation ofALP-As(III)-SDS system: 
1. Mclivaine, 2. BR and 3. Acetate buffer 
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Fig.5(B) Continuous variation curves of complexes of ALP with Co(II) at 
25 and at 35 "C 
Fig.5(C) Continuous variation curves of complexes of ALP with Ni(II) at 25 
and at 35 "C 
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Fig. 7(A) Fluorescence quenching CA« 320 nm) of ALP with As(III) at 25 "C 
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Fig. 7(B) Fluorescence quenching f^« 320 nm) of ALP with Co(II) at 25 "C 
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Fig. 7(C) Fluorescence quenching (X^ 320 nm) of ALP with Ni(II) at 25 'C 
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Fig.7(B) Fluorescence quenching (Xex 320 nm) of ALP with Zn(H) at 
25 "C, (1) 2.4^10-"M ALP, from (2) to 7:0.2^JO'^ 0.4^10-\ 
0.6x10- ",0.8x10- \l.OxlO'\ 1.2X10-"M of metal ions 
101 
Development of UV and Fluorescence Spectrophotometric Methods 
5 -] 
4 • 
3 -
Uu 
2 -
1 -
(A) 
A 
• 
0 • 
0 
y/^k 
' 
OJ 
/ k y( 
J^ y/U 
y/m 
0.6 0.9 
|As(ni)|10"'lVI 
A 
• 
* 25 °C 
• 35 °C 
1.2 1.5 
Fig.8(A) Stern-Volmer plots of ALP with As(III) at 25 and 35 "C 
0.6 0.9 
|Co(n)| IO'M 
Fig. 8(B) Stern-Volmer plots of ALP with Co(II) at 25 and 35 "C 
102 
Development ofUVand Fluorescence Spectrophotometric Methods 
0.9 
|Ni(n)| IO*IVI 
Fig. 8(C) Stern-Volmer plots of ALP with Ni(II) at 25 and 35 "C 
% 
3 -
4 
3 -
2 -
1 -
0 -
(D) 
A v ^ 
• y^ 
I •• 
jT m 
r -
y"^^ 
y^ • 
y/i 
y^ % 
A 
• 
*25°C 
- 35 °C 
0.3 0.6 0.9 
|Zii(II)| lO'M 
1.2 1.5 
Fig.8(D) Stern-Volmer plots of ALP with Zn(Il) at 25 and 35 "C 
103 
Development ofUV and Fluorescence Spectrophotometric Methods 
1 -] 
0.6 -
0.2 -
i£ -0.2 • 
-0.6 -
-1 -
(A) 
A 
• 
-1.4 
-8.8 
1 
-8.5 
4 / ' ^ 
' 
-8.2 
log|As(III)| 
• 35 °C 
1 
-7.9 
Fig.9(A) Double reciprocal plots of ALP with As(III) at 25 and 35 'C 
Fig.9(B) Double reciprocal plots of ALP with Co(II) at 25 and 35 X 
104 
Development ofUVand Fluorescence Spectrophotometric Methods 
^ 
^ i 
1 -| 
0.6 -
0.2 -
-0.2 -
-0.6 -
-1 -
(C) 
• 
-1.4 1 
-8.8 
i 
-8.5 
^y^ *y^ 
• ^ 
1 
-8.2 
log|Ni(ll)l 
^ 
^ 
*25°C 
• 35 °C 
1 
-7.9 
Fig.9(C) Double reciprocal plots of ALP with Ni(II) at 25 and 35 "C 
Fig.9(D) Double reciprocal plots of ALP with Zn(II) at 25 and 35 "C 
105 
Development of UV and Fluorescence Spectrophotometric Methods 
Table 1. Statistical data of calibration graph for the determination of ALP 
using proposed methods 
Parameters Spectrophotometric Spectrofluorimetric 
method method 
X^ax(nm) 
Bear's law limit (jxg ml"') 
Slope (m) 
Intercept (b) 
S.D. of residual (Sy/x) 
S.D. of intercept (Sa) 
S.D. of slope (Sb) 
Correlation coefficient (r) 
Variance (Sy/x^) 
Limit of detection (|ig ml"') 
Limit of quantification (i^ g ml"') 
255 
8.0-17.0 
0.362 
-2.694 
0.970 
1.113x10"^ 
1.482 
0.9875 
0.106 
13.520 
40.970 
Xe,= 520 
Xex = 320 
0.05-9.5 
178.17 
280.16 
72.142 
0.566 
8.434 
0.9978 
0.752 
1.048x10'^ 
3.178x10'^ 
Number of standard samples, n = 7. 
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Table 6. Thermodynamic parameters at 25 and 35 "C 
Metal ions 
As(III) 
Co(II) 
Ni(II) 
Zn(II) 
-AG/kJ.mor' 
25 T 
76.566 
76.230 
75.916 
74.775 
35 T 
88.126 
87.433 
87.203 
85.540 
AH/kJ.mor' 
2.518 
2.054 
2.483 
2.350 
AS/kJ.mor'lC' 
25 T 
0.265 
0.262 
0.263 
0.258 
35 T 
0.294 
0.290 
0.291 
0.285 
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CHAPTER- V 
Resonance Rayleigh Scattering, Second-Order Scattering 
Resonance Rayleigh Scattering, Second-Order 
Scattering and Frequency Doubling Scattering Spectra 
of Copper(II)-Flutamide System with Anionic 
Surfactants and its Analytical Applications 
INTRODUCTION 
Flutamide (FLD), chemically known as 2-methyl-N-[4-nitro-3-
trifluoromethyl) phenyl] propanamide [Fig.l] is widely used as antineoplastic 
(hormonal) and antiandrogen drug [1]. It is a powerful nonsteroidal androgen 
antagonist which is used to treat prostate cancer, is believed to block androgen 
receptor sites. This drug and its primary hydroxy metabolite decrease 
metabolism of C-I9 steroids by the cytochrome P-450 system at the target cells 
in the secondary sex organ [2]. It has been recently included in the United 
States Pharmacopoeia which involves a chromatographic method for the 
analysis of the pure drug and FLD capsules [3]. The number of different 
methods have been reported for determination of the Flutamide in 
pharmaceutical formulation and biological fluids, including polarography, 
spectrophotometry, GC and HPLC [5-12]. 
In this work, we are reporting the impact of ternary ion-association 
complexes on RRS, SOS and FDS spectra. Because the sensitivity of RRS 
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method is higher than those of SOS and FDS, the optimum conditions of the 
reactions and influence factors were mainly investigated by this method. We 
have found that Cu(II) reacted with FLD to form 1:1 cationic chelate 
[FLD'Cu]" ,^ in the pH range 2.2-7.0 Mclivaine's buffer, at room temperature, 
which can result in a little enhancement of intensities of RRS, SOS and FDS. 
The [FLD'Cu]* further reacted with anionic surfactants (AS) such as sodium 
lauryl sulfonate (SLS) and sodium- dodecylbenzene sulfonate (SDBS) to form 
1:1 ternary ion-association complex [FLD»Cu(II)](AS). The intensities of RRS, 
SOS and FDS were substantially enhanced. Three ion association complexes 
have similar spectral characteristics and the maximum RRS, SOS and FDS 
wavelengths were located at 345/345 nm, 610/305 nm and 430/860 nm 
respectively. The increments of scattering intensity (AI) were directly 
proportional to the concentration of FLD in certain ranges. The effects of 
concomitant substance were tested and it showed that the RRS method has a 
good selectivity. A sensitive, simple, selective and rapid method was 
developed for the determination of FLD in pharmaceutical formulations. The 
mechanism for the ion-association reaction and the reason of RRS 
enhancement has also been discussed. 
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EXPERIMENTAL 
Reagents 
Standard solution of FLD was prepared by dissolving 0.0276 g FLD 
(Sigma Aldrich) in 100 ml (40:60) ethanol-water mixture. For working solution 
it was diluted to 25 ngmf'. The working solution of Cu(II) (100 ngml"') was 
prepared by dissolving 0.1 g of CUCI2.2H2O which was diluted with water in 
250 ml flask. Anionic surfactants solutions: SLS, SDS and SDBS (Sigma) of 
1.0xlO~^M, LOXIO'^'M and 1.0xlO"^M, respectively, were prepared. 
Mclivaine's buffer solutions of different pH were prepared. 
General procedure 
A 0.5 ml of AS, 0.5 ml of Cu(II) suitable amount of FLD solution and 
1.0 ml of pH 5.0 Mclivaine's buffer were transferred into a 10 ml flask. The 
mixture was made up to the mark with water, shaken thoroughly and then left 
for 10 min. The RRS intensity (IRRS) of the systems were recorded with 
synchronous scanning at l^x = e^m- The SOS intensity (Isos) and the FDS 
intensity (l''^^) of the systems were recorded at X^m = 2Xe„ and IX^^ = "k^^, 
respectively. The Isos and IRDS were plotted against different wavelengths to get 
SOS and FDS spectra. The scattering intensities (IRRS, ISOS and IFDS) for the ion-
association complexes and, ij^^^, Io °^^  and lo'''^ ^ for the reagent blank were 
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measured at their own maximum, AIRRS = I'^ '^ ^-Io'^ ^, AIsos - I ~Io and 
AT - T ' ' ° M FDS AlpDS ~ A lo 
RSULTS AND DISCUSSION 
Spectral characteristics 
RRS spectra 
It can be seen (Fig.2A) that the RRS intensities of AS, Cu(II) and FLD 
themselves are very weak. The binary chelate of Cu(II) with FLD exhibits only 
a minor change in the RRS spectra but in presence of anionic surfactants 
(SDS, SLS and SDBS) RRS intensities are markedly enhanced due to the 
formation of ternary complex. All the reaction products have similar spectral 
characteristics as the maximum RRS intensity at 345 nm. The RRS intensity of 
the SDS system is highest among the three systems, followed by the SLS and 
SDBS. Fig.2B shows that the enhancement of RRS intensity for the FLD-
Cu(II)-SDS system is directly proportional to the concentration of FLD. The 
RRS method was therefore more effective to the determination of FLD. 
SOS spectra 
It has been observed that the SOS intensities similar to RRS intensities 
of AS, Cu(II) and FLD are very weak (Fig.3A). Formation of the binary chelate 
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shows a little change in the SOS spectra. It has been observed that the when 
binary chelate further reacts with SDS, SLS, and SDBS to form ternary 
complexes SOS intensities are greatly enhance. All the reaction products have 
similar spectral characteristics as the maximum SOS peaks are all the same at 
610 nm. The decrease in scattering intensities (AI^°^) of the system obeys the 
order SDS > SDBS > SLS. Taking FLD-Cu(II)-SDS as an example, when the 
X«x. is at 610 nm, the changes of SOS intensities with different concentration of 
FLD were investigated. It can be seen from Fig.3B that the enhancement of 
SOS intensity is linear to an increased concentration of FLD. The other two 
reaction systems under investigation followed the same pattern. 
FDS spectra 
The intensity of FDS spectra of individual components in solution are 
not very strong but the binary chelates shows a little enhancement. When the 
binary chelate reacts with SDS, SLS and SDBS forming ternary complexes, 
FDS intensities are enhanced to a greater extent. The reaction products have 
similar spectral characteristics at Xm^K 430 nm. The intensities of reaction 
products were different and their relative scattering intensities {Af°^) follows 
the order SDS > SLS > SDBS. When FDS Spectra of the system FLD-Cu(II)-
SDS A^x at 430 nm was taken intensities of FDS spectra is proportional to the 
concentration of FLD. The sensitivity of RRS method is higher than those of 
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SOS and FDS, therefore RRS method was apply to obtain optimum reaction 
condition. 
Optimum reaction conditions 
Effect of acidity 
The effect of different buffer solutions on RRS intensities were tested 
with Mclivaine's, Britson-Robinson and HAc-NaAc buffer and Mclivaine's 
buffer was found to be most suitable. Optimum pH range for the reaction was 
2.2-7.0, 2.2-6.8 and 2.2-6.9 for SDS, SLS and SDBS systems, (Fig.5) 
respectively. Thus, 1.0 ml of Mclivaine's buffer of pH 5.0 was taken in each 
case. 
Effect of the Cu(II) concentration 
It can be seen (Fig.6) that RRS intensity reached a maximum and then 
remained stable even when the concentration of Cu(II) was raised from 1.5-5.0 
(igml"'. The concentration of Cu(II) was kept constant at 3.0 fagmf' in 
subsequent experiments. 
Effect of the AS concentrations 
The RRS intensity enhanced gradually with increasing concentration 
of AS in FLD-Cu(II)-As system. When the concentrations of SDS, SLS, and 
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SDBS were kept at (1.0-5.0)xlO"V, (2.0-5.0)xlO"V and (2.0-4.0)xlO'-M, 
respectively, AIRRS attained maximum (Fig. 7). If AS is not adequate, the 
reactions would be incomplete but when AS is excessive, the intensities of 
RRS would decrease as a consequence of the formation of AS dimer by self-
aggregation. The concentration of anionic surfactants were therefore, suitably 
adjusted. 
Reaction speed and the stability of scattering intensity 
The reaction completed in 10 min at room temperature and RRS 
intensity remained constant for 2.5 h at least. 
Effect of ionic strength 
The ionic strength was maintained by NaCl and its influence on the RRS 
intensity was studied. AIRRS remained constant when the concentration of NaCl 
was kept below 1.0xlO~^M, but above this concentration of NaCl, AIRRS 
gradually decreased. The ion-association reaction occurs strictly under very 
low ionic concentration of NaCl. 
Sensitivity of method 
Varying concentrations of FLD was allowed to react with Cu(II)-AS in 
to form ternary complexes and their relative scattering intensities AIRRS, AIFDS 
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and AIsos were measured at their maximum scattering wavelengths after 10 
min. The calibration graphs of AIRRS, AISOS and AIpos against the 
concentrations of FLD were plotted (Table 1). It can be seen that the sensitivity 
of RRS method is higher than those of FDS and SOS though all these methods 
can be applied to determine FLD The detection limits (3a) of FLD by RRS 
method were 1.9 ng mf' for SDS, 2.1 ngmf' for SDS and 2.2 ngmf' for 
SDBS systems, respectively. Although the sensitivity of all the methods were 
higher by one to three order of magnitude than those of common HPLC, flow 
injection spectrophotometry, spectrophotometry and fluorimetry. The RRS 
method had much higher sensitivity of all (Table 2). They proved to be more 
suitable for the determination of trace amounts of FLD. 
Formation of ternary ion-association complex and its effect on the spectral 
characteristics 
The ion-association reaction 
Ratio of the ternary complex (FLD-Cu(II)-AS) was found to be 1:1:1 as 
established by Job's method. It can be formulated as [FLD»Cu(II)]AS. The 
reaction mechanism is depicted below: 
FLD + Cu(II) . • [FLD-Cu]^ 
[FLD»Cu]V AS' • ' [FLD»Cu]AS 
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The carbonyl group and nitrogen atoms on the propanamide appear to be 
most potential donor sites in FLD and expected to form a chelate through then 
tFLD»Cu(II)]*. Anionic surfactants (SDS, SLS and SBDS) at low concentration 
in weak acidic medium exist as monovalent anions SDS", SLS" and SDBS", 
respectively. They can react with [FLD»Cu(II)]* to form ternary ion-association 
complexes through electrostatic attraction and hydrophobic forces. 
Effect on RRS spectra 
It can be seen (Fig.2-4) that the formation of ion-association complexes 
can result in marked enhancement of RRS, FDS and SOS intensity. Since the 
sensitivity of RRS method is higher than those of others, it was used for the 
determination of trace amounts of FLD. The possible reason for RRS 
enhancement is given below: 
Resonance enhanced Rayleigh scattering effect 
When the wavelength of Rayleigh scattering is close to the molecular 
absorption band, the scattering can absorb the light energy through resonance 
to produce a re-scattering process. As a result the scattering intensity is greatly 
enhancement [13,14]. 
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Enhancement of hydrophobicity 
Since Cu(II), [FLD'CuCI^J^and AS' are hydrophilic they easily dissolve 
and cannot form an interface with water. When [FLD»Cu(II)]* reacts with AS~ 
to form the neutral ion-association complex [FLD»Cu(II)]AS, a hydrophobic 
liquid-solid interface appears owing to the presence of the aryl framework of 
the ternary complex. This hydrophobic interface is helpful in the enhancement 
ofRRS signal [15]. 
Enlargement of scattering molecular volume 
The formation of ion-association complex enhanced the scattering 
molecular volume or weight, which also enhanced the scattering intensity. 
According to the Rayleigh-scattering formula [30]: / = KCMlg (where, I = 
resonance Rayleigh scattering intensity, IQ = incident light intensity, C = 
concentration of solution, K = proportional coefficient and M = molecular 
weight) When K, C and lo are constant in Rayleigh-scattering formula, I is 
proportional to M. When binary chelate [FLD'CuCII)]"" (M.W.= 339.7) reacts 
with AS" (SDS, SLS and SDBS) to form ternary complex [FLD-Cu(II)]AS the 
molecular weight increases from 339.7 to 628.08, 612.08 and 688.18. It is 
obvious that the RRS intensity is directly proportional to the molecular volume 
or molecular weight of the complexes. 
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Selectivity of RRS method and its analytical application 
Effect of concomitant substances 
We investigated the effect of concomitant substances on the 
determination of FLD under optimum conditions. This method does not suffer 
any interference from commonly associated excipients and additives like 
sucrose, lactose, dextrose, starch, talc, stearic acid and sodium alginate. It is 
obvious that RRS method is highly selective. 
Analytical application 
Different amount of FLD was transferred into a 10.0-ml volumetric flask 
according to the general procedure. The % R.S.D (0.28-3.53) and % recovery 
(99.54-100.52) shows that the RRS method has a good repeatability (Table 3). 
Therefore, this method can be used for the determination of FLD in 
pharmaceutical formulation (Table 4). 
CONCLUSION 
The three methods for the determination of the FLD has been 
developed. It is demonstrated that FLD reacts with Cu(II) and anionic 
surfactants to form ternary ion-association complex in 1:1:1 molar 
ratio. As a result, the RRS, SOS and FDS intensities of complex 
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enhance remarkably. The increments (AI) are directly proportional to 
the concentration of FLD. 
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F3C, H N. V^vV° 
H3C' 'CH-O2N n U v^n3 
Fig.l Structure o/Flutamide (FLD) 
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Fig.2(A) RRS spectra of FLD-Cu(II)-AS systems: From 1 to 8: (1) FLD, (2) 
Cu(II)SDBS, (3) Cu(II)SLS, (4) Cu(II)SDS, (5) Cu(U)-FLD, (6) 
FLD-Cu(II)SDBS, (7) FLD-Cu(II)SLS and (8) FLD-Cu(II)-SDS. 
The concentration of FLD: S-OjugmC'; the concentration ofCu(II): 3.0 
Mgmr'; the concentration of SDS and SLS: 3.0^10'*M; the 
concentration ofSDBS: 4.0^10~^M 
450 550 
Wavelength (nm) 
Fig.2(B)RRS spectra of FLD-Cu(lI)-AS systems: From 1 to 7: the 
concentration of FLD: 0.5, LO, 2.03.0, 4.0, 5.0 and 6.0 ngmC' 
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F^.3(A) SOS spectra of FLD-Cu(II)-AS system: From 1 to 8: (1) FLD, (2) Cu(II)-
SDBS, (3) Cu(II)SLS, (4) Cu(Il)SDS, (5) Cu(n)-FLD, (6) FLD-Cu(U)-
SDBS, (7)FLD-Cu(II)-SLS and (8) FLD-Cu(ir)-SDS The concentration of 
FLD: ZOfJigmT^; the concentradon ofCu(H): lOfigmf'; the concentration 
ofSDS and SIS: SMlff^M; the concentration ofSDBS: 4.0^10'^M 
Fig.3(A) SOS spectra of FLD-Cu(II)-AS system: From 1 to 7: 
concentration of FLD: 0.3, 0.9L2, L6, 2.0, 2.6, and3.0/4gmr' 
the 
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Fig.4(A) FDS spectra of FLD-Cu(II)-AS systems: From 1 to 8: (l)FLD, 
(2) Cu(II)SDBS, (3) Cu(II)SLS, (4)Cu(II)SDS, (5) Cu(n)-FLD, (6) 
FLD-Cu(II)SDBS, (7)FLD-Cu(JI)SLS and (8)FLD-Cu(II)SDS. The 
concentration of CTRX: 2.5 ngmC'; the concentration of Cu(II): 2.5 
Mgmf'; the concentration of SDS and SLS: 3.0^10"'M; the 
concentration ofSDBS: 4.0x10~^M 
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Fig.4(B) FLD-Cu(II)-SDS system: From 1 to 7: the concentration of FLD: 
0.5,1.0,1.5, 2.0 2.5, 3.0 and4.0figmr' 
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concentration ofCu(II): 2.5jugmr' 
Fig.6 Effect of the Cu(II) concentration: (1) FLD-Cu(II)-SDS (2) FLD-
Cu(II)-SLS (3) FLD-Cu(II)-SDBS; The concentration of FLD: 2.5 
HgmT' 
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CHAPTER' VI 
Determination of Leflunomide: Resonance Rayleigh Scattering 
Determination of Leflunomide: Resonance 
Rayleigh Scattering Spectra and Non Linear 
Scattering Spectra of Leflunomide-Co(II)-Eosin Y 
System 
INTRODUCTION 
Leflunomide (LFD), [N-(4-trifluoromethylphenyl)-5-methyl-isoxazole-
4-carboxaniide] (Fig.l) is a novel isoxazol derivative with both anti-
inflammatory and immunosuppressive properties. It has been used to reduce 
the signs and symptoms of arthritis and to retard joint damage in patients with 
chronic rheumatoid arthritis. It is a prodrug, which is rapidly and non-
enzymatically converted to its active metabolite, A77 1726 after oral 
administration. It has been reported [1-4] that A77 1726 possesses 
immunomodulator effects of the drug by reversible inhibition of the enzyme 
dihydroorotate dehydrogenase and inhibits cell proliferation of lymphocytes. 
Since the conversion of LFD to A77 1726 in vivo is essentially complete, most 
pharmakokinetic studies have been focused to measure A77 1726 [5]. The in 
vitro investigation concerning its mode of action demonstrated that 
leflunomide mediates its effects, at least in part, by inhibition of cellular 
proliferation of a wide variety of cultured cell lines [1]. Several HPLC methods 
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have been reported for kinetic monitoring and determination of All 1726 in 
human blood plasma [6-11]. The levels of LFD and A77 1726 in the cells and 
in the incubation media has been determined by LC-MS/MS and HPLC [12]. 
Among available HPLC methods reversed phase columns with different size 
have been used for the quantification of the major metabolite. In a 
simultaneous determination of LFD and A77 1726 in human plasma performed 
by HPLC, the retention time of drug was found to be about 16 min [9]. It is 
relatively long time for an active content assay of LFD to use in routine 
laboratories. Recently, a pharmaceutical determination of LFD by FIA-UV 
detection has been reported [13]. 
Since no fluorescence study for the determination of 1-FD in 
pharmaceutical preparations has been made we have undertaken this project to 
analyse the drug by RRS, SOS and FDS methods. The optimum conditions of 
the reaction and influencing factor were investigated. The selectivity of the 
methods and analytical application were studied. In addition, the reaction 
mechanism was discussed. 
EXPERIMENTAL 
Reagents 
The stock solution of LFD (l.OxlO'^M) (Sigma Aldrich) was prepared 
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in 100 ml 30:70 ethanol-water mixture. A 1.0xlO~^M solution of Co(II) 
(C0CI26H2O Merck Ltd) was prepared and diluted to 10 ^igmf'. A 5.0x10"^M 
solution of Eosin Y (Merck Ltd) was diluted to 5.0 jigmf'. Britton-Robinson 
buffers (BR) of different pH value were prepared. 
General procedure 
To a 10.0 ml flask were added 1.0 ml BR buffer of pH 5.5, 1.5 ml of EY 
solution, 2.0 ml of Co(II), 0.5 ml of NaCl and an appropriate amount of 
standard LFD solution. The mixture was made up to the mark and mixed 
thoroughly. After 15min, the RRS spectra of the system were recorded with 
synchronous scarming at Xex = Xem- The SOS intensity (Isos) and the FDS 
intensity (IFDS) of the systems were recorded at Xem = 2>tex and 2Xeni = "^•^, 
respectively. The 1^ °^  and 1L^^ were plotted against wavelengths to get SOS 
and FDS spectra. The sample and reagent blank scattering intensities (IRRS, 
Isos, IFDS» I RRS. I SOS and I FDS) were measured at their ovm maximum scattering 
wavelength, AIRRS = IRRS ~I RRS. AISOS - Isos ~ I sos» AIpos ~ IFDS ~ I FDS-
RSULTS AND DISCUSSION 
RRS spectra 
The RRS intensity of LFD and EY separately are too weak (Fig.2). 
However, the binary chelate of LFD with Co(II) results in a little increase in 
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spectral intensity. When it further reacts with EY to form ternary ion-
association complex, the RRS intensity is markedly enhanced and the spectrum 
is well resolved. This ternary ion-association complex shows a strong peak at 
350 nm besides two weaker peaks at 500 and 560 nm. The EY are located at 
352, 503 and 565 nm. It is also observed that the enhancement in RRS intensity 
is directly proportional to the concentration of LFD in the range 0.009-3.0 
^gm^'. The RRS method can therefore, be effectively used for the quantitative 
determination of LFD. 
SOS and FDS spectra 
When the incident light of shorter wavelength passes through the 
solution, the SOS appears at Xem = 2X.ex, in the case of incident light of longer 
wavelength the FDS appears at X^ = l/2Xex.When the SOS and FDS intensities 
at different incident wavelengths were measured and plotted against the 
corresponding wavelength, the SOS and FDS spectra were obtained (Fig.3.,4). 
The SOS and FDS intensities of LFD, EY and binary chelate ([LFD<:o(II)]^) 
are weak, but when it reacts with EY to form ternary ion-association complex 
intensity of SOS and FDS spectra is enhanced appreciably. The maximum 
scattering wavelengths (kJKm) appear at 260/520 nm (SOS) and 780/390 nm 
(FDS). These increasing scattering intensities are proportional to the 
concentrations of LFD. The SOS and FDS methods can be used for the 
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determination of LFD 
Optimum conditions for the reaction 
Effect of the acidity 
The influence of different types of buffer on the RRS, SOS and FDS 
intensity were tested. The BR buffer showed the best results in the pH range 
4.2-6.5. We chose pH 5.5 for reaction in acidic medium (Fig.5). The 
appropriate amount of BR buffer was 1.5 ml. 
Effect ofCo(II) and EY concentration 
-I When the concentration of Co(II) was kept between 1.5-2.5 ^gmf , the 
RRS intensity reached maximum and remained nearly unchanged (Fig.6). The 
experimental concentration of Co(II) was, therefore, maintained at 2.0 figmf'. 
The results showed that when the concentration of EY was kept at 1.5 lagmP', 
the AIRRS reached maximum. The reaction was incomplete without substantial 
concentration of EY although in presence of its large excess the scattering 
intensity is reduced because of the self-aggregate of EY. 
Effect of ionic intensity 
Since the experimental results showed that it had little effect on RRS 
intensity, if NaCl concentration was kept below 0.05M the ion-association 
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reactions were investigated under a low ionic concentration of NaCl. 
Reaction speed and the stability 
At room temperature, the reaction could complete in lOmin and RRS 
intensity remained constant for 3h. Experiment was carried out in 30 min. 
Formation and composition of ion-association complex 
Structure of complex and reaction mechanism 
The composition of binary chelate [LFD»Co(II)]* and ternary complex 
LFD-Co(II)-EY has been established by Job's method (Fig.7) [14]. It is shown 
that LED forms a complex with Co(II) in 1:1 ratio but its reaction with EY 
leading to the formation of ternary ion-association complex [LFD»Co(II)]2EY 
exhibits 2:2:1 molar ratio. The mechanism is shown as follows: 
1. It is assumed that Co(II) is possibly coordinated with LFD through oxygen 
and amide nitrogen to form a four-membered ring as shown below: 
r I 
N C -
H,C F,C 
Co 
I 
/ N C 
/ 
H,C 
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2. EY in aqueous solution, exists as such species as HsL ,^ H2L and L ~ 
According to its dissociation constant (pKai=2.10, pKa2 =2.85, pKa3= 
4.95,[15], when pH is 5.3, the dissociation distribution of L ~ is about 
69.14% and that of HL is about 30.86%. The \}' is the dominant species if 
EY can react with [LFD»Co(II)]* to form a ternary ion-association complex 
[LFD«Co(II)]2EY. 
+ 
'^^^^^ 
Reasons for the generation and enhancement of RRS-resonance enhanced 
scattering effect 
Effect of absorption spectra on RRS 
Since RRS is a scattering-absorbing-rescattering process produced by 
the resonance of the scattering and absorption, RRS spectrum is closely related 
to the absorption spectrum. A comparison of RRS with absorption spectra 
(using reagent blank as a reference solution) shows that the RRS spectrum is 
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situated in its absorption band, which is prerequisite for RRS. As shown in fig. 
8, the three RRS peaks of the ion-association complex at 350nm, 500nm and 
560mn just correspond to its three absorption peaks at 255 nm, 340nm and 516 
nm, although there is some space between RRS peak and absorption bands. It is 
because when scattering molecule absorbs light energy at 255 nm, the 
absorption-rescattering process takes place. A small loss of energy during the 
absorption rescattering process makes the RRS peak red shifted from 250 nm to 
350 nm. The resonance enhanced effect then takes place and the scattering 
intensity is appreciably enhanced. 
Effect of molecular volume 
The formation of ion-association complex enhanced the scattering 
molecular volume or weight, which also enhanced the scattering intensity. 
According to the Rayleigh-scattering formula [30]: / = KCMIg (where, I = 
resonance Rayleigh scattering intensity, IQ = incident light intensity, C = 
concentration of solution, K = proportional coefficient and M = molecular 
weight) When K, C and IQ are constant in Rayleigh-scattering formula, I is 
proportional to M. The increase in volume of the scattering molecule is 
advantageous for the enhancement of scattering intensity [1.6]. When the 
molecular volume cannot be ascertained, we can use molecular weight. The 
molecular weight of free LFD is very low (270.2), but that of the ternary 
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complex is substantially high 1306.157. It appears that the enhancement in 
RRS intensity is proportional to the increase in molecular weight. 
Effect of molecular planarity and rigidity 
Due to the increase in molecular volume and bonding between positive 
and negative charges, the rotations of the aryl group of the dye molecules are 
limited. As a result, the molecular planarity and rigidity increase, which leads 
to the enhancement of RRS, FDS and SOS. 
The formation of hydrophobic surface 
Dinegative EY ion and [LFD»Co(II)]* as a monocation in aqueous 
solution can easily form hydrates. The scattering intensities are very weak 
under this condition. When they react with each other to form an ion-
association complex, their charges are neutralized and they lose hydrophilicity. 
Therefore, hydrophobic interface between the aryl framework of the ion-
association complex and aqueous phase enhances the scattering. The intensities 
of RRS and nonlinear scattering is therefore, markedly enhanced. 
The energy transfer between absorption, fluorescence and RRS 
There is a relationship of 'As one falls, another rises' between the 
absorbance, fluorescence and RRS intensity. On moving from pure LFD to 
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ternary ion-association complex of Co(II) and EY, the absorbance decreases 
and the fluorescence intensity quenches, but RRS enhances notably. Resonance 
Rayleigh scattering is a resonance enhanced scattering produced by the 
resonance between Rayleigh scattering and absorption of the same frequency. 
During this process, scattering enhances because it absorbs light energy a part 
of which is transferred to scattering through the resonance effect and hence as 
RRS enhances, the absorbance decreases. There is a relation between the 
energy released and the energy absorbed. The absorbed light energy (EA) is 
equal to the sum of the energies of light emitted (fluorescence) (EL), resonance 
scattering (ERRS) and non-radiation (EN), viz. 
Fluorescence quenching occurs when the energy of fluorescence is 
transferred to non-radiation (E ) energy. However, the existence of resonance 
scattering in large molecule or ion-association systems can not be ignored. The 
RRS spectrum lies in its fluorescence band, there would be an energy transfer 
from fluorescence to resonance scattering. The fluorescence quenching is not 
only the transfer of the radiation to non-radiation energy, but also the transfer 
between fluorescence and resonance scattering. A part of radiant 
fluorescence is transferred to resonance scattering through the resonance effect 
to produce a resonance light scattering. The synchronous change of 
fluorescence quenching and scattering enhancement can be seen from fig.9. 
147 
Determination of Leflunomide: Resonance Rayleigh Scattering 
The fluorescence quenching can be observed in the study of RRS of 
fluorescence systems. It is believed that the enhancement of RRS is a 
consequence of the energy transfer from light absorption and light emission to 
the scattering [17]. 
Sensitivity and selectivity of RRS method and its analytical application 
Sensitivity 
AIRRS of the LFD complex with Co(II) and EY was measured under 
optimum conditions. A plot of AIRRS against the LFD concentration was made. 
The regression equation, linear range, correlation coefficient and detection 
limit are listed in Table 1. Though all the three methods have high sensitivity 
the RRS is faster, simpler and cheaper and the detection limit falls between 
0.641-4.55 ngmf' 
Selectivity of RRS method 
We have investigated the effect of some common metal ions, salt and 
coexisting substances associated with the LFD in tablet form using the RRS 
method (Table 3). The result showed that this method does not suffer any 
interference from commonly associated excipients and additives of tablets such 
as lactose monohydrate, quinoline yellow, and titanium oxide. 
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Analytical application 
Different aliquots of LFD were transferred into a 10.0 ml volumetric 
flask and accuracy was checked through standard addition method (Table 4). 
The % recovery (98.88-101.60) reflects high accuracy of the procedure in 
addition to the precision as indicated by the very low values of the % R.S.D 
(1.022-2.846). The method is therefore recommended for the determination of 
LFD in pharmaceutical formulation. 
CONCLUSION 
The RRS, SOS and EDS methods has been developed for the 
determination of LFD in Pharmaceutical formulation. It is demonstrated that 
LFD reacts with Co(II) and EY to form ternary ion-association complex in 
2:2:1 molar ratio. As a result, the RRS, SOS and FDS intensities of complex 
enhanced remarkably. The increments (AI) are directly proportional to the 
concentration of LFD. 
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F,C 
H O 
.N C 
H,C 
N 
O' 
Fig.l Structure of Leflunomide (LFD) 
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Fig.2 RRS spectra of LFD-Co(II)-EY system: (1) LFD (2) EY (3) 
fLFD'Cofll)/" (4-8) LFD»Co(II)j2EY. (Concentration of LFD, 1.0, 1.5, 
2.0, 2.5 and 3.0 ngmT'). The Concentration of EY, 1.0 figmC' and 
Co(II),2.0figmr' 
Fig.3 SOS spectra of LFD-Co(II)-EY system: (1) LFD (2) EY (3) 
[LFD*Co(n)J'and (4) I.FD*Co(Il)]2EY. The Concentration ofEY, 1.0 
jugmf' LFD and Co(n), lOfigmf' 
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Fig.4 FDS spectra of LFD-Co(II)-EY system: (I) LFD (2) EY (3) 
lLFD»Co(II)t and (4) LFD»Co(II)j2EY. The Concentration ofEY, 1.0 
figmf' LFD and Co(II), 2.0 figmf' 
Fig.5 Effect of the acidity: LFD-Co(II)-EY system; Concentration of EY, 
1.0 Mgmr', LFD and Co(II), 2.0 figmf' 
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The concentration ofLFD 2.0 figmC' 
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Fig.9 The relationship between the absorbance, fluorescence and RRS 
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Interaction of CFP wifli Metal ions: Complex Formation of CFP witfi 
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2. ^. ^^^^ ^"^ ^Mi Ca'', Mg'\ Mn'\ Fe'*, Co'\ H\'\ Cu'' ^ Zn's)- Cefpodoxime proxetil (CFP)^ ^ o^^  
2704 345 nmofl^ i ^ 7lls] ^^-I t-V-S-JLe| l - i^4. '^^I pH^l^^ ±,^ S.^^-§r ^ ^1^ ^ isosbestic''d(305 
4 330nm)^ 1 4 4 ^ ^ 4 . *l-^-g-"5^^oHl^i 0-^^2] sa]Ei oj^ol ^^fl^-f-s^^l^Vcf. c f f - i ^ i ^ ^ 
^o]^o1]^^ CFP^ ^^«J-l-:i5ilE.ej.^chelatingenhancement fluorescence(CHEF)J:4<^l ^]^ «J=J-^ J-
i 7 > ^ 7 1 - ^ ^ °^ ^  %lSd4. «,M14 4 ^ ^ - 1 - 8 - Job"s 4 Benesi-Hildebrand wj-'ti °fl s^  «ll l^^ ^^  s] c^ j cf. *v 
1^ ^  Hl-^ i i - ^ 4-i- ^M 4 ^H^4. Ca'' < Mg'' < Co'* < Ni'" < Zn'* < Mn'" < Cu'^  < Fe'\ 
^n\0]: CFP; ^7j-^7^h ^>^J-£ ^^^l «,M1^^^; CHEF 
ABSTRACT. Spectrophotometric investigation of the interaction of Cefpodoxime proxetil (CFP) with Ca^ *, 
Mg^ *, Mn^ *, Fe'*, Co^ *, Ni^ *, Cu^ * and Zn^ * in acidic medium showed the formation of 1:1 complex. The ab-
sorption spectrum of pure drug exhibits two prominent peaks at 270 and 345 nm. Its spectra scanned at several 
pH exhibited two isosbestic points (305 and 330 nm) indicating the presence of zwitterionic condition of drug 
in solution phase. The fluorescence emission spectra of CFP in presence of different concentrations of metal 
ions showed enhancement in fluorescence intensity which is ascribed to chelating enhancement fluorescence 
effect (CHEF). The stoichiometry of the complexes was determined by Job's and Benesi-Hildebrand method. 
The stability of the complexes follow the order Ca '^'< Mg^ *< Co^ *< Ni^ *< Zn^ *< Mn^ *< Cu^ "< Fe'\ 
Keywonb: CFP, Fluorescence enhancement, Stability constant. Complex formation, CHEF 
INTRODUCnON 
Cefpodoxime proxetil (CFP) is a semisynthetic 
P-lactum antibiotic known as (RS)-l(isopropox-
ycarbonyloxy) ethyl (+)-(6R, 7R)-7-[2-(2-amino-
4-thiazolyl)-2-{(Z) methoxyimino} acetamido]-
3-methoxymethyl-8-oxo-5-thia-l-azabicyclo 
[4.2.0] oct-2-ene-2-carboxylate. It is an ester pro-
drug of cefpodoxime acid where a proxetil radical 
is attached to cefpodoxime acid {Fig. I). It is the 
third generation cephalosporin ester, used in the 
treatment of upper respiratory tract and urinary 
tract infection. In biological system cefpodoxime 
undergoes ester hydrolysis and converted into cef-
podoxime acid to exhibit its antibiotic activity.'"^ It 
has an asymmetric carbon at position 4 and is sup-
plied as racemic mixture of R and S-enantiomers. 
Only a few methods are reported to quantify 
-152-
<^ ^]^^\ CFP '-i±^A-%'. i^ ^=1 ^i"i^\ ^m -iKv °l-^ --4 CFP21 'H: H^i 153 
N \I «. C 
Fig. 1. Structure Cefpodoxime Proxetil (CFP). 
CFP,^ "'* nevertheless the analytical methods of de-
tection of CFP are handftii, and they employ RP-
HPLC. These methods are based on separation of 
the R- and S-isomers.' However, both the isomers 
are reported to exhibit similar biological activity, 
the use of highly sophisticated and time-consum-
ing methods is not always required for routine 
analysis of CFP from the diflFerent dosage forms. 
The discovery of cephalosporin from C.acrem-
onium culture by Brotzu and demonstration of its 
remarkable stability towards aqueous solution 
even at pH 2 as well as its excellent in vitro activity 
against penicillin-resistant organisms by Abraham 
and Newton, were major breakthroughs in the 
history of P-lactam antibiotics. The realization that 
fungi might be a good source for novel antibiotics 
spurred microbiologists to develop novel soil-
screening programmes for the investigation of mi-
crobial culture leading to the discovery of several 
o 
non-classical P-lactams like carbapenem and 
oxacephems. The reactivity of (i-lactam anti-
biotics is fundamentally linked to antimicrobial 
activity, it led Woodward'" to design and synthe-
size carbapenem group of compounds for evalua-
tion of their antibacterial activity through system-
atic screening of the soil microorganism. Numerous 
of these compounds show broad-spectrum anti-
microbial activity as predicted earlier and it was 
further substantiated by the subsequent discovery 
of thienamycin. It is unstable in its pure form and 
hence its derivatives are used which also led to the 
introduction of imipenem, which is regarded as 
one of the most effective drugs among the p-lactam 
antibiotics. Although several methods have been 
developed to determine the drug in biological flu-
ids and pharmaceutical preparations no eflFort 
seems to have been made to investigate the inter-
action of the drug with metal ions. 
In the present work an earnest effort has been 
made to study the interaction of the CFP with met-
al ions by fluorescence emission and absorption 
spectrophotometric measurements. Since quench-
ing or enhancement in fluorescence intensity of 
the drug in presence of metal ions occurs, the spec-
tra of the drug in presence of different concen-
trations of metal ions such as Ca^ *, Mg *, Mn '^, 
Fe^\ Co^\ W\ Cu^^ and Zn^' were scanned. The 
ratio of the drug to metal ions was determined by 
Job's method and Benesi-Hildebrand methods.'^" 
The absorption spectra of the drug in the pH range 
2.32-11.50 were run to see the zwitterionic con-
dition, apparent ionization constant and the iso-
sbestic point which indicate the presence of differ-
ent species in solution. The stability constant of 
the complexes formed between the drug and metal 
Table 1. Stability constant and other thermodynamic parameters of CFP complexes (Job's method) 
MCTai 
Ca^ * 
Mg^ ^ 
Mn^ ^ 
Fe^ ^ 
Co'^ 
Ni'^ 
Cu=^  
Zn^ ^ 
25 °C 
5.600 
5.915 
6.200 
6.287 
5.983 
6.130 
6.211 
6.184 
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logK 
35 X 
5.846 
6.044 
6.289 
6.356 
6.122 
6.276 
6.315 
6.297 
Gibbs energy change 
(-AG)(kJ.mol"') 
31.95 
33.75 
35.38 
35.87 
34.13 
34.97 
35.44 
35.28 
Enthalpy change 
(AH) (J.mor') 
270.22 
164.93 
49.97 
260.34 
244.95 
178.43 
240.25 
190.29 
Entropy change 
(AS) (J.mof' K"') 
108.13 
113.82 
118.91 
121.22 
115.38 
117.97 
119.93 
119.04 
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Table 2. Stability constant, Gibbs energy change of 
CFP complexes (Benesi-Hildebrand method) at 25 "C 
Metal 
Ca^ ^ 
Mg^ ^ 
Mn'* 
Fe^ ^ 
Co'* 
Ni^ ^ 
Cu'* 
Zn'* 
logK 
6.854 
6.869 
6.886 
6.919 
6.883 
6.884 
6.896 
6.889 
Gibbs energy change 
(-AG) (kJ.mol"') 
39.11 
39.19 
39.29 
39.48 
39.27 
39.28 
39.34 
39.30 
R= 
0.9843 
0.9784 
0.9769 
0.9914 
0.9807 
0.9845 
0.9668 
0.9706 
ion was also evaluated. 
EXPERIMENTAL 
nm. The ratio of ntetal to CFP was determined by 
Job's method. The linearity of CFP was found in 
the range 2x10"' to 6x10"^  mg/ml and the correla-
tion factor (R )^ 0.9236. 
Fluorescence study 
Solution of the CFP [l-'^w" M) and those of 
metal ions (I x 10"* to 7^ 10'^  M) were prepared. To 
prepare dilute solutions, an aliquot of stock sol-
ution was placed in a 10 ml volumetric flask and 
made up to the mark with distilled water. Spectra 
were recorded immediately after sample prepara-
tion in the optimum wavelength range 370-430 nm 
at optimum excitation wavelength of 335 nm. For 
calibration curve an aliquot of stock solution 
(1X10"* to 3 X10"' mg'ml) was prepared which showed 
linearity with correlation factor (R") 0.9652 
Instruments 
The absorption spectra were obtained with 
Elico-SL-i69 double beam UV-visible spectro-
photometer. Fluorescence emission spectra were 
scanned with Hitachi-F-2500FL-spetrophotometer. 
All potentiometric measurements were done with 
Elico-LI-120 pH meter. 
Methods and materials 
Double distilled water was used throughout 
Cefpodoxime proxetil (Lupin pharmaceutical Ltd, 
India), sodium hydroxide and metal chloride 
(Merck Ltd, Mumbai, India) and HCI (Ranbaxy 
fine chem. Ltd, India) were used as received. 
Preparation of solution 
Stock solution of Cefpodox\nr\e proxetil and 
metal salts of 1 x 10''' M were prepared in 1 x 10"^  M 
HCI. Stock solution of drug was stored at 4 °C. 
Spectrophotometric method 
Solutions of equimolar concentration (IxiO"^ 
M) of CFP and metal ions were prepared. The pH 
of the drug was adjusted between 2.32 to 11.50 by 
adding sodium hydroxide and hydrochloric acid 
(1 xlO'' M andl xlO'^M respectively). The absorp-
tion spectra were recorded in the range 250-380 
RESULTS AND DISCUSSION 
Spectrophotometric study 
The absorption spectrum of CFP (Ixio"* M) 
was run in the region 250-380 nm. It exhibited two 
peaks at 270 and 345 nm (Fig. 2). Since the first 
peak is very strong it was selected for further ab-
sorption studies. 
When the spectra of the drug were run at vary-
ing pH in the region 250-380 nm two isosbestic 
points, one at 305 nm and another at 330 nm were 
observed which indicated the presence of zwitter 
ionic condition in solution (Fig. 3).'" The appa-
•i 0.8 
250 270 290 310 330 350 370 
Wavelength (nm) 
Fig. 2. Absorption spectrum of CFP(I xJO"^  !VI)at pH 
5.15. 
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Fig. 3. Absorption Spectra of CFP (1 xlO"^  M) in (2.32-
11.50) pH range. 
rent ionization constant (pKa') of the drug was cal-
culated (8.92) by the following equation. 
pKa' = pH+log{(Ai-AM)/(A-AM)} (I) 
where, Ai = absorbance of drug in basic medium, 
AM = absorbance of drug in acidic medium, A= 
absorbance of drug in aqueous medium. 
The absorption spectra corresponding to the 
metal, drug and complexes were obtained in acidic 
medium. The concentration of cations and drug 
(CFP) were Ixio" M. The stoichiometry of the 
complexes was obtained by Job's methods'^" a 
sample of resulting plots is shown in Fig. 4. The 
stability constant of chelate formed is calculated 
by following equation 
K 
A / A „ a 
( C M - A / A „ C J ( C L - A / A . , C , ) (2) 
where, K is the stability constant of the metal che-
late formed in the solution, M = metal, L = ligand, 
X = mole fraction of the ligand at maximum 
absorption. A/Aex is the ratio of the absorbance to 
that indicated by the tangent for the same wavelength. 
Cx, CM and Ci are the limiting concentration of 
complex, metal ion and the drug respectively. 
The stability constant is related to the standard 
enthalpy changes AH and other thermodynamic 
function by the equation: 
AG = -2.303RTIogK = AH-TAS (3) 
where R is the gas constant T is the experimental 
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Fig. 4. Continuous variation curves of CFP and metal 
complexes. 
temperature, K is the binding constant at the corre-
sponding temperature. 
From the value of stability constant at diflFerent 
temperature the enthalpy changes can be calcu-
lated by using the equation: 
LogK2/K| = [l/r,-I/r2]AH/2.303R (4) 
The negative value of AG for the complexation 
process suggests spontaneous nature of such 
process. ' The positive value of AH suggests 
that these processes are endothermic and are fa-
vourable at higher temperature. Also it is entropi-
cally favourable. The positive value of H and S in-
dicates that hydrophobic force may play a major 
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Fig. 5. Mechanism of binding of CFP with metal ions: 
A. CFP, B. CFP-metai complex, C hydrolyzed form of 
complex. 
role in the interaction.'* It is reasonable to think, 
on the basis of these results that the metal ions 
form a five membered chelate ring with CFP. 
Fluorescence study 
The fluorescence emission spectrum of the pure 
drug is markedly different from its absorption 
spectrum in UV region. The emission spectrum 
run between 350-450 nm at excitation wavelength 
of 335 nm showed a peak at 400 nm. The addition 
of meta) ions to the drug causes enhancement or 
quenching in the fluorescence spectrum. We have 
noted an enhancement in fluorescence intensity at 
400 nm in each case {Ca^\ Mg^*, Mn^\ Fe^\ Co^\ 
Ni^ '^ , Cu^ "" and Zn^ "^ ) (Fig. 6) although the shape 
and position of emission spectrum remains 
unchanged. 
The stoichiometry and stability constant of the 
complexes was determined by Benesi-Hildbrand 
method. The Benesi-Hildebrand plots were ex-
amine to further characterize the stoichiometry of 
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Fig. 6. Fluorescence enhancement (at X«, 335nm) of 
CFP in presence of metal ions. 
the CFP-metal complexes. In case of a 1:1 com-
plex, the following equation is applicable: 
1 /F-Fo = 1 /(F..- Fo)K [Me]o + 1 /(F^- Fo) (6) 
In this approach, a graph of 1/(F - Fo) versus 
l/[Me]o, was made where F is the observed fluo-
rescence at each concentration tested, Fo is the flu-
orescence intensity of analyte in the absence of 
metal ion, F^  is the maximum fluorescence in-
tensity in presence of metal ions and [Me]o is the 
concentration of metal ion. A linear plot is re-
quired for this double reciprocal plot in order to 
conclude 1:1 stoichiometry. In such cases, a linear 
relationship has to be obtained when 1/(F - Fo) 
versus l/[Me]ois plotted. The stability constant is 
determined by dividing the intercept by the slope 
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Fig. 7. Benesi-Hildebrand's plots for 1:1 (CFP: metal 
complexes) 
of the straight line obtained in the double-recip-
rocal plot. (Fig. 7) 
as a visible emission. 
The reason of this enhancement lies in strong 
perturbation of the excited state upon coordmation 
of the metal ion. A low lying internal charge trans-
fer state due to the presence of electron donor and 
acceptor group in the CFP is the lowest excited 
state, this state is however, a less emitting state and 
in equilibrium with the 7i-7t excited state of the 
molecule, upon coordination with metal cation the 
PCT interaction becomes weaker since the elec-
tron withdrawing group is now electron rich moi-
ety due to the deprotonation of-NH group neces-
sary for coordination of metal cation. 
In the present work an attempt has been made to 
study the interaction of the CFP with metal ions by 
fluorescence emission, absorption spectrophoto-
metric and measurements. Since enhancement in 
fluorescence intensity of the CFP in presence of 
the metal ions occurs, the spectra of the drug in 
presence of different concentrations of several 
metal ions were scanned. The ratio of the drug to 
metal ions was determined by Job's and Benesi-
Hildbrand method. The absorption spectra of the 
CFP was run at different pH to see the zwitterionic 
condition, apparent ionization constant and the 
isosbestic point indicating the presence of diflFer-
ent species in solution. The stability constant of 
the complex formed between the drug and metal 
ion was also evaluated. 
Influence of metal ion concentrations 
The influence of metal ions concentration was 
studied in the range of 1 x 10"*-10x lO'^ M. The flu-
orescence study of interaction CFP with metal 
ions in acidic aqueous medium showed 1:1 
stoichiometry. Both these study also support the 
formation of 1:1 CFP:Metal complex, with the 
possibility of metal ions chelating with CFP by p-
actum carbonyl carbon and acidamide nitrogen. 
In general, the phenomenon of enhancement is 
observed because the complexation by cations 
causes increase in the redox potential of the donor 
so that the relevant HOMO energy decreases to a 
level lower than that of fluorophore. Consequently 
the excited state energy of fluorophore is dumped 
CONCLUSION 
In this paper the nature and magnitude of the in-
teraction of CFP with biologically important metal 
ion was investigated by fluorescence spectra and 
UV spectra. The experimental result indicated the 
formation of 1 :l complex of CFP with metal ions 
in acidic medium by Job's and Benesi-Hildbrand 
method. The absorption spectra at different pH 
showed the presence of two isosbestic point in-
dicating the existence of zwitterionic condition 
The thermodynamic parameters showed that the 
interaction between CFP and metal ion was spon-
taneous, and that the hydrophobic force was a ma-
jor factor in the interaction. 
2009, Vol 53. No. 2 
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ABSTRACT. A Kinetics pathway of oxidation of Cefpodoxime Proxetil by permanganate in alkaline medium 
at a constant ionic strength has been studied spectrophotometrically. The reaction showed first order kinetics in 
permanganate ion concentration and an order less than unity in cefpodoxime acid and alkali concentrations. 
Increasing ionic strength of the medium increase the rate. The oxidation reaction proceeds via an 
alkali-permanganate species which forms a complex with cefpodoxime acid. The latter decomposes slowly, 
followed by a fast reaction between a free radical of cefpodoxime acid and another molecule of permanganate 
to give the products. Investigations of the reaction at different temperatures allowed the determination of 
activation parameters with respect to the slow step of proposed mecfianism and fallows first order kinetics. The 
proposed mechanism and the derived rate laws are consistent with the observed kinetics. 
Keywords: Cepfodoxime proxetil. Permanganate, Kinetics, Themodynamics 
INTRODUCTION thiazol-4-yl)-2-methoxyiminoacetamido]-3-meth 
oxymethyl-3-cephem-4-carboxylic acid) {Fig. 1). 
Cefpodoxime proxetil (CFP) is one of the several CFP is an ester prodrug of Cefpodoxime acid (CFA), 
new cephems administered orally as inactive esters where a proxetil radical is attached to CFA. It is an 
of the antibiotic Cefpodoxime. It is (I-[isopropoxy- orally absorbed, broad spectrum, third generation 
carbonyl) oxy] ethyl ester of (z)-7-[2-(2-amino-1,3- cephalosporin ester impi icated in the treatment of 
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Fig. 1. Structure of Cefijodoxime Proxetil (CFP). 
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Fig. 2. Degradation Pathway of Cefjrodoxime Proxetil to 
Cefpodoxime acid. 
tron reduction followed by a quick reaction. " In 
this paper a simple and sensitive kinetic spectropho-
tometric method has been developed to establish 
the thermodynamic parameters of Cepfodoxime 
acid. The method is based on the oxidation of the 
drug by permanganate in alkaline medium. The 
present studies is aimed at checking the reactivity 
of CFA toward permanganate, at determining the 
redox chemistry of the Mn(VIl) in such media, and 
at arriving at a plausible mechanism. 
EXPERIMENTAL 
Apparatus 
A Shimadzu UV-visible 1601 spectrophotometer 
was used for all spectral measurements, pH-metric 
measurements were done with Elico-LI 120 pH 
meter and a water bath shaker NSW 133, India was 
used to control the temperature. 
upper respiratory tract and urinary tract infections. 
In the biological system, CFP undergoes ester hy-
drolysis and is converted into CFA to exhibit its 
antibiotic activity.'"^ CFP has an asymmetric carbon 
at position 4 and is supplied as racemic mixture of 
R- and S-enantiomers. Few methods are reported 
to quantify CFA.^ "^  The |J-lactum antibiotic is known 
to degrade by hydrolysis in alkaline solution (Fig. 
2).^ Hydrogen peroxide is used for degradation 
study in the development of pharmaceuticals. The 
HCI, NaOH, NH2OH and H2O2 at appropriate con-
centration were evaluated as degradation agents 
for cleaning or decontamination.* Permanganate ion 
oxidizes a larger variety of substrate and finds ex-
tensive application in organic synthesis. " During 
oxidation permanganate is reduced to various oxi-
dation states in acidic, alkaline and neutral media. 
The mechanism of oxidation depends on the sub-
strate and medium.'^  The process Mn(VII) to Mn(l V) 
can be divided into a number of partial steps and 
examined discretely. The MnCh appears only a after 
the complete consumption of Mn04'. No mechanistic 
information is available to distinguish between a 
direct one-electron reduction of Mn(Vn) to Mn(Vl) 
or a hypopermanganate ion is formed in a two-elec-
Materials 
The Cepfodoxime Proxetil was obtained from 
(Lupin pharmaceutical Ltd, India). Pharmaceutical 
preparations containing the studied compounds 
were purchased from commercial sources in the local 
market. The permanganate solution was prepared 
and standardized against oxalic acid.'* Potassium 
permanganate solution was prepared as described 
by Carrington and Symons." NaOH (Merck Ltd, 
Mumbai, India) and NaCI04 (Ranbaxy fine chem. 
Ltd, India) were employed to maintain the required 
alkalinity and ionic strength, respectively. 
Reagents 
Double distilled, de-ionized water was used th-
roughout. The chemicals used were of analytical 
grade. Stock solutions of the compounds were 
wrapped with carbon paper to protect them from 
photodecomposition. 
Kinetic procedure 
The oxidation of (CFA) by permanganate ion was 
followed under pseudo- first order conditions where 
CFA concentration was greater than manganese 
(VII) at 25 °C. The reaction was initiated by mixing 
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previously thermostated solutions of Mn04' and 
(CFA), which also contained required quantities of 
NaOH and NaCI04 to maintain alkaline medium 
and ionic strength, respectively. The temperature 
was maintained at 25 °C: The reaction was moni-
tored by a the decrease in absorbance of Mn04', at 
its absorption maximum of 525 nm. Earlier it was 
verified that there is no interference from other 
reagents at this wavelength. Application of Beer's 
Law for permanganate at 525 nm had earlier been 
verified, giving e, was found to be 2083 ± 50 dm 
mol"' cm'. The reaction was followed more than 
three half lives The first order rate constants kobs 
were evaluated by plots of log [Mn04] vs. time. 
The first order plots in almost all cases were linear 
up to 85% of the reaction and kobs were reproducible 
at 525 nm and an increasing absorbance of Mn(Vl) 
at 610 nm during the course of the reaction (Fig. 5). 
The effect of dissolved oxygen on the rate of reac-
tion was checked by preparing the reaction mixture 
and following the reaction in nitrogen atmosphere. 
No significant difference between the results obtain-
ed under nitrogen and in the presence of air was 
observed. Added carbonate had also no effect on 
the reaction rate. Regression analysis of experi-
mental data to obtain the regression coefficient r 
and the standard deviation S of points from the 
regression line was performed using a Microsoft 
excel-2007 program. 
RESULTS 
The absorption spectrum of CFP was exhibited 
two peaks at 270 and 345 nm {Fig. 3).'* After addi-
tion of potassium permanganate in the same medium 
is oxidized the (CFA) and exhibits a green colour 
of manganate ion, appears which absorbs at 610 
nm. It was empirically found that the blue colour 
originated from a mixture of violet Mn04' and green 
250 270 290 310 330 350 370 
Wavelength 
Fig. 3. Absorption spectrum of CFP. 
colour Mn04" rather than form the formation of 
hypopermanganate. The formation of Mn (VII) was 
also evidence by the decrease of the absorbance of 
Mn(VIl) at 525 nm and the increase of that of Mn( VI) 
at 610 nm during the course of reaction {Fig. 5).The 
intensity of the colour increases with time and hence 
a kinetic method based on the spectrophotometric 
measurement was developed. 
Stoichiometiy of the reaction 
The reaction mixture containing an excess of 
permanganate over (CFA) were mixed in the pre-
sence of 5.0 X 10"^  mol dm"* NaOH and at constant 
ionic strength / = 0.10 mol dm' were kept in a 
closed container under a nitrogen atmosphere at 25 
°C. After I h the manganese (Vll) concentration 
was assayed by measuring the absorbance at 610 
nm. The results indicated that 2 mols of manganese 
(Vll) consumed 1 mol of (CFA). Therefore, the 
reaction mechanism is proposed on the basis of the 
I iterature background and our experimental study 
as shown in eq 1. 
Reaction order 
The reaction order were evaluated from the slope 
of log kobs versus log concentration plots by the 
varying concentration of (CFA) and alkali keeping 
other factors constant. 
HjN 
/N^NH-"—k- / " +2Mn04-+20H-
O^^OH 
<:n. 
+ H2O (1) 
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25 
2 1-
2 3 
Time (mm) 
Fig. 4. First order plots for the oxidation of CFA by alka-
line MnO'at 25 "C; [CFA ] = 1.0 x 10"'; [OH-] =2 x 
10 ' ; / = 0.10/moldm'\[Mn(Vll)] x 10''mol dm'^ (1) 
0.6, (2) 0.8, (3) 1.0, (4) 2.0, and (5) 3.0. 
500 550 600 
Wavelength 
700 
Fig. 5. Spectral changes during the oxidation of [CFA ] by 
alkalineMnO'^  at 25 °C; [Mn(VIl)] = 1.0 x 10^, [CFA] = 
1.0 X IO' [OH] = 2 X 10•^  / = 0.10/moi dm"^ 
Effect of Concentration of Manganese (VII) 
At constant concentration of (CFA), 1.0 x 10"^  mol 
dm'"', and alkali, 5.0 x 10'^  mol dm''\ and at constant 
ionic strength, 0.10 mol dm", The oxidant KMn04 
concentration was varied in the range of 6 x 10'^-
6x10 mol dm''. All kinetic runs exhibited identical 
characteristics. The linearity of plots of log (absor-
bance) vs time, for different concentrations of per-
manganate, indicates order in manganese(Vn) con-
centration as unity {Fig. 4). This was also confirmed 
by the constant values of pseudo first order rate 
constants, A:obs, for different manganese(Vil) con-
centrations {Table 1). 
Effect of NaOH Concentration 
The effect of increasing cone of alkali on the 
Table 1. Effect of variation of [KMn04] ,[CFA] and 
[OH] on the oxidation of cefpodoxime acid by alkaline 
[KMn04] at il5°C and ionic strength / = 0.10/mol dm"' 
lO'x 
[KMn04] 
mol dm"' 
JO'x [CFA] 
mol dm"' 
lO'x [OFT] 
mol dm"' 
lO'kobs 
(S"') 
lO'kcal 
0.6 
0.8 
1.0 
2.0 
3.0 
4.0 
6.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
2.0 
0.6 
0.8 
1.0 
1.2 
1.4 
1.6 
1.8 
1.08 
1.09 
1.08 
1.07 
l.iO 
1.08 
1.09 
0.984 
1.05 
1.06 
1.37 
1.60 
1.72 
1.99 
0.984 
1.03 
1.07 
1.06 
1.60 
1.75 
2.02 
1.09 
1.09 
1.09 
1.09 
1.09 
1.09 
1.09 
0.983 
1.06 
1.07 
1.36 
1.58 
1.73 
1.98 
0.985 
1.04 
1.06 
1.07 
1.59 
1.76 
2.01 
reaction was examined at constant concentration 
of drug and permanaganate ion at 25 °C. The alkali 
concentration was varied in the range of 0.6 x 10'^  
to 1.0 X 10' mol dm' . The A:obs values increased 
with increase in concentration of alkali. 
Effect of [CFAJ 
The effect of (CFA) concentration on the reaction 
was studied at constant concentrations of alkali and 
permanganate and at a constant ionic strength of 
0.10 mol dm"' at 25 °C. The substrate, (CFA) was 
varied in the range of 5.0 x 10'^  - 5.0 x IQ-^  mol 
dm"". The kohs values increased with increase in 
concentration of (CFA) {Table 1). 
Effect of Ionic Strength 
The effect of ionic strength was studied by vary-
ing the NaCI04 concentration from 0.01 to 0.! 0 mol 
dm" at constant concentrations of permanganate, 
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Scheme 1 
(CFA), and alkali. It was found that increasing ionic 
strength had no effect on the rate of reaction. 
Effect of temperature 
The kinetics was studied at four different tem-
peratures under varying concentrations of (CFA), 
and alkali, keeping other conditions constant. The 
rate constants were found to increase with increase 
in temperature. The rate constant (k) of the slow 
step of Scheme 1 were obtained from the slopes 
and intercepts of \/kobs versus 1/[CFA) and 1/kobs 
versus 1/[0H"] plots at four different temperatures. 
The energy of activation corresponding to these rate 
constants was evaluated from the Arrhenius plot of 
log k versus 1/T and from which other activation 
parameters were obtained {Table 2). 
Pblymerization Study 
The possibility of free radicals was examined as 
follows: the reaction mixture, to which a the reaction 
mixture with methanol, precipitate resulted, sugge-
sting that the there was participation of free radicals 
in the reaction. 
DISCUSSION 
At the observe experimental condition at pH > 
12 the reductant product of Mn(VII) might be stopp-
ed. • Although During our study the colour of the 
solution undergoes a series of change from blue to 
green. It is probable that green color originated from 
the permanganate ion. The spectrum of green solu-
Table 2. Activation and Thermodynamic parameters for 
the oxidation of cefpodoxime acid by KMn04 in alka-
line medium and / = 0.10/mol dm'with respect to slow 
stepofSc/jeme 1 
Temperature (K) 10^k(S"') 
(a) Effect of Temperature 
293 
298 
303 
308 
(b) Activation Prameter 
Ea(kj mole') 
AH (kj mole') 
AS* (jk'mole') 
AG* (kj mole') 
2.7 
2.9 
4.8 
5.1 
values 
65.4 
61.7 
-120.4 
19.11 
Temperature (K) K, ( dm' mol') 10'^  K2 (dm' mol') 
(c) Effect of Temperature 
293 15.41 
298 17.74 
303 19.55 
308 21.71 
30.14 
26.69 
20.54 
18.76 
Thermodynamic 
Parameters using Ki values using K2 values 
AH (kj mole"') 
AS* (jk'mole') 
AG*(kj mole"') 
76.5 
128 
-5.6 
-61.7 
-63.2 
-6.71 
tion was identical to that of Mn04''. It is probable 
that the blue color originated from the violet of 
permanganate and the green from manganate, ex-
cluding the accumulation of hypomanganate. It is 
evident from the {Fig. 5) that the concentration of 
MnO'*' decreases at 525 nm due to Mn(VIl) and 
increases at 610 nm due to Mn(VI). As the reaction 
proceeds, slowly yellow turbidity develops, and 
after keeping for a long time the solution decolorizes 
and forms a brown precipitate. This suggests that 
the products formed might have undergone further 
oxidation resulting in a lower oxidation state of 
manganese. The results imply that first the alkali 
combines with permanganate to give an alkali-
permanganate species [Mn04 OH]"' in a prior 
equilibrium step, which is in accordance with lite-
rature ••"•• and also experimentally observed order 
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in OH" ion concentration. In the second step [Mn04-
OH]^' combines with CFAto form an intermediate 
complex. The fractional order with respect to CFA 
presumably results from the complex formation 
between oxidant and substrate prior to the slow step. 
The reaction between permanganate and CFA is 
supported by Michaelis-Menten plot which is linear 
with positive intercept which is in agreement with 
complex formation. Within the complex one-elect-
ron is transferred from CFAto Mn(VIl). Then this 
complex (C) decomposes in a slow step to form a 
species derived from CFA. All the results indicate 
a mechanism as given in Scheme 1. 
Rate= - " 1 ^ " ° * ' =kKiK2[Mn04-MCFA],[OH-], (2) 
dt 
The total [MnO'*] can be written as 
(MnOvl, = [Mn04-]f + [Mn04.0H]^-+ [Complex) 
= [Mn04),+ [Mn04-)[0H-] +KiK2[Mn04-][CFA][OH-] 
= [Mn04], (1+ Ki[OH-] + KiK2[CFA][0H-]) 
[Mn04-], 
(3) [Mn04-]f = 1+ K,[OH-] + K,K2[CFA][0H-] 
where "t" and " f stand for total and free. Si-
milarly, total [OH'] can be calculated as 
[OH-], = (OHIf + [Mn04.0H]2> [Complex] 
[OH-J, (4) 
[0H-],: 
1+ Ki[Mn04-] + K,K2lCFA]lMn04] 
In view of the low concentrations of Mn04' and 
CFA used in the experiment, in eq 4 the terms 
Ki [MnO/] and A:i/s:2[Mn04'][CFA] can be neglect-
ed in comparison with unity. 
Thus, 
[OHl, = [OH], 
Similarly, 
[CFAh = [LFA], 
(5) 
(6) 
Substituting equation 3, 5, and 6 in equation 2 
and omitting the subscripts, we get 
Rate = 
kKiK2[Mn04][CFA][OH] 
1+ Ki[OH-] + KiK2[CFA][0H-] 
(7) 
Equation 7 confirms all the observed orders with 
respect to different species, which can be verified 
by rearranging to eq 8. 
1 1 1 
kobs kK,K2(CFA][0H-] kKjlCFA] k (8) 
According to eq 8, other conditions being con-
stant, plots of 1/^ obs versus I/[CFA] and l/tobs 
versus \ /[OH] should be linear and are found to be 
so {Figs 6a and 6b). The slopes and intercepts of 
such plots lead to the values of A^ i, ^2, and k{Table 
2). The value of ^ 1 is in good agreement with the 
literature '^' Using these constants, the rate constants 
were calculated over different experimental condi-
tions, and there is a reasonable agreement between 
the calculated and the experimental values, which 
for the proposed mechanism {Table 1). The thermo-
dynamic quantities for the first and second equili-
brium step of Scheme 1 can be evaluated as follows: 
The [CFA] and [OH'] as in Table I were varied at 
four different temperature. The spectral evidence of 
the complex formation was obtained from U V-Vis 
spectral study."" It is also proved kinetically by the 
non zero intercept of the plots of 1/kobs versus 1/ 
[CFA] (r > 0.9997, S < 0.0148) {Fig. 6b). Accord-
ing to the rate law the plots of 1 /kobs versus I /[OH"] 
(r > 0.9987, S < 0.0124) and 1 Kb, versus 1 /[CFA] 
(r > 0.9998, S < 0.0151) should be linear {Figs 6a 
and b) from the slope and intercept, the value of k, 
Ki and K2 could be derived as 2.87 x 10"^ , 13.8 dm^ 
mole', and 22.36 dm" mole" respectively. The rate 
constant were calculated from these values {Table 1) 
which supports the proposed mechanism. The re-
action rate of CFA increased with increasing inten-
sity of the complex. The kinetics was studied at four 
different temperature and concentration of CFA and 
NaOH keeping all other conditions constant. The 
rate constant was found to increase with increasing 
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Fig. 6. (a) Rate law plots I/kobs versus 1/ [OH] of oxi-
dation of cefpodoxime acid by KMn04 in alkaline me-
dium at different temperatures (circumstance as in Table 
1). (b) Rate law plots 1 /kobs versus 1/ [CPP] of oxidation 
of cefjxjdoxime acid by KMn04 in alkaline medium at 
different temperatures (circumstance as in Table 1). 
temperature. The rate constant k of the slow step of 
Scheme 1 were obtained from the slope and inter-
cept of 1/kobs versus 1/[CFA] and 1/kobs versus 1/ 
[OH'] plots at four different temperatures. The 
activation parameters corresponding to these con-
stant were evaluated from the Arrhenius plot of log 
k versus 1/T and are listed in Table 2. The experi-
mental value of AH* and AS* were both favorable 
for electron transfer process. The high negative 
value of AS* indicate that interaction of the reaction 
ions of similar charges form an activated complex 
and is more ordered than the reactants due to loss of 
degree of freedom. The hydroxyl ion concentration 
i.e. Table I was verified at four different temperature 
and the K| value were determined from a {Fig. 6a) 
as shown in Table 2. Similarly CFA concentration 
as in Table 1 was varied at four different temp and 
K2 values were determined at each temp {Fig. 6b) 
as listed in Table 2. The effect of temp on reaction 
rate is well known and important in the various 
activation parameters of the reaction product. A 
Arrehenius plot was made for the variation of Ki 
with temperature (i.e. log Ki versus 1 /T). The values 
of the enthalpy change of the first equilibrium step 
Ki of the reaction (AH), enthalpy of the reaction (AS) 
and free energy of raction (AG) were calculated as 
listed in Table 2. Similarly thermodynamic para-
meters for second step K2 are calculated such as 
enthalpy; entropy and free energy of activation of 
the reaction product were calculated using Eyring 
equation. 
LogK/T = [iogkb/h + S/2.302R]-AH/2.303Rl/T 
The plot of log K2/T versm 1/T was linear with 
correlation coefficient of-0.9996 AH'^  was evaluated 
from the slope (- AH/ 2.303R 1/T) and AS' from the 
intercept [log kb/h + S/2.302R] of the compiled 
Eyring plot. The Gibbs free energy of activation 
was determined by AG'' = -2.303 RT log K at room 
temperature. These values are given in Table 2.The 
proposed mechanism supported by the above ther-
modynamic parameter. A comparison of the later 
values (from K2) with those obtained for the slow 
step of the reaction shows that these values mainly 
refer to the rate-limiting step, supporting the fact 
that the reaction before rate determining step is 
fairly fast and involves low activation energy." 
The negative value of indicate that the complex 
(C) is more ordered than the reactant.' A detailed 
mechanistic explanation is given in Scheme 2. 
CONCLUSION 
It is interesting to note that the oxidant species 
[MnO'*'] required a pH > 12 below which the system 
becomes anxious and the reaction proceeds to 
Mn(IV) which slowly develops yellow turbidity. The 
oxidant, manganese(VII), exists in alkali media as 
alkali-permanganate species [Mn04-0H]^", which 
takes part in the chemical reaction. The role of 
hydroxyl ions is essential to the chemical reaction. 
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Scheme 2. Mechanistic Interpretation for the Oxidation 
of CFA by Alkaline Permanganate 
The given mechanism is consistent with all the 
experimental evidence. The rate constant of slowest 
step involved in the mechanism are evaluated and 
activation parameters with respect to slowest step 
of reaction were computed. The overall mechanistic 
sequence described here is consistent with the final 
product, mechanistic and kinetic studies. 
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Binding Constant: Fluorescence Quenching of 
CiproHoxacin with Fe(III) and Zn(II) 
K S SinniQi*, AYA/ MOHO, AHTAB Asi AM, PARWA/ KH\N and SHMSIA BANO 
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Absorbancc and fluorescence sijcctial pattern ot ciprotloxjcin in 
absence and presence ol Fe(III) and Zndl) has been studied jt loom 
teinpcraturc and undei physiological condition The lluorescencc spectra 
of the drug in piescncc of the different quantities and ditteient concen-
trations ol the FeCiri) and Zndl) showed the quenchmi; of ciprolloxat in 
It was obscr\'ed that with increasing quantiij of the quenchei tlie emission 
intensity decreases with negligible \anaiion in the peak position The 
absorption spectra ot the drug at difierent pH exhibits two isosbestic 
points ai 320 and 350 nm indicating the presence ot three chemical 
species m solution. The ratio of the two reacting components, the drug 
and the metal ions was determined by absorption and lluorescence spectro-
photonietncally 
Key Words: Ciprofloxacin, HCI, Fluorescence quenching. Binding 
constant. Stability constant. 
INTRODUCTION 
Cipronoxacin is fl-cyclopropyl-6-nuoro-l,4-ciihydio-4-oxo-7-(piperazmyl)-
quinolone-3-carboxylic acidj one of the fluoroquinolones used as broad spectnttn 
drug against gram positive and gram negative bacteria. It has been found that the 
activity of qutnolone drugs is completely lost if consumed with antacids containing 
aluminum or magnesium because the drug is neutralized At higher pH precipitation 
occurs and the drug is inade unavailable for absorption' "* The mechanism of intei-
action of quinolone with metal ions is based on the chelation of the metal with the 
carbonyl and carboxyl groups of the drug (Fig. 1). The antibacterial activity ot the 
drug has also been found to be reduced manifold after chelation"* of the metal ions 
via these groups. 
Pig i Sit uctiirc of ciprofloxacin 
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The interaction of fluoroquinolones with metal ions has attracted considerable 
interest not only for the development of analytical techniques but also to provide 
information about the mechanism of action of the pharmaceutical preparation^ 
Since the metal ions cause fluorescence quenching of the di-ug, spectrofluorimetric 
method for quantitative determination of the quinolone type drugs has been devel-
oped'* besides titrimetric" spectrophotometeric'", electrochemical", electrophoretic'-
and chromatographic'-' techniques. 
The maximum solubility ofthe ciprofloxacin has been reported at 37 'C, which 
also happens to be the normal temperature of human body although the intci action 
of drug with metal ions has been studied in a wide range of temperature between 25 
-60 °C''' ' \ Since we have to mimic the biological system under physiological condi-
tion we have studied, the interaction of Fedll) and Zn(ll) with ciprofloxacin at 
room temperature using absorption and fluorescence emission spectrophotometry 
at pH 3.98. The stability of the Fe(lII) and Zn(ll) complexes has been calculated by 
spectrophotometric and fluorescence emission spectrophotometric techniques. The 
fluorescence spectroscopy has been widely used to monitor the molecular interaction 
because of its high sensitivity, reproducibility and relatively easy use. Since no 
detailed fluore.scence study on the binding interaction of ciprofloxacin with Fe(lll) 
and Zn(II) has been done so for, a through investigation was therefore made using 
this technique. Such interactions between ciprofloxacin and these metal ions can 
cause fluorescence quenching. Therefore, valuable information's such as binding 
mechanism, binding constant and binding sites can be obtained using fluorescence 
quenching study of ciprofloxacin by these metal cations. In addition the thermody-
namic parameters of the process were also proposed in this work. 
EXPERIMENTAL 
Fluorescence emission spectra were scanned using a Hitachi-F-2500 FL-spectro-
photometer. The absorption spectra were obtained with Elico-SL-169 double beam 
UV-Vis spectrophotometer. All potentiometiic measurements were carried out with 
Elico-I>I-120pH meter. 
Ciprofloxacin was purchased from Windlas Biotech. Ltd.(India). All solvents 
and chemicals were of analytical grade. Double distilled water was used throughout. 
Sodium hydroxide, Fe(N0i)i.9H:0 (Merck Ltd., Mumbai. India) ZnCl: (anhydrous) 
(SDH Pvt. Ltd. India) and hydrochloric acid (Ranbaxy fine chem. Ltd., India) were 
used as received. 
Preparation of solutions: The stock solution of ciprofloxacin HCl (5 x 10" M) 
prepared in 1 x 10'^  M HCl was stored at 4 °C and those ofthe metal salts (1 x 10"^ M) 
were prepared in double distilled water, respectively. All working solutions were 
prepared by dilution with double distilled water. 
Spectrophotometeric methods: Solutions of equimolar concentration (1 x 
10"* M) of ciprofloxacin HCl and metal ions were prepared. The pH of the drug was 
adjusted between 2.12 to 10.50 by adding .sodium hydroxide and hydrochloric acid 
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(1 X 10' M lo 1 X 10"^  M). The absorption bpectra were recorded in the range 230-
360 nm. The ratio of metal to ciprofloxacin.HCl was determined by Job's method. 
The linearity of ciprofloxacin HCl was found in the range 3.5 x 10"''-7.5 x 10"* mg/mL 
and the correlation factor (R )^ 0.9629. 
Fluorescence spectrophotometeric methods: Solution of the ciprofloxacin 
(5 x 10"'' M) and those of metal ions (1 x lO^M to 10.5 x 10"'' M) were prepared. To 
prepare dilute solutions, an aliquot of stock solution was placed in a 10 niL volumetric 
flask and made up to the mark with distilled water. -Spectra were recorded immedi-
ately after sample preparation in the optimum wavelength range 3(K)-600 nm at 
optimum excitation wavelength of 315 nm. For calibration curve an aliquot of stock 
solution (5 X 10"'-1 x 10 ^ mg/mL) was prepared which showed linearity with corre-
lation factor (R') 0.9739. 
RESULTS AND DISCUSSION 
Absorption studies: The absorption spectrum of ciprofloxacin run at room 
temperature and at constant pH 3.98 displayed a strong peak at 272 nin and a weak 
absorption at 315 nm (Fig. 2). When the UV spectra of the drug were run at vai7ing 
pH, at room temperature and, under physiological condition, the strong peak was 
shifted to lower wavelength while the broad peak was shifted to higher wavelength. 
The decrease in the position and intensity of the first peak is attributed to the extent 
of ionization of the carboxylic group while the increase in the intensity and height 
of the peak at 315 nm occurs as a consequence of protonation of the piperazinyl 
nitrogen on 7-carbon atom. Two isosbestic points appearing at 320 and 350 nm 
indicated the presence of three chemical species in solution (Fig. 3) similar to those 
observed by Bark and Barrel!'"'. 
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Fig .2. Absorption spectrum of ciprofloxacin 
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Fig. 3. Absorption spectra of ciprolloxacin 
(I X IO'M)al different pH (2.12-10.50) 
al 25 "C 
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The apparent ionization constant (pKa') of tiie drug was calculated (6.871) by 
the following equation. 
pKa' = pH + log {(A, - AM)/(A - AM)) (1) 
where. Ai = Absorbance of drug in basic medium, AM = Absorbance of drug in 
acidic medium, A = Absorbance of drug in aqueous medium. The pure drug has 
maximum solubility at pH 5 although it increases in the presence of Fe(II) and 
Fe(IH) ions'*. 
The stability constant of the complexes were calculated by the continuous vaiiation 
method using the following equation: 
K=- A/Ae>Cx 
( C M - A / A „ C X ) ( C L •nA/A„Cx)" (2) 
where, K is the stability constant of the metal chelate foimed in solution. M = 
metal, L = ligand, n = X/(l-X) where X is the mole fraction of the ligand at maximum 
ab.sorption. A/A^ -x is the ratio of the observed absorbance to that indicated by the 
tangent for the same wavelength. Cx. CM and Ci are the limiting concentration, 
metal ion concentration and the ligand concentrations, respectively. 
The continuous variation curves are shown in Fig. 4. The ratio ol'ciprotloxacin: 
metal, is 2:1, which is quite obvious. The fairly large value of log k of the two 
complexes (Table-1) suggests that they are pretty stable in acidic medium only. 
The drug under this condition must be acting as ionophore since the solubility of 
the drug is maximum in presence of Fe(IIl). However, precipitation occurs when 
the solution becomes alkaline'"". 
1.8 
1.6 
14 
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Fig. 4. Continuous variation curves of equimolar solutions of ciprofloxacin and (A) he(lll) 
and (B) Zn(n) at 25 "C 
Fluorescence study: The absorption spectrum of the daig is markedly different 
from its emission spectrum, which is attributed to different molecular geometries 
(Fig. 5) in ground and excited states. The piperazinyl group of ciprofloxacin acts as 
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TABLE-1 
STABILITY CONSTANT (log K AND -AG OF THE FORMED 
CHELATES AT 25 °C BY ABSORPTION STUDY 
Metal logK AG(kJmol') 
Fe(IlI) 
Zn(II) 
9.378 
9.381 
-33.509 
-53.526 
Basic medium 
Zwitterion 
Acidc medium 
Increasing acidity 
Zwitter ion condition decreasing 
Fig. 5. Zwitterion formation and intramolecular charge transfer of drug in solution phase 
at var>'ing pH 
electron donor while the keto group acts as electron acceptor. Since all investigations 
were done in acidic medium, ciprofloxacin exists in zwitter ionic form. The peaics 
in the absorption spectra are due to intramolecular charge transfer, the greater the 
number of resonating suuctures the stronger the fluorescence emission. 
1962 S\ddiqi el al. A'.idii J. Chew. 
The fluorescence spectra are very sensitive to the nature of the metal quencher, 
which is reflected from the emission spectra of the drug in presence of the F-e(III) 
and Zn(Il) quencher. They showed a consistent decrease in the intensity of tluores-
cence with increasing concentration of the metal ion until it was nearly completely 
quenched (Fig. 6) as a consequence of the complex formation between the metal 
ions and ciprofloxacin. 
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Fig. 6. The fluorescence emission spectra of drug quenched (.A) Fe(Ill) and (B) Zn(ll) 
Many workers''''" have studied the interaction of drug with metal ions at temper-
ature exceeding 37 °C in order to show the Stem-Volmer plot although such experi-
ments above body temperature do not mimic the biological system. We. therefore, 
did all the experiments at room temperature. The fluorescence intensity increases 
rapidly with decrease in temperature. The lower stability at higher temperature also 
suppoils lowering in quenching. The fluorophore is quenched both by collision and 
complex formation with the metal ions. The complex formation is mainly due to 
ion dipole interaction. 
Fluorescence quenching refers to any process in which the fluorescence intensity 
of a given fluorophore decreases upon adding a quencher. Assuming that the fluore-
scence intensity of a fluorophore-quencher complex is negligible as compared to 
an unquenched fluorophore, the intensity in the absence (F„) and presence (F) of 
the quencher is expressed by Stern-Volmer equation 
F. , /F=l+Ksv[Ql (3) 
where [Q] is the concentration of quencher, Ksv is the Stern-Volmer constant which 
is the equilibrium constant of the complex formed in the static quenching process. 
If a system obeys the Stern-Volmer equation, a plot of h/F-l i.v. |Q| will give 
straight line with a slope of Ksv and y-axis intercept. Fig, 8 represents the quenching 
of ciprofloxacin by Fe(I!I) and Zn(II), respectively. The linearity of Stern-Volmer 
plot (Fig. 7) increases with increasing concentration of quencher. The values of 
Ksv and correlation coefficient are shown in Table-2. 
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TABLE-2 
STERN-VOLMER CONSTANT (Ksv, BINDING CONSTANT (log k), 
BINDING SITE AND REGRESSION COEFRCIENT AT 25 and 35 °C 
Metal 
Fe(ni) 
Zn(n) 
Ksv/mol' 
25°C 35°C 
3.36x10^ 2.77x10^ 
2.97x10^ 2.48x10^ 
logK 
2 5 T 35°C 
9.42 9.58 
9.46 9.60 
n 
25"^ 
1.88 
1.89 
35 *t 
1.97 
2.01 
R-
25 °C 
0.982 
0.981 
35 °C 
0.950 
0.965 
The metal ions with large nuclear charge and small size will experience greater 
ion-dipole interaction and hence the emission intensity in the case of Zn(II) should 
be less than that for Fedll) although Fefill) has greater nuclear charge and smaller 
ionic radius. 
The large value of stability constant of the complexes fonned in solution reflects 
strong interaction between ciprofloxacin and the metal ions. 
Binding constant and binding sites: For static quenching, the relationship 
between intensity and the concentration of quencher can be described by the binding 
constant formula-'-": 
1964 Siddiqi ff (//. Asian J. Cheni 
log(F„-F)/F = log K + n log IQl (4) 
where K is the binding constant (Table-3), n is the number of binding sites per 
ciprofloxacin. After the fluorescence quenching intensities on ciprofloxacin at 315 nm 
were measured, the double-logarithm algorithm was assessed by eqn. 4. Fig, 8 
shows double-logarithm cune and Tablc-2 gives the coixesponding calculated results. 
The linear correlation coefficient for all the curves are larger than 0.945, indicating 
that the interaction between metal ions and ciprofloxacin agrees well with the site-
binding model underlying eqn. 4. The results illustrate that there is a strong bmding 
force between ciprofloxacin and metal ions and approximately two binding site 
would be formed in each case which is consistent with the previous studies that in 
acidic medium ciprofloxacin and metal ions form 2:1 complex. 
TABLE-3 
THERMODYNAMICS PARAMETERS AT 25 AND 35 °C 
Metal 
Fe(IIl) 
Zn(Il) 
AG (kj mol') 
25°C 35°C 
-53.77 -56.54 
-54.01 -56,62 
118.59 
98,94 
AS (kJ mol' K ') 
25°C 35T 
180.85 183,96 
181.57 184,16 
Thermodynamic parameters and nature of binding forces: Considering the 
dependence of the binding constant on the temperature a thermodynamic process 
was considered to be responsible for this interaction. Therefore, the thermody-
namic parameters dependent on tcmpx:rature were analyzed in order to further charact-
erize the forces acting between drug and metal ions. The thermodynamic parameters 
enthalpy changes (AH), entropy changes (AS) and free energy changes (AG) are the 
main evidences to determine the binding mode. If the temperature does not vary 
significantly, the enthalpy changes (AH) can be regarded as constant. The free energy 
change (AG) can be estimated from the following equation, based on the binding 
constant at different temperatures. 
AG = - 2.303 RT log K (3) 
where R is the gas constant, T is the experimental temperature and K is the binding 
constant at the corresponding temperature. 
From the value of stability constant at different temperature the enthalpy changes 
can be calculated by using equation: 
logK.VKi = [ 1/Trl/T:]AH/2.303R (4) 
The entropy changes can be calculated by using equation: 
AG = AH-TAS (5) 
Thermodynamics parameters for the interaction of metal ions and ciprofloxacni 
are shown in Table-3. The negative value of AG means that the interaction process 
is .spontaneous. The +ve AS value obtained for all investigated complex is character-
istic of chelation. It occurs because the water molecules that are normally arranged 
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in an orderly fashion around the ciprofloxacin and metal ions have acquired a random 
configuration as a result of chelation. This is referred as gain in contlgurational 
entropy". The +ve value of AH indicate that the processes are endothermic and 
binding between metal ions and ciprolloxacin is mainly AS-driven. with little contri-
bution from the enthalpy factor. 
Conclusion 
It is concluded that the drug stays as zwitter ions. Ionization of carboxylic 
group and protonation of piperazinyl group occui-s. The two isosbestic points indicate 
the presence of three chemical species in solution. The result shows that the complex 
of ciprofloxacin with Fe(lll) and Zn(ll) are fairly stable. The thermodynamic para-
meters showed that the interaction between ciprofloxacin and metal ion was spontan-
eous and that the hydrophobic force was a major factor in the interaction. 
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Fluorescence Enhancement of Levosulpiride 
Upon Coordination with Transition Metal Ions 
and Spectrophotometric Determination of 
Complex Formation 
K. S. Siddiqi, Shaista Bano, Ayaz Mohd, and 
Aftab Aslam Parwaz Khan 
Department of Chemistry, Aligarh Muslim University, Aligarh, India 
Abstract: Absorbance and fluorescence spectral pattern of levosulpiride in 
absence and presence of first row transition metal ions (Mn-Zn) has been studied 
at room temperature under physiological condition. The fluorescence spectra of 
the drug in presence of different concentrations of transition metal ions showed 
enhancement in fluorescence intensity of levosulpiride. The photophysical 
changes owing to the direct interaction between metal ion and the amide nitrogen 
of levosulpiride has been described in terms of CHEF (chelating enhancement 
fluorescence) effect. The absorption spectra of the drug at different pH exhibited 
two isosbestic points at 255 and 275 nm respectively, indicating the presence of 
three chemical species in solution. The ratio of the drug to metal ions is found 
to be 2:1 and the logK of the resulting complex was determined spectrophotome-
trically and potentiometrically. The apparent ionization constant of levosulpiride 
is found to be 8.98. The low value of stability constant suggests that complexes 
may dissolve and the drug can be absorbed. 
Keywords: Absorption study and stability constant, fluorescence enhancement, 
levosulpiride 
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1. INTRODUCTION 
Levosulpiride, a levo enantiomer of sulpiride, chemically known as 
5-(amino sulfonyl)-N-[( 1 -ethyl-2-pyrrolidinyl)methyl]-2-methoxy benza-
mide is used as antipsychotic, antidyspeptic and antiemetic medicine 
(Fig. 1). This drug has also been used for the treatment of male sexual 
disorder and a dose of 25mg/day for 60 days resulted in complete 
recovery. The studies are mainly concerned with the validation and 
determination of levosulpiride in human beings. The drug is fairly stable 
in human serum and urine which has been tested in different patients. It 
has been found that the drug can be detected in a concentration range of 
0.25-200 ng/ml in human serum and 0.2-20 |xg/ml in urine by HPLC 
(Cho and Lee 2003; Geo, Balbi, and Speranza 2002). The bioavailability 
of the drug at a dose of 100-200 mg/day is approximately 20-30% only 
(Jin et al. 2004). Levosulpiride has both antiemetic and prokinetic prop-
erties because it antagonizes dopamine receptor in the central nervous 
system and gastro-intestinal tract (Mansi et al. 2000; Nagahata et al. 
1995). Recently, it has been shown that levosulpiride has moderate 
agonistic effect on 5HT4 receptors in the nervous system and is useful 
in the treatment of depression or Schizophrenia (Tonini et al. 1999). 
Patients treated for functional dyspepsia over a period of one month 
did not show any adverse effect. The doses of levosulpiride range between 
50-75 mg/day over a period of 30 days and showed no adverse effect 
except for fatigue, headache, and drowsiness (Lozano et al. 2007). It is, 
therefore, considered an effective and safe drug in the treatment of 
dyspepsia. It has been shown that the levosulpiride does not interfere 
with most of the drugs, but drinking during this period should be 
avoided. As a precaution, the drug should be avoided in pregnancy 
and during lactation period. 
The major work done on the sulpiride thus far, concerns its identi-
fication, determination, and efficacy against dyspepsia, psychosis, and 
male sexual disorder. However, absorption and fluorescence emission 
spectrophotometric behavior of the drug under physiological condition 
and its interaction with several cations has not been studied so far. 
OCH, 
Figure 1. Structure of levosulpiride. 
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In this communication, we are, therefore, reporting the electronic 
and fluorescence emission spectra of the drug in the presence and absence 
of transition metal ions at different pH, ranging from 2.38 to 10.6 in 
order to find the effect of pH on the absorption of drug in aqueous 
medium. Fluorescence emission spectra of the drug in presence and 
absence of metal ion has been recorded to examine if quenching or 
enhancement in fluorescence intensity occurs. Stability constant and 
other physical parameters of the complexes formed in solution have also 
been calculated. 
2. EXPERIMENTAL 
2.1. Instruments 
The absorption spectra were obtained with Elico-SL-169 double beam 
UV-visible spectrophotometer. Fluorescence emission spectra were 
scanned with Hitachi-F-2500FL-spectrophotometer. All potentiometric 
measurements were done with Elico-LI-120 pH meter. 
2.2. Methods and Materials 
Double distilled water was used throughout. Levosulpiride (Sun 
Pharmaceutical Industries, Jammu, India), sodium hydroxide (Merck 
Ltd, Mumbai, India) anhydrous zinc chloride (SDH Pvt. Ltd India), 
and HCl (Ranbaxy Fine Chem. Ltd, India) were used as received. 
2.3. Preparation of Solution 
Stock solution of levosulpiride and metal salts of 1 x 10~^M were 
prepared in double distilled water. Stock solution of drug was stored 
at 4°C. 
2.4. Spectrophotometric Method 
Solution of equimolar concentration (1 x 10"'* M) of levosulpiride and 
metal ions was prepared. The pH of the drug was adjusted between 
2.31 to 10.6 by the use of only sodium hydroxide and hydrochloric acid 
(1 X 10~' M to 1 X 10~^M) to avoid interactions with buffer solution. 
The absorption spectra were recorded in the range 200-330 nm. The ratio 
of metal to levosulpiride was determined by Job's method. 
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2.5. Potentiometric Method 
For potentiometric study the following solutions were titrated against stan-
dard NaOH. The ionic strength was maintained at 0.1 M by NaCl and the 
total volume was kept at 50 ml by adding appropriate amount of water. 
(a) 5ml (1 X 10"' M) HCl + 5ml (1 x 10"' M) NaCl + 40ml water. 
(b) 5ml (1 X 10-' M) HC1 + 5 ml (1 x 10"' M) NaCl + 10 ml (5 x 10"^ M) 
drug + 30 ml water. 
(c)5ml(l xlO" 'M)HCl- | -5mI(l x lO"'M) NaCl+10ml (5 x 10"^ M) 
drug+ 20 ml (5 x 10~'*M) metal ions+ 10 ml water. 
2.6. Fluorescence Spectrophotometric Method 
Solution of the levosulpiride (7xlO-^M) and those of metal ions 
(1.2 X 10~^M to 8.4 X 10"^ M) were prepared. The steady state fluores-
cence spectra of the drug were recorded in the Agm = 270-430 nm with 
excitation at the maximum centered on /exc = 275nm. This wavelength 
was chosen in order to avoid the inner-filter effect and to obtain the most 
complete as possible emission spectrum. 
3. RESULTS AND DISCUSSION 
3.1. Spectrophotometric Study 
The levosulpiride solution (1 x IO ' ^ 'M) was prepared in double distilled, 
demineralized water, and its absorption spectrum was run in the region 
200-330 nm. It exhibited two peaks at 216 and 295 nm (Fig. 2). Since 
the first peak is very strong, it was selected for further absorption studies. 
When the spectra of the drug were run at varying pH in the region 
200-330 nm, two isosbestic points, one at 255 nm and another at 
275 nm, were observed which indicated the presence of three chemical 
species in solution in equilibrium with each other (Fig. 3) (Park et al. 
2000). 
The apparent ionization constant (pKa') of the drug was calculated 
(Table 1) by the following equation: 
pKa' = pH + log{(Ai - A M ) / ( A - AM)} (1) 
where Ai = Absorbance of drug in basic medium. AM = Absorbance of 
drug in acidic medium, and A = Absorbance of drug in aqueous medium. 
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200 230 260 290 
Wavelength (nm) 
320 
Figure 2. Absorption spectrum of levosulpiride (1 x 10 ""M) at room tempera-
ture (pH 5.6). 
The metal to levosulpiride ratio was determined by continuous 
variation method (Fig. 4) at their respective Amax (Table 1). It was found, 
in each case, that two moles of the drug are bonded to one mole of the 
metal ion which seems quite reasonable because, of all the donor groups. 
-• - l .pH2.31 
— 2.pH5.60 
-*-3.pH6.31 
-«-4.pH7.40 
^«-5.pH8.35 
-^6 .pH9.60 
7. pH 10.60 
200 230 260 290 
Wavelength (nm) 
320 
Figure 3. Absorption Spectra of levosulpiride (1 x 10~'*M) at different pH (room 
temperature). 
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Table 1. Apparent 
Potentiometrically 
8.753 
ionization constant (pKa ') of the drug 
Spectrophotometrically 
8.98 
the amide nitrogen appears to be the most plausible site for coordination 
as it is the proper combination of hard acid and hard base. 
The stability constant of the complexes were calculated by the follow-
ing equation: 
j . ^ A/AexCx 
(CM - A/AexCx)(CL - nA/AexCx)" ^ ' 
where K is the stabiHty constant of the metal chelate formed in solution, 
M = metal, L = drug, n = X/(I - X ) , and X is the mole fraction of the 
ligand at maximum absorption. A/Agx is the ratio of the observed absor-
bance indicated by the tangent for the same wavelength. Cx, CM, and CL 
are the limiting concentrations of the complex, metal ion, and the ligand, 
respectively (Salem 2005; El-Kommas et al. 2007). The value of log K is 
shown in Table 2. 
3.2. Potentiometric Study 
To calculate the stabiHty constant of metal chelates, the acid dissociation 
constant of the drug was first determined from the titration curve for HCl 
1.55 
1.35 
u 
c 
€ 
o 
to 
<: 
0.95 yv/#^ W 
0.75 '^^'y^ \6 
0.55 Y / 
0.35 "^ -
0 0.2 0.4 0.6 0.8 1 
Moleftaction of drug 
-^MnGI) -^Fe(III) -^Co(H) 
-»-Ni(IJ) .^^_cu(ii) -^Zn(fJ) 
figure 4. Continuous variation curve of levosulpiride with metal ions. 
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Table 2. The stability constant potentiometrically and spectrophotometrically 
Metal ions 
Mn(II) 
Fe(III) 
Co(II) 
Ni(II) 
Cu(II) 
Zn(II) 
Potentiometrically 
logK 
8.82 
8.907 
9.028 
8.895 
9.174 
9.045 
-AG (KJ/mol) 
50325.57 
50821.39 
51512.39 
50753.51 
52345.44 
51609.39 
Spectro] 
logK 
9.3965 
9.3981 
9.4328 
9.4000 
9.5413 
9.4396 
Dhotometrically 
-AG (KJ/mol) 
53615.00 
53652.32 
53822.12 
53634.90 
54441.20 
53860.92 
in the presence and absence of the drug. The average number of proton, 
HA associated with levosulpiride at different pH was calculated and max-
imum value of ITA is 1 which suggests that it has one dissociable proton. 
The formation curve was obtained by plotting the average number of 
ligand attached per metal ion (n) versus free ligand exponent (pL) (Jeragh 
et al. 2007; Irving and Rassotti 1953). The apparent ionization constant 
and the average value of stability constant are shown in Tables 1 and 2, 
respectively. According to average value in Table 2, the following general 
remarks can be made: 
1. The maximum value of n was about 2, so it is presumed that complex 
is formed in a 2:1 (Drug: Metal) ratio. 
2. The very low concentration of metal ion solution used in the present 
study was 5 x 10~'*M and precludes the possibility of formation of 
polynuclear complexes (Sanyal and Sengupta 1990). 
3. The metal titration curve is displaced to the right hand side of the 
ligand titration Curves along the volume axis (Fig. 5), indicating a 
proton release upon complex formation. 
4. All calculation of stability constant has been successful for the low pH 
region. Therefore the formation ofhydroxo species (e.g. [ML (OH)], 
[MSx_i (OH)]"^ where L is ligand, S is the solvent molecule, and x is 
the number of solvent molecule bound) could be neglected. 
The value of AG is -ve indicating that chelation process proceeds 
spontaneously. This is evaluated by both method potentiometrically 
and spectrophotometrically. 
3.3. Fluorescence Study 
The fluorescence emission spectrum of the pure drug is markedly 
different from its absorption spectrum in the UV region, which is 
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Figure 5. Potentiometric titration curve of levosulpiride with metal ions. 
attributed to its different geometry in the ground and excited states 
(Fig. 6). When the emission spectrum of the pure drug is run between 
270-430 nm at an excitation wavelength of 275 nm, a strong peak at 
300 nm and two weak emission peak at 342 and 406 nm were observed 
(Fig. 7). The 5-aminosulfonyl 2-methoxy benzamide group of levosulpir-
ide acts as an electron acceptor where as the pyrrolidinyl group acts as 
electron donor. The peak in absorption spectra is due to the intramolecu-
lar charge transfer between the acceptor and donor groups. The addition 
of the metal ion to the drug can cause either enhancement or quenching 
in the fluorescence emission spectrum (Quang et al. 2007). We have noted 
an enhancement of fluorescence intensity at 300 nm in each case 
(Mn-Zn). The shape and position of emission spectrum of levosulpiride 
in presence and absence of transition metal ions remains unchanged, 
which suggests no significant change in the overall electronic structure 
of drug upon addition of metal ions (Fig. 8). The relative enhancement 
in the fluorescence intensity I/Io is shown in Table 3. 
The enhancement in emission intensity of levosulpiride in the 
presence of various metal ions follows the order Fe^ "'" > Ni^ "^  > Cu^ "^  > 
Zn"^ "^  > Co "^^  > Mn^ "^  (Fig. 9). The enhancement in emission intensity 
does not follow any trend from Mn-Zn, although it is minimum in the 
case of Mn, probably due to its half filled 'd' orbital. Although the transi-
tion metal ions are known to effectively quench fluorescence (Ghosh and 
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H 
'OCH, 
+ 
Hz 
^OCH, 
CHj 
r CHj 
" W 
Figure 6. Showing different ionic species in the solution at different pH. 
Bharadwaj 1996; Varnes, Dodson, and Wehry 1972; Rurack et al. 1993; 
Kemlo and Shepherd 1977), we observed over two fold increase in inten-
sity as a consequence of photo induced charge transfer besides the chela-
tion of the amide nitrogen resulting in CHEF (Chelating enhancement 
fluorescence) effect (Choi et al. 2006; Kim et al. 2007; Kim et al. 2003). 
300 
270 320 370 
Wavelength(nin) 
420 
Figure 7. Fluorescence Emission spectra of levosulpiride (7 x 10"^ M) at room 
temperature. 
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Figure 8. Fluorescence enhancement (at 300 nm) of levosulpiride with Mn(II), 
Fe(III), Co(II), Ni(II), Cu(II), and Zn(II) at room temperature. 
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Table 3. The relative intensity and limiting concentration 
Metal ions 
Mn(II) 
Fe(III) 
Co(II) 
Ni(II) 
Cu{II) 
Zn(II) 
I/Io 
1.24 
3.13 
1.52 
2.41 
2.37 
1.53 
Limiting concentration 
3.6 |im 
3.6 urn 
3.6|.im 
3.6|am 
3.6|im 
3.6 Jim 
It is accepted that aromatic compounds having amide groups are strongly 
quenched by intersystem crossing to a triplet state and/or by the rota-
tional relaxation linked to excited state rotation around the CO-NH 
and N-alkyl bonds. This may explain why, when complexed by cations, 
these rotors are less available for relaxation (Kawakami et al. 2002). 
An increase of rigidity of the system by metal cation complexation may 
therefore be an explanation for the fluorescence enhancement. In general, 
the phenomenon of enhancement is observed because the complexation 
by cations causes increase in the redox potential of the donor so that 
• Mn(II) IFe(!II) •Co(II) •Ni(II) 
Tran<;itim mptal 
ICu(n) !n(II) 
Figure 9. The enhancement in emission intensity of levosulpiride in presence of 
various metal ions follows the order Fe^+ > Ni^ + > Cu^+ > Zn^ "^  > Co^+ > Mn""*". 
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the relevant HOMO energy decreases to a level lower than that of 
fluorophore. Consequently the excited state energy of fluorophore is 
dumped as a visible emission (Quang et al. 2007). The reason for this 
enhancement lies in strong perturbation of the excited state upon 
coordination of the metal ion. A low-lying internal charge transfer state, 
due to the presence of electron donor and acceptor group in the levosul-
piride, is the lowest excited state. This state is, however, a less emitting 
state. And, in equilibrium with the n-n* excited state of the molecule, 
upon coordination with metal cation, the PCT interaction becomes 
weaker since the electron withdrawing group is now an electron rich moi-
ety due to the deprotonation of-NH group necessary for coordination of 
metal cation. 
In the present work, an attempt has been made to study the interac-
tion of the drug with metal ions by fluorescence emission, absorption 
spectrophotometric, and potentiometric measurements. Since quenching 
or enhancing in fluorescence intensity of the drug in presence of the metal 
ions occurs, the spectra of the drug in presence of different concentra-
tions of several metal ions were scanned. The ratio of the drug to metal 
ions was determined by Jobs method. The absorption spectra of the drug 
was run at different pH to see the zwitterionic condition, apparent ioniza-
tion constant, and the isosbestic point indicating the presence of different 
species in solution. The stability constant of the complex formed between 
the drug and metal ion was also evaluated. 
4. CONCLUSION 
The effect of cation binding on the photophysical properties of levosul-
piride was studied. A dramatic fluorescence enhancement was observed 
upon binding of transition metal ions. This was interpreted in term of 
the control of photoinduced charge transfer (PCT) and CHEF. The sta-
bility constants, which is calculated by spectrophotometrically and poten-
tiometrically, suggest that the complexes are fairly stable in solution. 
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Binding Interaction of Captopril with IVIetal Ions: 
A Fluorescence Quenching Study 
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The binding interaction of captopril (CPL) with biologically active metal ions Mg^*, Ca^*, Mn^*, Co^*, Ni^ *, 
Cu^* and Zn'* was investigated in an aqueous acidic medium by fluorescence spectroscopy. The experimental re-
sults showed that the metal ions quenched the intrinsic fluorescence of CPL by forming CPL-metal complexes. It 
was found that static quenching was the main reason for the fluorescence quenching. The quenching constant in the 
case of Cu"' was highest among all quenchers, perhaps due to its high nuclear charge and small size. Quenching of 
CPL by metal ions follows the order Cu^*>Ni^*>Co^'^>Ca^''>Zn^''>Mn''>Mg^". The quenching constant K^^, 
bimolecular quenching constant K^, binding constant K and the binding sites "n" were determined together with 
their thermodynamic parameters at 27 and 37 *C. The positive entropy change indicated the gain in configurational 
entropy as a result of chelation. The process of interaction was spontaneous and mainly AS-driven. 
Keywords captopril (CPL), fluorescence quenching, metal-drug complex, stability constant 
Introduction 
Captopril, 1 -[2(5)-3-mercapto-2-methyl-1 -oxopropyl]-
L-proline (Figure 1), is an angiotensin converting en-
zyme inhibitor drug for the treatment of hypertension, 
heart failure following myocardial infarction and dia-
betic nephrotherapy.' It inhibits the active sites of a zinc 
glycoprotein, the angiotensin converting enzyme (ACE), 
blocking the conversion of angiotensin(I) to angio-
tensin(II), the level of which is elevated in patients with 
hypertensions. CPL has three different potential donor 
groups (Sthioi, Oacid and Oamidc) which may bind with 
metal ions to form 1 I 1 complexes in acidic medium 
and 1 : 2 complexes^ in nearly basic medium (pH 6— 
8.2). The key functional group in the metabolism of 
CPL is the sulftiydryl group.' CPL is oxidized at its 
sulfliydryl group after dissolution in water to form its 
disulfide and is found in human urine after CPL admini-
stration. It has an equilibrium conformation between cis 
and trans isomers, however, the trans isomer is the ac-
tive form when bound to the enzyme." It also acts as a 
free radical scavenger.^ 
o 
H O O C ' ' ^ 
Figure 1 Structure of CPL. 
Over the last decade, close attention has been paid to 
the interaction of CPL with various metal ions^ as drug 
metal interaction may result in the formation of a stable 
metal-drug complex, which may deplete the blood with 
trace element. On the other hand the side effect that can 
arise during CPL treatment' may well be caused by the 
interaction of CPL with other metal ions present in the 
plasma." Therefore, to gain a deeper insight into the 
mechanism of the inhibition and side effect of CPL, 
equilibrium and structural studies were earlier per-
formed with several metal ions.' Studies have also been 
done on the use of transition metal ions for quantitative 
spectrophotometric determination of CPL in pharma-
ceutical formulations.'" CPL has also been assayed 
spectrofluorimetrically after reacting with fluorogenic 
reagents" or reducing Ce(IV) to fluorescent Ce(IIl).'^ 
The fluorescence spectroscopy has been widely used 
to monitor the molecular interaction because of its high 
sensitivity, reproducibility and relatively easy use. Since 
no detailed fluorescence study on the binding interac-
tion of CPL with Mg'*, Ca-" ,^ Mn^^ Co'*, Ni^^ Cu^* 
and Zn has been done so for, a thorough investigation 
was therefore made using this technique. Such interac-
tions between CPL and these metal ions can cause fluo-
rescence quenching. Therefore, valuable information 
such as binding mechanism, binding constant, and 
binding sites can be obtained using fluorescence 
quenching study of CPL by these metal cations. In addi-
tion the thermodynamic parameters of the process were 
also proposed in this work. 
Experimental 
Instruments, methods and materials 
The fluorescence emission spectra were scanned 
with a Hitachi-F-2500FL spectrophotometer. The phase 
modulation method was used to obtain fluorescence 
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lifetime by an SLM48000S spectrofluorometer (SLM 
Aminco, Rochester, NY). The procedure for lifetime 
measurement was described in reference.' Doubly dis-
tilled water was used throughout. CPL (Across organ-
ics), sodium hydroxide, metal chloride (Merck Ltd, 
Mumbai, India), and HCl (Ranbaxy Fine Chem. Ltd, 
India) were used as received. 
Preparation of solution 
The stock solution of CPL in aqueous acidic medium 
(1 X 10"' mol'L"') was stored at 4 °C and metal salts 
of 1X10"^ mol'L"' were prepared in doubly distilled 
water. 
The working solution of theCPL (8X 10_ mol 'L ' ) 
and those of metal ions (1X 10 * to 18X10 * mol'L ') 
were prepared. The steady state fluorescence spectra of 
the dmg were recorded in the X^m of 320—360 nm with 
excitation at the maximum centered at Acx=305 nm. 
The excitation wavelength was chosen such that ab-
sorbance at this excitation wavelength was less then 
0.02 to minimize the inner-filter effect and to obtain the 
most complete emission spectrum as possible. 
Results and discussion 
Figure 2 shows the emission spectra of CPL in the 
presence of metal ions of various concentrations. It was 
observed that the fluorescence intensity of captopril de-
creased regularly with the increasing concentration of 
metal ions without any change in emission maxima and 
shape of peaks. As there was no significant Xan shift 
with the addition of metal ions, it was indicated that 
metal ion could quench intrinsic fluorescence of CPL 
and that the interaction between CPL and metal ion in-
deed existed without inducing any conformational 
change in it under the condition studied here. 
Quenching can occur by a variety of molecular in-
teractions, viz. excited-state reactions, molecular rear-
rangement, energy transfer, ground state complex for-
mation (static quenching) and collisional or dynamic 
quenching. Static and dynamic quenching can be dis-
tinguished by their different dependence on temperature 
and excited state life time. Dynamic quenching is diffu-
sion controlled because the quencher must diffuse to the 
fluorophore during the life time of excited state. Since 
high temperature will result in large diffusion coeffi-
cient, the bimolecular quenching constants are expected 
to increase with temperature. If the K^^ decreased with 
increased temperature, it could be concluded that the 
quenching process was static rather than dynamic.'^''' 
Static quenching implies either the existence of a sphere 
of effective quenching or the formation of a ground 
state non-fluorescent complex, whereas collisional or 
dynamic quenching involves the collision and subse-
quent formation of a transient complex between an ex-
cited state fluorophore and a ground state quencher. The 
excited state complex dissociates upon radiative and 
non-radiative deactivation. In order to confirm the 
quenching mechanism the procedure of fluorescence 
quenching was first assumed to be dynamic. For dy-
namic quenching the mechanism can be described by 
the Stem-Volmer equation.'^ 
Fo/F=l+/^qro[Q] = l+/:sv[Q] (1) 
where, Fo and F are the fluorescence intensities in the 
absence and presence of the quencher, respectively, K^ 
is the bimolecular quenching rate constant, ^sv is the 
dynamic quenching constant and TO is the average life 
time of the molecule without quencher. Figure 3 dis-
plays the Stem-Volmer plots of quenching of CPL by 
different metal ions and at different temperatures. 
Based on the experimental data in Figure 3, the dy-
namic quenching constants and bimolecular quenching 
constants at different temperatures are shown in Table 1. 
It is evident from the table that the K^ values in each 
case are considerably larger than those possible for dif-
fusion controlled quenching in solution (about 10 L* 
mor ' -n s " ' ) . Usually, large K^ beyond the diffu-
sion-controlled limit indicates that some type of binding 
interaction exists between fluorophore and quencher. 
It was observed that ATsv decreased with increasing tem-
perature for all metal ions. It can be therefore, con-
cluded that the quenching is not initiated by a dynamic, 
but probably by a static process. Among all the metal 
quenchers, Cu quenches CPL the most effectively. 
The quenching constant by Cu^^ is larger than those by 
other metal quenchers and that of Mg^ is the minimal, 
which follows the order Cu^^>Ni^^>Co^''>Ca^''> 
Zn^*>Mn^"^>Mg^'^. Cu^ "^  is well known as a strong 
quencher because of its electronic structure (d ). 
Quenching by this type of substance most likely in-
volves the donation of an electron from the fluorophore 
to the quencher, and the ion dipole interaction between 
Cu^^ and the molecule will also be strong due to the 
large nuclear charge and the relatively small size com-
pared with other metals. Cu^' usually introduces easily 
accessible low energy levels, which can give rise to en-
ergy and electron transfer processes and is capable of 
quenching the fluorescent excited state of the mole-
Table 1 
27 and 37 
Stem-Volmer and bimolecular quenching 
•c 
KJih-mof^) 
27 'C 37 "C 
A'q/(L'mor' 
27 "C 
constant 
•s-') 
37 "C 
at 
Ca 2.82X10' 2.57X10" 8.47X10'^ 7.71X10'^ 
Mg LSexiO" 1.21X10" 4.08X10'- 3.63X10'^ 
Mn 1.89X10" 1.83X10" 5.67X10'^ 5.49X10'^ 
Co 3.05X10" 2.73X10" 9.16X10'^ 8.19X10'^ 
Ni 4.11X10" 3.66X10" 12.34X10'^ I0.99XI0'^ 
Cii 6.42X10" 5.09X10" 19.3X10" !5.28XI0'^ 
Zn 2.66X10* 2.32X10" 7.98X10" 6.96X10'^ 
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Figure 2 Fluorescence enhancement (at X„ 305 nm) of CPL with Ca(II), Mg(II), Mn(II), Co(Il), Ni(Il), Cu(!I) and Zn(I!) at room tem-
perature. 1: 7.0 nmol'L"' CPL, from 2 to 8: 2, 3, 6, 8, 10, 12, 18 nmol«L"' of metal ions. 
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cule." The larger K^y and Kq values of Ni '^" in com-
panson to Co^ , Mn^ "^  and Zn^^can be explained in 
terms of its smaller ionic radius and larger nuclear 
charge In cases of Mn^^ and Zn "^  the ^sv and ^q are 
quite small due to their half filled and completely filled 
"d" orbitals, respectively The ^sv and K^ values for 
Ca^ "^  are larger than those of Mg^ "^  probably because 
of its higher reactivity and lower ionization potential 
Binding constant and binding sites 
For static quenching, the relationship between inten-
sity and the concentration of quencher can be described 
by the binding constant formula 18 19 
\g(Fo-F)/F=\gK+nlg[Q] (2) 
where K is the binding constant, and n is the number of 
binding sites per CPL After the fluorescence quenching 
intensities of CPL at 340 nm were measured, the dou-
ble-logarithm algonthm was assessed by Eq (2) Figure 
4 shows double-logarithm curve and Table 2 gives the 
corresponding calculated results The linear correlation 
coefficients for all the curves are larger than 0 970, in-
dicating that the interaction between the metal ions and 
CPL agrees well with the site-binding model underlying 
Eq (2) The value of binding constant for these 
CPL-metal complexes follows the same order as men-
tioned in cases ofK^y and A'q values and is m agreement 
with the Irving-Williams series in cases of transition 
metal series 
Table 2 Binding constant 
cient at 27 and 37 "C 
ivieiai " 
ig/f 
27 'C 37 r 
binding 
n 
27 "C 
site and 
37 •c 
regression 
27 
R 
V 
coeffi-
37 "C 
Ca 
Mg 
Mn 
Co 
Ni 
Cu 
Zn 
2319 
1359 
1285 
2 887 
3416 
4811 
2 535 
2 580 
1492 
1 710 
2 828 
3 450 
5 049 
2 922 
0 58 
0 39 
0 35 
0 65 
0 74 
100 
0 58 
061 
0 43 
044 
0 66 
0 76 
107 
0 68 
0 996 
0 998 
0 985 
0 998 
0 999 
0 999 
0 999 
0 997 
0 960 
0 993 
0 997 
0 998 
0 998 
0 997 
Thermodynamic parameters and nature of binding 
forces 
Considenng the dependence of the binding constant 
on the temperature a thermodynamic process was con-
sidered to be responsible for this interaction Therefore, 
the thermodynamic parameters dependent on tempera-
ture were analyzed in order to further characterize the 
forces actmg between CPL and metal ions The ther-
modynamic parameters enthalpy changes (AH), entropy 
changes (AS), and free energy changes (AG) are the 
main evidences to determine the binding mode If the 
temperature does not vary significantly, the enthalpy 
changes (AH) can be regarded as constant The free en-
ergy change (AG) can be estimated from the following 
equation, based on the binding constant at different 
temperatures 
A G = - 2 303/?71g/!: (3) 
where R is the gas constant, T is the experimental tem-
perature, and K is the binding constant at the corre-
sponding temperature 
From the values of stability constant at different 
temperatures the enthalpy changes can be calculated by 
using equation 
\g(K2/K,) = i\/T,- \/T2)AH/2 303/? (4) 
The entropy changes can be calculated by using 
equation 
AG^AH-TAS (5) 
The thermodynamics parameters for the interaction 
of metal ions and CPL are shown in Table 3 The nega-
tive value of AG means that the interaction process is 
spontaneous The positive AS value obtained for all in-
vestigated complex IS characteristic of chelation, which 
occurs because the water molecules that are normally 
arranged in an orderly fashion around the CPL and 
metal ions have acquired a random configuration as a 
result of chelation This is referred as gam m configura-
tional entropy " The positive value of AH indicate that 
the processes are endothermic and binding between the 
metal ions and CPL is mainly AS-driven, with little con-
tribution from the enthalpy factor 
Table 3 Thermodynamics parameters at 27 and 37 "C 
Metal -
AG/(kJ'mor') 
27 'C 37 "C 
-A///(kJ'mor')- A5/(kJ'mor''K"') 
27 'C 37 "C 
Ca 
Mg 
Mn 
Co 
Ni 
Cu 
Zn 
-1332 
- 7 808 
- 7 386 
- 1 6 58 
- 1 9 62 
-14 82 
-8 575 
-9 828 
-16 24 
-19 82 
- 2 7 63 - 2 9 00 
-1456 - 1 6 7 8 
46 59 
23 76 
75 50 
67 59 
6 160 
42 32 
68 93 
0 199 
0 105 
0 276 
0 280 
0 085 
0 233 
0 261 
0 1981 
0 1043 
0 2752 
0 2704 
0 0838 
0 3371 
0 2604 
Conclusion 
In this paper we have investigated the nanire and 
magnitude of the interaction of CPL with biologically 
important metal ions Mg"'', Ca""^ , Mn-^ Co "^", Ni^ "", 
Cu and Zn' by fluorescence spectroscopy Since the 
Stem-Volmer quenching constants, A'sv in all cases are 
inversely proportional to temperature, it indicates that 
probable quenching mechanism is initiated by static 
quenching Cu ' is the best quencher among all the 
metal ions The thermodynamic parameters showed that 
the interaction between CPL and metal ions was spon-
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taneous and entropically favored in which entropy in-
creased and Gibbs free energy decreased The positive 
value of AS indicates the gam in configurational en-
tropy 
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Abstract The kinetics and mechanism of oxidation of 
levofloxacin (LF) by manganese(VII) in alkaline medium 
at constant ionic strength was studied spectrophotometn-
cally The reaction exhibits 2 1 Mn LF stoichiometry and is 
first order in permanganate but fractional order in both LF 
and alkali Decrease in the dielectric constant of the med-
ium results in a decrease in the rate of reaction The effects 
of added products and ionic strength have also been 
investigated The mam products identified were hydroxyl-
ated LF and Mn(VI) A mechanism involving free radicals 
IS proposed In a composite equilibrium step, levofloxacin 
binds to Mn04~ to form a complex that subsequently 
decomposes to the products Investigations of the reaction 
at different temperatures allowed the determination of the 
activation parameters with respect to the slow step of the 
proposed mechanism 
Introduction 
Potassium permanganate is widely used as an oxidizing agent 
as well as in analytical chemistry These reactions are gov-
erned by the pH of the medium Of all the oxidation states of 
manganese from -1-2 to -1-7, permanganate, manganese(VII), 
IS the most potent oxidant in acid as well as m alkaline media 
Permanganate oxidation finds extensive applications in 
organic synthesis [1,2], especially since the advent of phase 
transfer catalysis [3-5] Kinetic studies are important sources 
of mechanistic information on such reactions, as demonstrated 
A A P Khan A Mohd S Bano A Husain 
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Department of Chemistry Aligarh Muslim University, 
Aligdrh, UP 202002, India 
email ks_siddiqi@yahoo co in aizi_pasha@yahoo com 
by the results referring to unsaturated acids both in aqueous 
[3-6] and in non-aqueous media [7] The mechanism of oxi-
dation depends on the nature of the substrate and pH of the 
system [8] In strongly alkaline medium, the stable reduction 
product [9-11] of permanganate is manganate ion, MnOa^" 
Mn02 appears only alter long time, i e , after the complete 
consumption of Mn04~ No mechanistic information is 
available to distinguish between a direct one-electron reduc-
tion to Mn(VI) and a mechanism in which a hypomanganate 
ion IS formed in a two-electron reduction followed by its rapid 
re-oxidation[12, ]'>>] 
Levofloxacin (LF), (-)-(S)-9-fluoro-2 3-dihydro 3-methyl-
10-(4-methyl-l-piperazinyl)-7-oxo-7H pyndo [1,2,3-de]-
l,4-benzoxazine-6-carboxylic acid hemihydrate, is one of 
the commonly used fluoroquinolone antimicrobials, being 
the active S-isomer isolated from racemic ofloxacin Lev-
ofloxacin possesses a broad spectrum of activity against 
vanous bacteria, including Gram-positive and Gram-
negative microorganisms [14] It is also active against the 
causes of atypical respiratory infection such as Chlamidia 
pneumoniae and Mycoplasma pneumoniae [ 15] Because of 
Its effective antibacterial activity and low frequency of 
adverse effects on oral administration, levofloxacin has 
been widely used for the treatment of infectious diseases, 
such as community-acquired pneumonia and acute exac-
erbation of chronic bronchitis [16] The antibactenal action 
of the quinolones is not linearly proportional to their con-
centration, and the optimum concentration must be main-
tained to prevent the surviving bacteria from regrowing 
[17] The intrinsic fluorescence of fluoroquinolones is used 
for their determination in biological samples after their 
preliminary extraction with organic solvents [18] A 
method was proposed for determming these antibiotics in 
biological fluids using a mixed-ligand complex formed by 
terbium and triphenylphosphine oxide [19] The interaction 
^ Springer 
Transition Met Chem (2010) "^ 5 117-123 
of fluoroquinolones with metal ions has attracted consid-
erable interest not only for the development of analytical 
techniques, but also to provide information about the 
mechanism of action of the pharmaceutical preparation 
[20]. Since the metal ions cause fluorescence quenching of 
the drug, spectrofluonmetric methods for the quantitative 
determination of the quinolone type drugs have been 
developed [21] besides titrimetric [22], spectrophotometric 
[23], electrochemical [24], electrophoretic [25] and chro-
matographic [26] techniques. The accumulation of fluoro-
quinolone antibiotics in aquatic environments, even in low 
concentrations, may cause threats to the ecosystem and 
human health by inducing multiplication of drug resi.stant 
bacteria as a result of long-term exposure Chemical oxi-
dation of pollutants in drinking and waste water by per-
manganate ion has been widely used The present study is 
an attempt to explore the mechanism of oxidation of lev-
ofloxacin by permanganate in alkaline medium on the basis 
of kinetic parameters 
concentration range, and f was found to be 2083 ± 50 dm 
mor ' cm"' (compared to the literature, e = 2200 [9]) The 
first-order rate constants k„t,^ were evaluated from plots of 
log [permanganate] versus time The plots in all cases were 
linear up to 75% of the reaction (Fig 1), and fcobs values were 
reproducible at 526 nm, notwithstanding the increasing 
absorbance of Mn(VI) at 610 nm during the course of the 
reaction (Fig. 3). The effect of dis.solved oxygen on the rate 
of reaction was checked by following the reaction in nitrogen 
atmosphere No significant difference between the results 
obtained under nitrogen and in the presence of air was 
observed. In view of the all-pervading contamination of basic 
solutions by carbonate, the effect of carbonate on the reaction 
was also studied Added carbonate had no effect on the 
reaction rate Nevertheless, fresh solutions were used during 
the experiments Regression analysis of the experimental data 
to obtain the regression coefficient r and the standard devia-
tion 5 was performed using Microsoft Excel 2007 
Experimental 
All chemicals used were of analytical reagent grade, and 
double distilled water was used throughout the work. A 
solution of levofloxacin (Sigma-Aldrich) was prepared by 
dissolving a known amount of its hydrochloride salt in 
distilled water. The permanganate (Ranbaxy Fine Chem. 
Ltd, India) solution was prepared and standardized against 
oxalic acid by a standard procedure [27] Potassium man-
ganate .solution was prepared as described by Carrington 
and Symons [28]. KOH (Merck Ltd.) and KNO, (Merck 
Ltd.) were employed to maintain the pH and ionic strength, 
respectively. 
The absorption spectra were obtained with an Elico-SL-
169 double beam UV-vis spectrophotometer. All potenti-
ometnc measurements were carried out with an Elico-LI-
120 pH meter, and the products were analyzed using a 
Nicolet 5700-FT-IR spectrometer (Thermo, USA). 
Kinetic measurements and procedure 
The oxidation of LF by permanganate was followed under 
pseudo first-order conditions where LF was greater than 
manganese(VII) at 25 °C. The reaction was initiated by 
mixing thermally equilibrated solutions of Mn04~ and LF 
that also contained the required quantities of KOH and 
KNOi to maintain alkalinity and ionic strength, respec-
tively The reaction was monitored by the decrease in 
absorbance of MnO^" at its absorption maximum of 526 nm 
It was venfied that there is no interference from other 
reagents at this wavelength. Beer's Law was obeyed m this 
Results 
The reaction orders were determined using the slopes of 
log fcobs versus log (concentration) plots by varying the 
concentration of the reductant and 0H~ while keeping 
other factors constant. With fixed concentrations of LF, 
1.0 X lO""* mol dm~\ and alkali, 20 x 10"'' mol dm"\ 
at constant ionic strength, 0 10 mol dm"' the permanga-
nate concentration was varied in the range of 4 0 x 10"^ to 
6.0 X lO"** mol dm~' All kinetic runs exhibited identical 
characteristics The linearity of plots of log (absorbance) 
versus time, for different concentrations of permanganate, 
indicates that the order in Mn(VIl) is uniform (Fig. 1) This 
was also confirmed by the constant values of the pseudo 
first-order rate constants, <:„hs, for different Mn(VII) 
1.1 IS 
Time (mm) 
Fig. 1 First order plots of the oxidation ot levofloxacin by pemidn-
ganate in aqueous alkaline medium [LF] = 1 x I0~\ [OH") = 
2 X 10"' and / = 0 10/mol dm"' [MnOi'Jx 10" mol dm" ' = (A) 
0 4, (B) 0 8, (C) 1 0, (D) 2 0 and (E) 3 0 
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Table 1 Effects of (LF], [MnO, ] and (0H~] on the oxidation of 
levottoxacin by permanganate in aqueous alkaline medium at 25 °C 
and ionic strength /=0.10/mol dm" 
10" X [MnO^-] 10' X [LF] lO' x [OH"] Jtc.i x itf k^^ x 10* 
Table 2 FT-IR frequencies (cm' ' ) 
Compound i'(OH) i(C=0) 1,,,,,, (C(X)) is,,„(C(X)) 
mol dm mol dm" mol dm" ( S - l ) 
0.4 
0.8 
1.0 
2.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3,0 
3.0 
3.0 
0.4 
0.6 
0.8 
1.0 
4.0 
6.0 
3.0 
3.0 
3.0 
3.0 
3.0 
3.0 
2.0 
2.0 
2,0 
2,0 
2,0 
2,0 
2.0 
2.0 
2.0 
2.0 
2.0 
0,4 
0.8 
1,0 
2.0 
4.0 
6.0 
4.12 
4.12 
4.12 
4.12 
4.12 
3.67 
3.76 
3.12 
4,28 
5,38 
5.41 
2,19 
2,39 
2,84 
3,32 
3.61 
4.43 
4.10 
4.10 
4.10 
4.10 
4,10 
3.65 
3.74 
4.10 
4,25 
5.35 
5.40 
2.18 
2.38 
2.82 
3,30 
3.60 
4.41 
concentrations (Table 1). The LF concentration was varied 
in the range of 4.0 x 10~'* to 6.0 x 10"^ mol dm"'' at 
constant alkali and permanganate concentrations and con-
stant ionic strength of 0.10 mol dm"-* at 25 °C. The k^t,^ 
values increased with increase in LF over the concentration 
range shown in (Fig. 4). At low concentration of LF, the 
reaction was first order in LF and at high concentration of 
LF, the reaction was independent of LF. The effect of alkali 
on the reaction was studied at constant concentrations of 
LF and permanganate and a constant ionic strength of 
0.10 mol dm"-* at 25 "C. The alkali concentration was var-
ied in the range of 1.0 X 10~''tol.O X 10~^mol dm~\The 
rate constant increased with increa.se in alkali concentration 
(Fig. 5), indicating a fractional-order dependence of the rate 
on alkali concentration. 
Stoichiometry and product analysis 
Different reaction mixtures containing LF and an excess of 
Mn04" with constant OH~ and KNO3 concentration were 
kept in closed vessels under nitrogen atmosphere at room 
temperature. After 2 hours, the Mn(VII) concentration was 
Levofloxacin 3411 1722 1622 1462 
Oxidation Product 3305 1626 1586 1442 
assayed by measuring the absorbance at 526 nm. The 
results indicated a 1:2 stoichiometry, as given in Scheme 1. 
The main reaction products, Mn(VI) and 9-fluoro-2,3-
dihydro-3-methyl-5-hydroxy-l0-(4-methyl-l-piperazinyl)-
7-0X0-7H pyrido [ 1,2,3-de]-1,4-benzoxazine-6 carboxyiic 
acid, were isolated and identified with the help of TLC 
and characterized by FT-IR. The FT-IR spectra of LF 
and its complexes are similar. The (C=0) band appears at 
1,722 cm"' in the spectrum of LF; the complexes show this 
band at ca. 1,626 cm"', suggesting that the coordination of 
the ligand occurs through the carboxylate oxygen atom. A 
carboxylate ligand can bind to the metal atom as a mono-
dentate ligand, giving changes in the relative positions of 
the anti.symmetric and .symmetric stretching vibrations with 
the aim of deducing the coordination mode (29, 30], The 
FT-IR spectra of the complex (Table 2) give a separation 
>I(X)cm~', suggesting monodentate bonding for the car-
boxylate group. 
Effects of ionic strength, dielectric constant 
and temperature 
The effect of ionic strength was .studied by varying the 
potassium nitrate concentration from 0.01 toO.IO mol dm"-* 
at constant concentrations of permanganate, LFand alkali. 
Increasing ionic strength had no effect on the rate constant. 
The effect of the dielectric constant (D) was studied by 
varying the /-butanol-water content (v/v) in the reaction 
mixture with all other conditions held con.stant. The rate of 
reaction increa.ses with increasing /-butanol volume. The 
plot of log *„hs versus l/D was linear with positive slope 
(Fig. 2). 
The kinetics was also studied at four different temper-
atures with varying concentrations of LF and alkali, 
keeping other conditions constant. The rate constants were 
found to increase with increase in temperature. The rate of 
the slow step was obtained from the slopes and intercepts 
of l/*obs versus 1/[LF] and 1/^ ob,, versus 1/[0H~] plots at 
four different temperatures (25-37 °C). The activation 
energy corresponding to these rate constants was evaluated 
Scheme 1 Formation of 
hydroxylated LF and Mn(Vl) 
' V 
J 
OH 
2:.,.\ + 2 MnO/ + 2 OH' f 0 . 
O O 
OH 
- - ' • • • - • - ^ X Q ^ + :Mn04^+H20 
\ 
•Q Springer 
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1/DlO-
Fig. 2 Effect of dielectric constant on the oxidation of levofloxacin 
by alkaline Mn04" at 25 °C 
from the Arrhenius plot of log k versus l/T from which 
other activation parameters were also obtained (Table 3). 
Test for free radicals 
400 45U 500 550 600 
Wa\elencth dim) 
650 700 
Fig. 3 Spectral changes during the oxidation of levotloxacm (LF) by 
MnOj" in alkaline medium at 25 ='C (MnOj"! = I x 10"", 
(LFJ = I X 1 0 ' \ (0H"1 = 2 X 10"' and / = 0 lO/mol dm" ' 
To test for the involvement of free radicals, acrylonitrile 
was added to the reaction mixture, which was then kept for 
Table 3 Activation and thermodynamic parameters for the oxidation 
of LF by alkaline permanganate with respect to the slow step of the 
reaction Scheme 2 
Temperature(K) IO-\ (S-') 
Effect of Temperature with respect to the slow step of Scheme 2. 
293 10.6 
298 11.8 
303 12.2 
310 13.5 
Value 
Activation parameter 
Ea (kJmole"') 
AH (kJmole"') 
AS ± (Jk"'mole' ') 
AG ±(kJmole- ') 
149 
11.9 
-143.2 
63.10 
Effect of temperature (K) lO'^ ATj (dm"^  mol~') lO~'^Ki (dm^ mol"') 
EquUibrium constants Ki and K2 at different temperatures 
293 5.44 6.17 
298 7.59 6.69 
303 9.62 5.32 
310 12.43 4.34 
Thermodynamic parameters 
AH (kJmole"') 
AS ± (Jk-'mole'') 
AC ± (kJmole"') 
K, values 
58.1 
123 5 
- 8 7 
K2 values 
-78.6 
-89 7 
-8.35 
24 h under nitrogen. Addition of methanol, resulted in the 
precipitation of a polymer, suggesting the involvement of 
free radicals in the reaction. The blank experiment of 
reacting either permanganate and LF alone with acryloni-
trile did not induce polymerization under the same condi-
tions. Initially added acrylonitrile decreased the rate of 
reaction [3\]. 
Discussion 
Under our experimental conditions at pH > 12, the 
reduction product of Mn(VTI), i.e., Mn(VI), is stable, 
and no further reduction is initially observed [10]. 
However, on prolonged standing, the green Mn(VI) is 
reduced to Mn(IV) under our experimental conditions. 
Permanganate ion in alkaline medium exhibits various 
oxidation states, such as Mn(VII), Mn(V) and Mn(VI). 
During this reaction, color changes from violet Mn(VII) 
to dark green Mn(VI) through blue Mn(IV) were 
observed. It is clear from Fig. i that the concentration of 
Mn04~ decreases at 526 nm, while increases at 610 and 
460 nm are due to Mn(VI). As the reaction proceeds, a 
yellow turbidity slowly develops, and after keeping for a 
long time the solution decolourises and forms a brown 
precipitate. This suggests that the initial products might 
have undergone further oxidation resulting in a lower 
oxidation state of manganese. It appears that the alkali 
combines with permanganate to give [Mn04 0H]^~ [32, 
33]. In the .second step, [Mn040H]-" combines with 
levofloxacin to form an intermediate complex. The var-
iable order with respect to LF mo.st probably results 
£1 Springer 
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from the complex formation between oxidant and LF 
prior to the slow step A plot of l/<:„hv versus 1/[LF] 
(Fig 1) shows an intercept in agreement with complex 
formation Further evidence for complex formation was 
obtained from the UV-vis spectra of reaction mixtures 
Two isosbestic points were observed for this reaction 
(Fig 3), mdicatmg the presence of an equilibnum before 
the slow step of the mechanism [34, 35] In our pro-
posed mechanism, in the complex one electron is 
transferred from levofloxacin to Mn(VII) The cleavage 
of this complex (C) is assigned as the slowest step, 
leading to the formation of an LF radical intermediate 
and Mn(Vl) The radical intermediate reacts with 
another Mn(VII) species, [MnOa 0H]^~, to give the final 
products, Mn(VI) and the alcohol (Scheme 2) The effect 
of the ionic strength and dielectric constant on the rate 
IS consistent with the involvement of a neutral molecule 
in the reaction The suggested structure of complex (C) 
IS given in Scheme 2 
From Scheme 2, the rate law (Eq 7) can be derived as 
follows 
Rate dt kK|K3 fMn07j,[LF],[OH- IO 
[Mn04],= [MnO;], + [Mn04 OH]2" + [Complex] 
= iMnO-],+ [MnO-]lOH-l 
+ kK|K2[MnO<,] [LF] [OH [ 
[MnO,-],= [MnO;],(H- K,[OH-]+ KiK^lLF] [OH"]) 
[Mn04], [MnO,-],= 1 + K|[0H-1+ K|K2[LF][0H-
(2) 
where "t" and "f' stand for total and free Similarly, total 
[0H~] can be calculated as 
[0H-], = [0H"1,+ [Mn04 OH]^" + [Complex] 
(OH-jt (3) [OH- i + K| [MnO;] + K|K2[LF1 [MnO^ ' 
In view of the low concentrations of MnOa and 
levofloxacin used in the experiment, in Eq ^ the terms 
/f|[Mn04-] and KtK2[Mn04~] [LF] are neglected Thus, 
[OH-],- [OH-j, (4) 
The total [Mn04 ] can be written as 
Similarly, 
[LF).= |LF), 
Substituting Eq 2 4, and "i in Eq 1 we get 
(5) 
Scheme 2 Proposed 
mechanism for the oxidation of 
levofloxacin by alkaline MnOJ 
M n 0 4 + 0 H I M n O i O m ^ 
Complex (C) 
IMnOjOHj^ -
Slow 
Mn 
#-11 \ 
U °~A 
MnOj ' . H , 0 
• IMnO^OHp-
• M n O j ^ -
^ Springer 
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+ K|K2[LF](0H-
Rate 
[MnO -^] — Knbs — 
+ K|K2[LF][0H-
kK|K2[LF] [OH-
1+K,10H-J + K'K-[LF1[0H-
(6) 
(7) 
Equation 7 is consistent with the observed orders with 
respect to different species, which can be verified by 
rearranging to Eq. 8. 
1 1 
+ : 
1 1 
Kobs k K,K2[LF)[0H-] K.KzlLF] K (8) 
According to Eq. (8), other conditions being constant, 
plots of l/^ ob, versus 1/[LF] and l//tobs versus 1/[0H~] 
should be linear (Figs. 4 and 5). The slopes and intercepts 
of such plots lead to the values of ^ i , K2 and k (Table 3). 
With these values, the rate constants were calculated under 
different experimental conditions, and there is a reasonable 
agreement between the calculated and experimental 
values [36] (Table 1). The thermodynamic quantities for 
the first and second equilibrium steps of Scheme 2 can be 
evaluated. The [LF] and [0H~] (as in Table )) were varied 
at four different temperatures. Van't Hoff s plots of logATi 
versus 1/7 and \0gK2 versus I/T gave the values of 
enthalpy of reaction AH*, entropy of reaction AS* and free 
energy of reaction AG, calculated for the first, and second 
Fig. 4 Plots of l/A„hs versus l/(LF] at four different temperatures 
0.2 0.3 0.4 
1/fOHl 10'(dm'mole') 
0.S 0.6 
Fig. 5 Plots of \lk^ versus 1/[0H ] at four different temperatures 
equilibrium steps (Table 3). A comparison of the latter 
values (from ^^ 2) with those obtained for the slow step of 
the reaction shows that they mainly refer to the rate-
limiting .step, supporting the fact that the reaciion before 
the rate determinmg step is fairly fast and involves low 
activation energy [37, 38]. The moderate values of AH* 
and AS* were both favorable for electron transfer pro-
cesses. The value of AS* that is within the expected range 
for radical reactions has been ascribed to the nature of 
electron pairing and unpairing processes and the loss of 
degrees of freedom formerly available to the reactants upon 
the formation of a rigid transition state [39]. The negative 
value of AS* indicates that complex (C) is more ordered 
than the reactants [40,41 ]. The enthalpy of activation and a 
relatively low value of the entropy and a higher rate 
constant of the slow step indicate that the oxidation most 
probably occurs via inner-sphere mechanism [42, 43]. 
Conclusion 
It is noteworthy that the oxidant species [Mn04"] required 
the pH 12, below which the system gets disturbed and the 
reaction proceeds further to give a more reduced of Mn(IV) 
product, which slowly develops yellow turbidity. In this 
reaction, the role of pH is crucial. The rate constant of the 
slowest step and other equilibrium constants involved in 
the mechanism were evaluated and activation parameters 
with respect to the slowest step were computed. The pro-
posed mechanism is consistent with product, mechanistic 
and kinetic studies. 
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Abstract: Kinetics and mechanism of substitution of cyanide ion in 
hexacyanoferrate(II) by EDTA catalysed by mercury(II) has been studied 
spectrophotometrically at 365 nm in potassium hydrogen phthalate buffer of pH 
= 5.0 and ionic strength, I = 0.1 M, maintained by (KNO3) at 25 °C. Effect of the 
pH and concentration of the EDTA, [Fe(CN)*'6] on the rate of reaction has been 
studied. The kinetics and mechanism of the reaction has been shown through 
dissociative mechanism. The mechanism of ligand substitution in the complex 
together with the kinetic data has been shown. The catalytic activity of 
mercury(II) has also been studied as a function of its concentration. The 
maximum reaction product was detected at pH = 5 after which a decline in 
absorption occurs followed by precipitation. It is an inexpensive method to 
identify and remove the cyanide ion in solution even in very low concentration of 
the order of 10"''M. 
Keyword: Kinetics, Hexacyanoferrate(n), EDTA, Mercury(II), Thermodynamics, Mechanism. 
Introduction 
It has been demonstrated that of all the heavy metals mercury(II) easily forms bonds to 
cyanide and slowly removes it from hexacyanoferrate(II). Kinetics and mechanism of ligand 
replacement in low spin Fe(II) complex has been done, although it is limited to the study of 
pentacyano(L)ferrate(II) complex'' . Few studies have been done in aqueous electrolyte and 
micellar media to acquire an in depth knowledge of the mechanistic scheme^" .^ The 
oxidation kinetics of the hexacyanoferrate(II) complex by various reagents in acidic and 
basic media have been studied and all these investigation have been applied to specific 
analytical problems'""'^. K4[Fe(CN)6''"] hardly undergoes exchange reaction as CN itself is a 
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very strong ligand although slow exchange of labelled CN" group or aminopyridine has been 
demonstrated. Under UV light reversible aquation occurs leading to the formation'-* of 
[Fe(CN)5H20]^". However, only mono substituted [Fe(CN)5L]-'" have been obtained either 
through photochemical or by dissociation reaction or by metal catalysed substitution reaction . 
[Fe(CN)f,''-] + H2O >• [Fe(CN)5H20]'+CN- (1) 
Hexacyanoferrate(II) reacts with EDTA according to the following equation 
[Fe(CN)5H20]^- + EDTA *- [ Fe(CN)5EDTA]'- + H.O (2) 
CN +H2O >• HCN + OH (3) 
Mercury(II) readily forms complex with cyanide ion but decomposition occurs in UV 
light. 
Hg^* + [Fe(CN)6'"] + H2O • [Fe(CN)5H20]'" + HgCN' (4) 
HgCN* H^ *^  HCN + Hg^* (5) 
In the present work, we have studied the kinetics of substitution of CN by EDTA, 
catalysed by Hg** A probable mechanism of the reaction has been proposed. Any attempt to 
study the substitution of CN" by phenanthroline, pyridine, hydrazine and piperazine resulted 
in precipitation even in low concentration. 
Experimental 
Double distilled, de-ionized water was used throughout. The chemicals used were of analytical 
grade. Stock solutions of the compounds were wrapped with carbon paper to protect them from 
photodecomposition. The mercury(II) and hexacyanoferrate(Il) solutions were diluted just 
before use. The desired pH= 5 of the reaction mixture was maintained by adding KHP-NaOH 
buffer'^ . The ionic strength was maintained at O.I M by adding appropriate amount of KNO3 
Apparatus 
The absorption spectra were obtained with double beam UV-vis spectrophotometer (Elico-
SL-169). pH-metric measurements were done with Elico-LI 120 pH meter. 
Procedure 
All the solutions were thermally equilibrated for about 30 minutes at 25 °C and 2.0 mL of 
each EDTA, phthalate buffer of pH = 5.0 and mercury(II) chloride were mixed in a flask 
and left for 10 min to ensure complete reaction. Finally, 2.0 mL of [FeCCN)^ ]'^  was added to 
this mixture and the wavelength of maximum absorption (365 nm) was determined (Figure 1). 
Effect of pH 
The reaction was studied first by fixed time kinetic method in the pH ranges 1-13. Figure 2 shows 
plots of absorbance (measured at t =5 and 10 minutes after mixing the reagents) versus pH of the 
reaction mixture. It was found that, with increasing pH the absorbance increases and attains 
a maximum between pH 5.0 to 5.5. However, above this pH the absorption decreases which 
is due to the deficiency of protons. The rate is reduced at low pH value due to the formation 
of various protonated forms of [Fe(CN)6]''" which are less reactive than [Fe(CN)f,''] itself'^ . 
Effect of EDTA 
The complex formation with EDTA is influenced by a change in the pH of solution which is 
perhaps due to ionization of the metal complex at low pH and hydrolysis of the metal ion at 
higher pH. The effect of EDTA was examined as a function of its concentration at a fixed 
Spectroscopic and Substitution Kinetic Studies S105 
pH 5. A plot of initial rate versus EDTA is shown in Figure 3. Almost constant rate was 
obtained in the concentration range 2xJ0'^ to 7x10"^ M and finally decrease at still higher 
concentrations. A fixed concentration 4x 10"'* M was thus selected as optimum. 
1.5 
< 
0.5 -
200 300 400 
Wavelenth 
500 
Figure 1. Absorption spectra of reactants and products: (A) [EDTA] = IXIO"^ ; (B) [Fe(CN)5]^ 
= 5X10^M (C) [Fe(CN)6]'' = 4X10"*M, [EDTA] = 4X10"' M, [Hg^l = 3X10"^  M and pH = 5.0 
< 
1 6 
pH 
11 16 
Figure 2. Effect of pH on Hg^* catalysed substitution of CN" in hexacyanoferrate(II) by 
EDTA ion at [Fe(CN)6''"] = 5X10"' M, EDTA = SXlO"^  M, [Hg^l = 3X10"^  M, Temp = 25 °C 
andI = 0.1M(KNO3). 
10 
9 
03 
X 
> 
20 10 15 
[EDTA], M 
Figure 3. Effect of EDTA on initial rate at [Fe(CN)6^"] = 3.5X10"^ M, [Hg^l = 3x10"' M, 
pH = 5, Temp =25 °C and I = 0.1 M (KNO3) 
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Effect oflFe(CN)f,f on the initial rate 
Dependence in [Fe(CN)(,'*] was found, changing from first order at lower concentration to 
higher concentration not zeroth order, Keeping all parameters constant, effect of the 
concentration of [Fe(CN)6'*"] on the reaction rate was studied in the concentration range 
5x 10""* to 2x 10"^  M, Figure 4.A variable order. 
0 1 
CM CM CM 
-log[Fe (CN)6] 
Figure 4. Dependence of the initial rate on [Fe(CN)6'''] in presence of [Hg"^ *] at [EDTA] 
3X10"M, [Hg^l = 3x10-^ M, pH 5.0, temp = 25 "C and 0.2 M (KNO3). 
Effect of[Hg^*] on initial rate 
The concentration of mercury(Il) was kept between IxiO"' to 2X10"'M and those of the 
[Fe(CN)6'*"] and EDTA were kept constant. The pH and temperature were maintained at 5 
and 25 "C respectively. The results are shown in Figure 5. The large variation in [Hg'*] was 
selected in order to test the linearity between initial rate and [Hg'*] for its analytical 
application and also the changing role in [Hg"*] mixture. A plot of the absorbance measured 
after an interval of one min versus [Hg^*] as a function of pH is given in Figure 5. 
1.25 
21 26 11 16 
[HgO^I, M 
Figure 5. Dependence of the initial rate of substitution of CN' in [FeCCN)^ '' ] by EDTA on 
[HgCb] at [Fe(CN)/-] =3.5x10' M, [EDTA] = 3x10' M, pH = 5, temp = 25 "C and I = 
0.1 M(KNO:,). 
It clearly indicates that the rate increases linearly until the ratio of the [Fe(CN)(,'* ] and [Hg^ *] 
reaches 1:1 .When the concentration of [Hg^T exceeds that of [Fe(CN)6''"] the absorption begins to 
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decrease and follows a non-linear pattern. The intercept computed from the initial linear 
portion of the Figure 5 provides the rate due to the uncatalyzed path. However, decline in the 
rate of reaction at higher [Hg^*] is probably due to the formation of a binary adduct, 
[Fe(CN)6*'. HgCla]. In a separate experiment it was observed that a white precipitate is 
formed immediately after mixing [Fe(CN)6*] with [Hg^*] in 1:2 molar ratio which rapidly 
turned blue, confirming the formation of a binuclear complex. A similar observation has also 
been made by Beck'^. 
Effect of temperature and ionic strength 
The rate of the [Hg"*] catalyzed ligand exchange between [Fe(CN)6'' ] and EDTA was 
studied as a function of temperature in range 20-30 "C. The higher temperature was 
avoided due to the possibility of decomposition of [Fe(CN)5EDTA]-'. The Arrhenius 
equation was used to determine the activation energy (Ea) for the catalyzed reaction and 
the other activation parameters, viz. enthalpy of activation (AH'*) and entropy of activation 
(AS*) were calculated using Eyring equation. The values of activation parameters are 
found to be Ea = 78.2 kJ mol' , AS* = -48.67 JK"' mole"' and AH* = -52.5 kJ mole'.The 
effect of ionic strength on the initial rate of reaction was also studied employing (KNO3) 
for maintaining ionic strength in the 0.015 to 0.2 M range. The higher ionic strength was 
avoided due to the limited solubility of (KNO3). When KCl was used to maintain the ionic 
strength the rate was found to decrease considerably. This is probably due to a subsequent 
decrease in [Hg^*] or [HgCr] along with the concentration of an ion-pair formation 
between [Fe(CN)6''] and [Hg^l'*. 
Results and Discussion 
The following Scheme for the mercury(II) catalyzed ligand exchange between [Fe(CN)6'' ] 
and EDTA has been proposed: 
[Fe(CM)6l ' ' "+Hg^* + H z O - * ^ 2*N *^ [Fe(CN)6'- (Hg^^) ( H 2 O ) ] (6) 
uncataly I, X N H g (CN)sFe : ' 
J = ^ 
-HgCN kj (slow) 
3-[Fe(CN)sH20 ] 
-H2O 
Fast 
+EDTA 
K3 .-
[Fe(CN)5EDTA] 
(7) 
(8) 
(9) 
(10) 
HgCN* + H \ Hg2* + H C N ( I I ) 
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Formation of the complex, [Fe(CN)5EDTA]^' through the catalyzed path can be written as: 
d [ Fe(CN)5EDTA]^ 
dt K2 [A^] 
(12) 
While, that for the uncatalyzed path the 
rate = k'[Fe(CN)6*] (13) 
where, k' is a composite rate constant involving a concentration term. If the rate 
determining step is taken to be the composition of the activated complex (A"*), the activity of 
the mercury(II) at low concentration can be easily explained by the above mechanism. The 
overall rate for uncatalyzed reaction can be expressed through equation (13) using a non 
limiting concentration of EDTA. 
Rate = 
d [Fe(CN)5EDTA]' 
dt 
= k'[Fe(CN),'-] + k^ K [Fe(CN),^-][Hg-1[H2Q] 
l+K[Fe(CN),'] 
:i4) 
The second term in the above equation refers to the rate of the catalyzed reaction and 
explains the variable order dependence in [Fe(CN)f,'' ]. K is defined as the equilibrium 
constant for the association of the mercury (II) with water and [Fe(CN)6''"]. Since water is in 
a large excess, the equation (14) is reduced to equation (15) 
Rate = k'[Fe(CN)6'-] + k'2K[Hg'l[Fe(CN)6''] (15) 
Now equation (15) yields the observed rate constant (kobs) as expressed by equation (16) 
k„bs = k'+k'2K[Hg'l (16) 
where, k'2 = k2+ [H2O]. 
A plot of the initial rate versus [Hg"*] at low [Fe(CN)6^"] is given in Figure 6. In case of 
higher [Fe(CN)6'*"], equation (14) takes the form of equation (17). 
Rate = k' [Fe(CN)6'] + k2'[Hg-1 (17) 
15 n 
13-
O) 
T5 
10 
Hg2^ 
Figure 6. [Fe(CN)6^] = 8x10^ M, [EDTA] = 5X10^ ^ M, pH = 5, temp. = 25 °C, I = 0.1 M (KNO3). 
The value of the initial rate (V|) as a function of [Hg^*] at low [Fe(CN)6''"] is listed in 
Table 1. The value of the k' and k2' have been calculated from the plot Figure 6 of initial rate 
versus [Hg^"] using equation (17) at specified experimental condition. The rate constant k' and 
k2 are found to be 4.17x10'^ s"' and 2.50 s ' respectively, at I = 0.1 M, pH = 5, temp = 25 "C 
.The value of k|' and k2S0 obtained are substituted in equation (17) to evaluate the equilibrium 
constant K at various [Hg^*] at low [Fe(CN)6''"]. The K (Table 1) and the average value of 
log K (2.80) in our case is comparable with that reported by Beck for |Fe(CN)6'' . Hg(CN)2] 
complex (logK = 2.38)' . Although the values of k2 have been calculated employing high 
[Fe(CN)6'^ ] using equation (17) it can be obtained even at low fFe(CN)(,''"] using equation (18) 
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Table 1. Calculation of K by varying [Hg^*] at constant [Fe(CN)6^]. [Fe(CN)6* ] = 8x 10^ M, 
[Hg^l = 5X10*- M, pH = 5, temp= 25 "C and I = 0.1 M (KNO3), 
[Hgh X 10 ^ M Vi X 10"* K(calcd.) 
2 
4 
6 
8 
10 
3.5 
5.9 
7.9 
10.6 
12.6 
Average log K = 2.80 
k,- Rate-k'rFefCNk"! 
709.07 
660.02 
610.60 
625.80 
601.80 
(18) 
K[Fe(CN)6'l [Hg-1 [H^O] 
However, the values calculated from this equation are almost identical. The ionic 
behavior of [Hg"*] may be represented by the following reactions. 
Hg2* + Ci ^ = ^ HgCr (19) 
HgCI * + Cr ^ ^ : ^ HgCIa (20) 
It has been shown that when Hg(N03)2 reacts with [Fe(CN)6''] in solution the resultant 
was Hg2[Fe(CN)6''"]'^ , which has also been verified from the absorption spectra of both the 
reacting components and the eventual product. This is quite obvious because the [Hg"*] is 
more electropositive than K* ion. The activation energy calculated for this reaction is a little 
less than the reported values in the literature^^'^' for the replacement of CN" in nearly similar 
reaction systems. The entropy of activation is negative and is expected if the virtual 
solvations of the activated complex and its highly charged dissociation products are 
considered. Thus, the activation parameters provide further support to the proposed 
mechanism. 
Conclusion 
In the present work we have studied the kinetics of substitution of CN' by EDTA catalyzed 
with [Hg^*]. A probable mechanism of the reaction has been proposed. The results presented 
here clearly demonstrate work, EDTA as a chelating agent was used for the neutralization of 
CN" in complex formation which is more effective and inexpensive. The values of 
thermodynamic parameters for complex formation are found to be Ea = 78.2 kJ mol"', AS*" = 
-48.67 JK"' mole"' and AH^ = -52.5 kJ mole"'. The negative value of shows the exothermic 
nature of reaction. 
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